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1.1 General Introduction 
 
Infertility is a major issue in both human and animal medicine with a great 
economic impact on reproduction. In order to better understand the common causes 
of infertility it is necessary to understand the basic physiology underlying the 
complex process of folliculogenesis and luteogenesis (Campbell et al., 2003).  
The lack of extensive understanding of the factors involved in regulating 
follicular and oocyte maturation has resulted in the slow process of developing in 
vitro systems for the study of folliculogenesis (Campbell et al., 2004). However, 
domestic ruminants represent a valuable in vivo model system for the study of the 
endocrine and local mechanisms regulating follicular development not only in 
ruminants but also in humans (Campbell et al., 2003) and have thus been extensively 
used in reproduction research. 
Improved understanding of the basic cellular mechanisms of ovarian physiology 
may improve biotechnology strategies in livestock reproduction and enhance fertility 
protocols for endangered species. Similarly, a better understanding of these 
reproductive processes could lead to innovative strategies to improve reproductive 
health in women (McLaughlin and McIver, 2009, Stellflug et al., 1997, Campbell et 
al., 2003, Skinner, 2005). 
 
1.2 Endocrine control of the oestrous cycle in sheep 
 
1.2.1 Seasonality of the breeding season 
 
Seasonal reproduction is most evident in wild species as domestication and 
artificial selection have, over the centuries, contributed to minimize the effects of 
season on reproductive activity. Seasonal breeders rely on environmental cues to 
synchronize their fertile period. Photoperiod is the most common synchronizing 
agent and entrains the endogenous rhythm of reproductive activity as it shows 
minimum variation through the years as opposed to temperature and food availability 
(Rosa and Bryant, 2003). Species that rely on photoperiod to synchronize their 




sheep are considered short-day breeders and become sexually active in response to 
decreasing day length in late summer to early autumn (Rosa and Bryant, 2003, 
Thiery et al., 1995, Stellflug et al., 1997). 
Sheep breeds originating from temperate climate in mid or high latitudes (greater 
than 35°) are seasonal breeders. On the other hand, in tropical and sub-tropical 
environments (between 35° North and 35° South) ewes are either completely 
aseasonal or intermittently polyoestrus. While the breeding season of these animals 
can still be initiated by declining day length, food quality and availability play a 
much more important role in regulating breeding activity than photoperiod. In 
general, the higher the latitude the greater the photodependence and the more 
restricted the period of breeding activity. British sheep breeds demonstrate a distinct 
seasonality with long anoestrous periods, while Mediterranean breeds are 
comparatively less seasonal (Rosa and Bryant, 2003). 
Photic stimuli (light) is received by the retinal photoreceptors and transmitted to 
the suprachiasmatic nuclei of the hypothalamus which regulates the endogenous 
circadian rhythm. The message is then transmitted to the pineal gland which converts 
the neural information into a hormonal signal in the form of melatonin. Melatonin is 
secreted following a circadian rhythm with significant secretion occurring only in the 
absence of daylight (Rosa and Bryant, 2003, Stellflug et al., 1997, Thiery et al., 
1995). Melatonin influences the onset of the breeding season by decreasing the 
sensitivity of the hypothalamus to oestrogen negative feedback and increasing the 
pulse frequency of hypothalamic gonadotrophin releasing hormone (GnRH), re-
establishing regular cyclicity (Stellflug et al., 1997, Thiery et al., 1995, Moenter et 
al., 1992, Rosa and Bryant, 2003). 
 




Gonadotrophin releasing hormone (GnRH), a decapeptide produced and released 
by the hypothalamus, is responsible for the majority of the endocrine events that 




hypophyseal gonadotrophin release and consequent follicular development and 
ovulation. A variation in the frequency and amplitude of GnRH pulses alters 
gonadotrophin secretion by the hypophysis (Thiery et al., 1995, Stellflug et al., 1997, 
Caldani et al., 1995, Caraty et al., 1995, Stabenfeldt and Edquist, 1996, Tilbrook and 
Clarke, 1995). As follicular development progresses and oestrogen secretion by the 
dominant follicle increases, there is a reduction in GnRH pulse amplitude and an 
increase in its frequency before the GnRH surge that causes the onset of the pre-




 The gonadotrophins, produced by the adenohypophysis, are the follicular 
stimulating hormone (FSH) and the luteinizing hormone (LH). FSH is responsible 
for the earlier stages of growth and development of follicles while LH is mainly 
responsible for the final maturation of the follicle and causes the rupture of follicular 
wall and ovulation with consequent formation of a corpus luteum (CL). An important 
synergism exists between the two gonadotrophins. Follicles must be properly 
developed by FSH before LH induced ovulation can occur. An increase in oestrogen 
secretion and GnRH pulse frequency leads to the ovulatory LH surge. At this time 
the constant exposure of the hypophysis to elevated GnRH causes a decrease in its 
responsiveness to the decapeptide resulting in the termination of the pre-ovulatory 




During follicular development, the theca layer produces androgens which are 
converted by the granulosa cells of the growing follicle into oestrogen (17β-estradiol) 
(Driancourt, 2001). There is a significant seasonal variation in the responsiveness of 
the hypothalamic-hypophysis axis to the negative feedback action of oestrogen on 
LH secretion in sheep, which appears to be mainly dictated by the photoperiod 
(Webster and Haresign, 1983, Hansel and McEntee, 1977, Herbison, 1995). There 




(1) short-term negative feedback, (2) long-term negative feedback and (3) transient 
positive feedback. The positive feedback occurs in response to the rising levels of 
oestrogen during the follicular phase of the oestrous cycle  while the low levels of 
oestrogen observed during the luteal phase and anoestrus result in the short and long-
term suppression of GnRH and gonadotrophin release (Clarke et al., 2009). This 
negative feedback control on tonic LH secretion results from the combined action of 
oestrogen and progesterone during the breeding season, however during seasonal 
anoestrus, a marked change of hypothalamic responsiveness to oestradiol alone can 
be observed (Webster and Haresign, 1983). Oestrogen is also responsible for 
oestrous behaviour in all species including sheep, however, small amounts of 
progesterone priming are necessary for the induction of oestrus in sheep during the 
first reproductive cycle of the breeding season (Hansel and McEntee, 1977, 
Herbison, 1995, Stellflug et al., 1997, Legan et al., 1985).  
 The main developing follicle is also responsible for the production of inhibin. 
Inhibin is a glycoprotein hormone which inhibits the production and secretion by the 
pituitary gland of the gonadotrophins, especially FSH. Inhibin is a major selective 
feedback regulator of the secretion of FSH and its actions occur at the levels of the 
pituitary gland and not on the synthesis or secretion of GnRH (Stabenfeldt and 
Edquist, 1996). 
An illustrative diagram of the hormonal interactions that occur during the 






Figure 1. A diagrammatic representation of the hormonal interaction taking place 




1.2.3 Hormone interaction during anoestrus 
 
During seasonal anoestrus, LH continues to be released but with lower frequency 
than during the follicular phase of the cycle during the breeding season (Rosa and 
Bryant, 2003). Progesterone levels remain virtually undetectable while FSH 
concentrations do not seem to vary from those found during the breeding season 
(Rosa and Bryant, 2003). Although progesterone levels are low and no 
gonadotrophin surge occurs, neither the ovary nor the hypothalamus are inactive 
(Rosa and Bryant, 2003). Follicular development does not stop, follicular growth and 
regression are taking place and mature follicles are present. These follicles are 
responsive to gonadotrophins and capable of ovulating if induced by GnRH or LH 
(Rosa and Bryant, 2003). The LH pulse system, although active, is compromised as 






































anoestrus are capable of producing oestrogen which now has greater ability to 
suppress LH release. Therefore, growth of the dominant follicle can not be 
maintained for a long enough period to increase oestrogen concentrations and thus 
exert positive feed-back on the hypothalamus-hypophysis axis and induce a pre-
ovulatory LH surge (Rosa and Bryant, 2003). The negative feedback of oestrogen on 
LH secretion is brought about via a change in the pattern of melatonin secretion 
which is associated with a reduction in GnRH pulse secretion rather than a reduction 
of pituitary response to GnRH. As sheep GnRH neurons do not express steroid 
hormone receptors, it has been suggested that the response to oestrogen feedback that 
leads to anoestrus involves afferents to GnRH neurons which have the potential to 
receive and transmit steroidal feedback signals (Rosa and Bryant, 2003). Kisspeptin 
cells posses oestrogen receptors and provide direct synaptic output to GnRH neurons 
stimulating GnRH release. Furthermore, positive feedback of oestrogen on GnRH 
release is associated with increased kisspeptin gene (Kiss1) expression while the 
negative feedback of oestrogen is associated with reduced Kiss1 and kisspeptin levels 
(Clarke et al., 2009).  
At the end of anoestrus, with a change in the pattern of melatonin secretion, 
responsiveness to oestrogen negative feedback diminishes increasing GnRH pulse 
secretion and therefore LH pulses. As follicles undergo further development in the 
presence of increased LH, oestrogen production is enhanced leading to the induction 
of the first pre-ovulatory LH surge and re-establishment of cyclicity (Rosa and 
Bryant, 2003). Absence of ovulation during seasonal anoestrus is thought to be due 
to reduced frequency of LH pulses (Wallace et al., 1986, McNatty et al., 1984, 
McLeod et al., 1982a). 
The transition from anoestrus to reproductive activity is gradual with the 
occurrence of an initial short cycle as the first CL regresses prematurely 5-6 days 
after its formation. It is only after the 1
st
 ovarian cycle that behavioural oestrus is 








1.3 Follicular growth and development 
 
Although differences exist between ruminant species, general follicular dynamics 
are very similar. Follicles grow in a wave-like fashion with periodic FSH surges 
being associated with follicular wave development. Dominant follicle selection 
involves a decline in FSH and acquisition of LH responsiveness. Periodic 
anovulatory follicular waves continue to emerge until the occurrence of a LH surge 
during the follicular phase of the oestrous cycle which leads to ovulation (Adams, 
1999). 
 
1.3.1 Stages of follicular development 
 
Folliculogenesis begins with the recruitment of pre-granulosa cells to form the 
primordial follicles in the foetus and neonatal ovary of mammals (McLaughlin and 
McIver, 2009). Follicular development involves a gonadotrophin independent 
(primordial follicles) and a gonadotrophin dependent (primary, secondary and 
tertiary follicles) phase before the follicle is ready for ovulation (Figure 2). 
 
Figure 2. Diagram illustrating follicular development and corpus luteum formation 
in the sheep during the breeding season. 
Gonadotrophin independent 
(primordial follicle) 
Gonadotrophin dependent  
(2 mm) 
 
Appearance of LH receptors in 









1.3.1.1 Gonadotrophin independent phase 
 
During the gonadotrophin independent phase of follicular development the 
oocyte increases in size and activity and the follicular cells which initially formed 
around the oocyte begin to grow and divide, transforming into granulosa cells 
(Stabenfeldt and Edquist, 1996). The first follicles form when primary oocytes are 
enveloped by a single layer of flattened granulosa cells and are denominated 
primordial follicles (Fortune, 2003, Stevens and Lowe, 1993) 
The primary determinant of reproductive performance in female mammals is the 
size and longevity of the primordial follicle pool (McLaughlin and McIver, 2009). It 
has been widely accepted that an animal is born with a finite primordial follicle 
population. However, some data have been generated that support the belief that 
post-natal oogenesis can occur in mice (McLaughlin and McIver, 2009). So far it has 
not been proved that these newly formed follicles can contribute to the pool of 
ovulated oocytes but it is thought that they may play a role in providing support for 
the depleted ovarian reserve (McLaughlin and McIver, 2009, Lee et al., 2007). 
 It has been reported that in humans and most domestic animals the first 
primordial follicles can be detected as early as mid-gestation but only after 2 to 4 
days post-birth in rodents, and that specific factors expressed by the oocyte regulate 
primordial follicle formation (McLaughlin and McIver, 2009, Fortune, 2003). 
Up to now, many aspects of primordial follicle population dynamics remain 
unanswered. From the pool of primordial follicles packed in the ovarian cortex some 
grow to develop into primary, secondary and antral follicles whilst others remain 
quiescent (Stevens and Lowe, 1993). The “production line” hypothesis suggests that 
the first oocytes to enter meiotic arrest during embryonic gonad development are the 
first oocytes to activate in adult life. This hypothesis is based on the belief that 
oocytes produced in late mammalian life are more likely to be chromosomally 
imbalanced and thus dysfunctional. This hypothesis is supported by studies that 
found that oocytes close to the corticomedulary junction are amongst the first to 
activate whereas oocytes located further within the cortex activate later in life. This 
hypothesis that follicles do not activate and mature randomly has been contested by 




activate simultaneously and thus it is suggested that initiation of primordial follicle 
growth was subject to extreme factors (McLaughlin and McIver, 2009). However, 
once activated to grow the oocyte controls the rate of follicular development. 
Furthermore, primordial follicle activation also appears to require close 
communication with somatic cells and its factors (McLaughlin and McIver, 2009). 
The assembly of primordial follicles early in ovarian development and the 
transition from primordial to primary follicle are critical processes in ovarian 
biology. Primordial follicle assembly and development are coordinated by locally 
produced paracrine and autocrine growth factors. Progesterone is known to influence 
follicular assembly (Skinner, 2005); however, the re-establishment of growth and 
development of primordial follicles is not fully understood. A complex network of 
cell to cell interactions is required to control the primordial to primary follicle 
transition (Skinner, 2005, Stabenfeldt and Edquist, 1996). 
It has been suggested that a gonadotrophin-independent intraovarian feedback 
loop exists regulating both the rate of primordial follicle recruitment and early 
follicular development. However, the factors involved in this feedback are still 
unknown (Campbell et al., 2004). 
 
1.3.1.2 Gonadotrophin dependent phase 
 
When the primordial follicles leave the resting pool in the ovarian cortex the 
flattened granulosa layer becomes cuboidal and starts to show signs of proliferation 
(Fortune, 2003, Stevens and Lowe, 1993). These follicles are then considered 
primary follicles. 
These primary follicles further develop into secondary follicles which start with 
the formation of a second layer of granulosa cells, progress through the addition of 
six or seven layers and terminate with the gradual development of an antral cavity 
(Fortune, 2003). As the follicle matures and the granulosa layer increases in 
thickness, the ovarian stromal cells that surround the follicle develop into 2 layers. 
The inner layer of stromal cells is denominated theca interna and is the source of 
androgens which will be converted into oestrogen by aromatase, produced by the 




steroidal secretory function (Stevens and Lowe, 1993). While in mice a distinct theca 
layer can be observed during the late primary/early secondary stage of follicular 
development, primate, bovine and ovine follicles only appear to develop distinct 
thecal layers during the mid or late secondary stage (Fortune, 2003). 
In secondary follicles the oocyte is surrounded by proliferating granulosa cells 
(McLaughlin and McIver, 2009), the theca layer has its own vascular network but the 
granulosa layer remains avascular (Kaczmareck et al., 2005)  
The follicular stages can be classified according to many different methods 
developed in many different species. Based on histological findings Braw-Tal and 
Yossefi (1997) have proposed the classification of the different bovine follicular 
stages into primordial, primary, small pre-antral, large pre-antral and small antral as 
detailed in Table 1. This classification has also been used as a framework to describe 
ovine follicular development (Fortune, 2003). 
 
Table 1. Classification and characterization of small bovine follicles according to 




Follicle diameter (μm) 
Defined theca 
interna 
Primordial  1 < 40 - 
Primary 1-1.5 40-80 - 
Small pre-antral 2-3 81-130 - 
Large pre-antral 4-6 131-250 + 
Small antral > 6 250-500 ++ 
 
Under the appropriate gonadotropic stimulation, granulosa and theca cells of 
follicles continue to proliferate and differentiate until ovulation. Follicular 
angiogenesis is initiated early during follicular development and continues 
throughout follicle growth (Kaczmareck et al., 2005). 
As the granulosa develops under the influence of FSH and oestrogen it begins to 
synthesize and release secretions that cause cell separation, resulting in the formation 
of the antrum (Stabenfeldt and Edquist, 1996). Once the antrum is formed, the 




the follicular fluid by layers of granulosa cells called cumulus oophorus and the large 
follicle, at this stage, is ready to ovulate (Stevens and Lowe, 1993).  
In sheep and cattle the life-span for a primordial follicle to reach ovulation is 
approximately 4 to 6 months (Hunter et al., 2004, Campbell et al., 2004). 
 
1.3.2 Hormonal regulation of folliculogenesis 
 
FSH plays an important part in early follicular development (Fortune, 2003). 
However, studies have shown that early folliculogenesis is not FSH dependent 
(Campbell et al., 2000). Follicles are able to reach the small antral stage of 
development in the absence of gonadotrophins but follicles exposed to FSH appear 
healthier and have a larger number of proliferating cells than those deprived of the 
hormone (Campbell et al., 2000). Although not essential, FSH seems to work as a 
modulator of early folliculogenesis by influencing the size of the pre-antral 
population (McLaughlin and McIver, 2009) and the rate at which pre-antral follicle 
development proceeds (Campbell et al., 2000). 
Follicular development prior to ovulation involves important morphological and 
functional changes in the theca and granulosa layers (Monget and Monniaux, 1995) 
and can be classified into 3 stages: recruitment, selection and dominance (Driancourt, 
2001). 
During the recruitment phase a pool of follicles is produced from which one or 
more pre-ovulatory follicles are eventually selected. Once selected, these follicles 
become dominant and progress towards ovulation while all other recruited follicles 
undergo atresia and regress. The process of recruitment and selection is controlled by 
endocrine and paracrine factors, including various intraovarian growth factors. In 
nature the number of ovulatory follicles produced per oestrous cycle is closely 
related to the species and breed of the animal. However, ovulation rate can be 
manipulated by administration of exogenous hormones (Hunter et al., 2004). 
The follicular recruitment process is characterized by gonadotrophin-dependent 
folliculogenesis in which FSH is the key hormone involved. Follicles of 0.8 to 2 mm 
in diameter are sensitive to gonadotrophins but only become gonadotrophin 




cows (Driancourt, 2001, Hunter et al., 2004). FSH enables inhibin production and 
stimulates aromatase activity within the granulosa cells of the developing follicles. 
Androgens, produced by the theca layer under the influence of LH, are converted by 
aromatase into oestrogen. Oestrogen stimulates granulosa cell multiplication and 
additional FSH receptors to appear (Driancourt, 2001, Campbell et al., 2004, 
Stabenfeldt and Edquist, 1996). Oestrogen, however, has a negative feedback on 
FSH secretion which leads to a decrease in FSH levels by the selection stage 
(Driancourt, 2001). There is a switch from FSH to LH dependency as the follicle 
matures, however, it has been found that FSH alone can induce follicular growth to 
healthy pre-ovulatory size as long as FSH levels remain sufficiently high (Hunter et 
al., 2004). 
During the selection process a dominant follicle appears while the other follicles 
of the cohort regress by atresia (Driancourt, 2001, Berisha and Schams, 2005). FSH 
induces the formation of LH receptors in the granulosa cells of mature follicles 
(Stabenfeldt and Edquist, 1996). The selected dominant follicle appears to be the first 
to develop LH receptors. LH receptor induction may be partially mediated by 
insulin-like growth factor (IGF)-1 (Driancourt, 2001). Increased inhibin and 
oestrogen produced by the selected follicle cause progressive negative feedback on 
FSH synthesis and release. FSH levels, at this point, are below the threshold for 
further follicular selection. The dominant follicle can now use LH to support its 
growth while smaller follicles have their development halted (Hunter et al., 2004, 
Stabenfeldt and Edquist, 1996). In sheep and cattle LH receptors can be detected in 
the granulosa layer of follicles 3.5 mm and 9 to 10 mm in diameter, respectively 
(Hunter et al., 2004). 
During follicular dominance, the dominant follicle grows and matures while the 
subordinate follicles regress completely. LH is the key hormone involved in the final 
growth of the dominant follicle. LH induces androgen output by the theca cells 
stimulating oestrogen secretion by the granulosa cells (Driancourt, 2001). Oestrogen 
affects LH release by influencing both the hypothalamus and the anterior 
hypophysis. Through the stimulation of catecholaminergic neurons, oestrogen 
influences GnRH secretion. In the hypophysis, oestrogen increases the sensitivity of 




increases, GnRH pulses increase in frequency resulting in the pre-ovulatory LH 
surge (Stabenfeldt and Edquist, 1996). 
Even though LH receptors are present in the granulosa cells soon after dominant 
follicle selection, locally produced luteinization-inhibiting factors prevent the 
granulosa from becoming prematurely luteinized. After the LH surge, however, the 
granulosa becomes responsive to LH, begins to secrete progesterone and stimulates 
the production of intrafollicular substances which promote the rupture of the follicle 
and ovulation (Stabenfeldt and Edquist, 1996).   
In domestic animals follicles continue to grow and develop during all phases of 
the oestrous cycle, including the luteal phase. In cattle, several dominant follicles 
develop during the luteal phase of the cycle at approximately 10-days intervals. 
Either the second or the third dominant follicle to develop during the luteal phase 
goes on to be the ovulatory follicle, depending on the timing of the initiation of 
regression of the CL. If CL regression occurs earlier, the second dominant follicle 
continues to develop through to ovulation; if later, the third dominant follicle 
becomes the ovulatory follicle (Stabenfeldt and Edquist, 1996). Bovine pre-ovulatory 
follicles reach a maximum of 16-22 mm in diameter while ovine ones range from 5-7 
mm in dimater (Hunter et al., 2004). 
The recurrent succession of recruitment, selection and dominance is termed as 
follicular wave. Sheep are shown to have 2 to 4 consecutive follicular waves per 
cycle (Driancourt, 2001, Berisha and Schams, 2005). The rising FSH at the time of 
luteal regression stimulates the development of antral follicles signalling the 
beginning of the follicular waves (Hunter et al., 2004). Very seasonal animals show 
no follicular waves during seasonal anoestrus and follicles do not exceed 3 to 4 mm 
in diameter. The wave pattern is slowly re-established during the transition towards 
the breeding season (Driancourt, 2001). 
 Although it is well established that ovarian function is regulated primarily by 
the pituitary gonadotrophins and their receptors, it is also evident that locally 
produced factors, such as steroid hormones, peptides and growth factors have 
essential modulatory roles in follicular development and ovulation (Berisha and 




growth (Hunter et al., 2004) while others, like the growth hormone (GH), are known 
to be required only at certain stages of follicular development (Fortune, 2003). 
The time covered by follicular development, ovulation, formation of the CL and 
atresia of the latter is termed oestrous cycle, and the interval between them averages 
16 to 17 days in sheep (Hansel and McEntee, 1977, Bazer et al., 1994, Stabenfeldt 
and Edquist, 1996, Stellflug et al., 1997). The length of the follicular phase, however, 
corresponds to only 2 to 3 days (Hunter et al., 2004). 
 
1.4 Luteal growth and development  
 
CL development is characterized by a series of morphological and biochemical 
changes in the theca and granulosa layers of the ovulatory follicle. Its main function 
is to secrete progesterone which is essential for the maintenance of pregnancy. The 
CL is one of the few adult tissues that undergo development, function and regression 
during every cycle (Schams and Berisha, 2004). 
 
1.4.1 Ovulation and CL formation 
 
Ovulation in the ewe occurs 14 hours after the end of the LH surge and around 30 
hours after the onset of oestrus (Stellflug et al., 1997, Bazer et al., 1994). CL 
formation consists of changes in the theca interna and granulosa cells of the pre-
ovulatory follicle that occur after the pre-ovulatory LH surge (Berisha and Schams, 
2005, Kaczmareck et al., 2005, Schams and Berisha, 2004). It has been suggested 
that the theca interna cells of the pre-ovulatory follicles differentiate into small luteal 
cells while the granulosa cells develop into large luteal cells. Small and large luteal 
cells are referred to as parenchymal cells and, together with fibroblasts and 
endothelial cells, form the basic structure of the CL (Berisha and Schams, 2005, 
Sawyer, 1995, Schams and Berisha, 2004).  
Both small and large luteal cells synthesize and secrete progesterone. LH 
receptors can be found in early CL in both small and large luteal cells. LH stimulates 
progesterone production by small luteal cells while large luteal cells remain 




found mainly in small luteal cells, large luteal cells are responsible for 80% of the 
total progesterone produced by the CL. Growth hormone (GH) receptors are mainly 
found on large luteal cells and GH is thought to be a more powerful stimulator of 
progesterone production in early CLs than LH (Schams and Berisha, 2004). Other 
factors are known to influence luteal progesterone and oxytocin secretion, such as the 
members of the IGF family. As the CL matures small luteal cells increase in numbers 
but not in size, whereas large luteal cells increase in size but not in number (Berisha 
and Schams, 2005, Sawyer, 1995).  
Progesterone is essential for the maintenance of pregnancy and is produced by 
the CL, the placenta or both. In pigs and goats the maintenance of the CL is essential 
as placental progesterone production is very low. In cows, dogs, sheep and horses 
progesterone production during early pregnancy is extremely dependent on the 
presence of the CL but the placenta becomes the main source of of progesterone 
production as the pregnancy progresses. However, in sheep and primates, luteal 
production of progesterone continues throughout pregnancy even though placental 
production is dominant (Stabenfeldt and Edquist, 1996). 
Tissue growth and development depend upon the establishment of adequate 
blood supply. The rapid growth of ovarian tissues must be equally accompanied by a 
rapid development of new blood vessels (Berisha and Schams, 2005, Kaczmareck et 
al., 2005, Reynolds et al., 2000, Redmer et al., 2001, Miyamoto et al., 2005). 
The extent of angiogenesis within the CL reaches a maximum within 2 to 3 days 
after ovulation (Reynolds and Redmer, 1998, Berisha and Schams, 2005), and the 
early CL is resistant to endometrial prostaglandin 2α (PGF-2α). As the CL matures, 
the majority of steroidogenic cells establish contact with one or more capillaries, thus 
making the CL one of the most highly vascularised organs in the body. It is also at 
this time that the CL acquires the capacity to undergo luteolysis in response to 
endometrial PGF-2α (Sawyer, 1995). 
 Due to the absence of progesterone priming, a short-lived CL results from the 
first ovulation of the breeding season in ewes (Stellflug et al., 1997). Progesterone is 
known to affect CL functionality in an autocrine and/or paracrine way. During the 
early luteal phase the lack of progesterone exposure reduces further production of 




action as opposed to endometrial PGF-2α which has a luteolytic effect (Schams and 
Berisha, 2004). During the mid luteal phase progesterone exposure inhibits 
endometrial PGF-2α secretion thus preventing early luteal regression. It is thought 
that progesterone represses the onset of apoptosis in the CL by a progesterone 
receptor-dependent mechanism. Progesterone also stimulates synthesis of LH 
receptors in the CL, stimulating further progesterone production (Schams and 
Berisha, 2004).  
It has also been suggested that abnormal luteal function is due to inadequate 
follicular development before ovulation (Southee et al., 1988b). Insufficient vascular 
support after ovulation and reduced number of luteal receptors are considered to be 
some of the causes of defective luteal function whilst the short life-span of the CL is 
attributed to premature PGF-2α release from the endometrium (Stellflug et al., 1997, 
Mann and Lamming, 2000). 
 Ovarian blood flow is highly correlated with progesterone concentration in 
systemic blood. Therefore, inadequate luteal function has also been associated with 




Luteal regression is caused by episodic release of PGF-2α from the uterus which 
reaches the CL by a counter current system between the uterine vein and the ovarian 
artery. During early and mid luteal phases, progesterone inhibits endometrial PGF-2α 
secretion, however, by the late luteal phase the endometrium loses its sensitivity to 
progesterone and low receptor numbers are observed (Schams and Berisha, 2004). 
Although progesterone inhibits luteolysis at an early stage it has an important 
role in the production of PGF-2α later in the cycle. The endometrium of ewes is 
stimulated by progesterone to increase phospholipids stores (arachidonic acid source) 
and cycloxygenase (COX) enzymatic activity necessary for the conversion of 
arachidonic acid to PGF-2α (Bazer et al., 1994). As concentration of progesterone 
declines, PGF-2α pulses increase in magnitude and frequency. The initiation of 
luteolysis involves oxytocin which engages in a positive feedback with PGF-2α 




The normal CL contains a finite store of oxytocin. Luteal oxytocin synthesis and 
secretion are restricted to large luteal cells and achieve a maximum in the early luteal 
phase (Sawyer, 1995, Wathes and Lamming, 1995). However, endometrial oxytocin 
receptors must develop before the luteal oxytocin store is depleted (Wathes and 
Lamming, 1995). In sheep, endometrial oxytocin receptors are high between oestrus 
and days 4 to 5 of the cycle, low between days 5 and 13 and increase rapidly between 
days 14 and 16 (Bazer et al., 1994). The development of oxytocin receptors in the 
uterus is induced by oestrogen produced by the developing antral follicles 
(Stabenfeldt and Edquist, 1996). 
Although oxytocin receptor levels are high during the early luteal phase they are 
under a negative inhibition by progesterone during the first 10 to 13 days of ovine 
(Bazer et al., 1994) and 16 to 17 days of bovine luteal phase (Mann and Lamming, 
2000). Progesterone receptors are then in low numbers during day 12 and 14, 
allowing a rapid increase in oxytocin receptors in the late luteal phase. From day 14 
(luteolytic period) ovine endometrium has low numbers of progesterone receptors 
and increasing oestrogen and oxytocin receptors (Bazer et al., 1994). Oxytocin then 
binds to its receptor and triggers the release of PGF-2α (Bazer et al., 1994). About 5 
pulses of PGF-2α occur every 25 hours between days 14 and 17 or until the CL is 
depleted of its oxytocin store (Bazer et al., 1994, Ronayne et al., 1990).  
Functional luteolysis involves the decline in progesterone secretion and begins 3 
to 6 hours after the initiation of PGF-2α release (Stabenfeldt and Edquist, 1996). The 
main luteolytic action of PGF-2α is a rapid decrease in luteal blood flow (Berisha 
and Schams, 2005, Miyamoto et al., 2005, Sawyer, 1995, Reynolds and Redmer, 
1998, Nett et al., 1976) with an increase in the number of other cell types such as 
immune cells and fibroblasts (Al-zi'abi et al., 2003). PGF-2α, however, initially 
stimulates a temporary vasodilatation of the local blood vessels. This acute increase 
in blood flow then triggers the cascade of luteolysis by stimulating the release of 
vasoconstrictive peptides and inflammatory cytokines (Berisha and Schams, 2005, 
Miyamoto et al., 2005) The regression of the CL is usually complete within 24 to 48 
hours in large domestic species (Stabenfeldt and Edquist, 1996). 
 The high correlation between systemic levels of progesterone and blood flow 




luteal function (Nett et al., 1976). 
  
1.5 Hormone induced ovulation 
 
A great number of methods have been developed to stimulate and induce cyclic 
activity in ewes. The methods may vary in their approach but all of them involve the 
manipulation of follicular growth and luteal life-span (Husein and Kriddli, 2003). 
The use of rams and/or hormones to induce oestrus and ovulation facilitates out-of-
season breeding, the use of artificial insemination and embryo transfer. 
Unfortunately, ovulatory therapy can result in the formation of dysfunctional CL and 
progesterone deficiency is a possible factor involved in pregnancy failure (Murdoch 
and Van Kirk, 1998, Pearce et al., 1987). 
 
1.5.1 GnRH induced ovulation  
 
 Pulsatile secretion of GnRH is responsible for the pulsatile release of LH 
from the pituitary which results in the last stages of follicular development and 
subsequent ovulation. Large doses of GnRH given to seasonally anoestrous animals 
result in an immediate pre-ovulatory type LH surge followed by a downregulation of 
LH release thereafter (McLeod et al., 1982b, Stabenfeldt and Edquist, 1996). 
However, small but frequent doses of  GnRH result in a sustained elevation of 
circulating LH sufficient to induce the final stages of follicular development and 
ovulation in approximately 100% of treated animals (Stabenfeldt and Edquist, 1996, 
McLeod et al., 1983, McLeod et al., 1982a, McLeod et al., 1982b, McNatty et al., 
1982, Southee et al., 1988b, Southee et al., 1988a). In essence, the small-dose 
multiple injections of GnRH given to stimulate an increase in LH pulses are designed 
to promote the pattern of LH release seen during the follicular phase of the oestrous 
cycle. 
The induction of ovulation with GnRH in seasonally anoestrous ewes is often 
associated with inadequate luteal function (Southee et al., 1988a, Southee et al., 
1988b, McLeod et al., 1982b). The lack of normal luteal function in such animals has 
been attributed to inadequate follicle development before the induction of ovulation 




as 3-5 days before the start of GnRH treatment, even if it only raises plasma levels 
for about 30 h, the subsequent CL gives rise to a pattern of progesterone secretion 
typical of a normal luteal phase (Southee et al., 1988b, Pearce et al., 1987). 
Progesterone treatment prior to GnRH treatment results in approximately 100% 
normal luteal function against 20 to 40% of non-primed animals (McLeod et al., 
1982b,  Bartlewski et al., 2001, Hunter et al., 1988, Husein and Kriddli, 2003, 
Haresign et al., 1996, Southee et al., 1988a). 
Oestrus occurs concomitant with the pre-ovulatory LH surge in all ewes pre-
treated with progesterone. The LH surge in these animals, as in cyclic ewes, occurs 
due to oestrogen positive feedback and not due to the direct effect of multiple low-
dose injections of GnRH. Ewes primed with progesterone have an LH surge 
significantly later than the non-primed animals (39 and 20 hours after the start of the 
GnRH treatment, respectively), allowing their follicles to be exposed to LH secretion 
for longer. A reduced exposure to LH has been suggested as one of many 
explanations for the formation of defective CL (McLeod et al., 1982b). Progesterone 
priming, however, has no effect on the time of onset, duration or amplitude of the 
pre-ovulatory LH surge (Legan et al., 1985).  
The delayed occurrence of the LH surge does not seem to be essential for normal 
luteal function as some of the non-primed ewes are capable of producing a functional 
CL even though their LH surge occurs at the same time as that of the animals that 
developed defective CLs. This suggests that progesterone may have a direct effect on 
the ovary, either by synchronizing follicular development before the start of the 
GnRH treatment or by possibly increasing responsiveness of the developing follicles 
to gonadotrophins (Southee et al., 1988b). When given intravenously, a GnRH bolus 
is able to produce an immediate pre-ovulatory LH surge (Hunter et al., 1988). When 
this was used to avoid any delay in the pre-ovulatory surge between progesterone 
primed and non-primed animals it indicated that the extended exposure of pre-
ovulatory follicles to episodic LH secretion prior to the pre-ovulatory LH surge is not 
a pre-requisite for the maintenance of the CL after ovulation (Haresign et al., 1996). 
The exact mechanism of action of progesterone priming on subsequent normal 
luteal function is still not clarified. However, progesterone priming does not 




duration or amplitude of the pre-ovulatory LH peak. Progesterone priming does not 
have any effect on the timing, duration or amplitude of the LH surge, supporting the 
concept that progesterone priming does not promote normal luteal function by 
altering patterns of LH secretion during the pre-ovulatory period (Haresign et al., 
1996). Although much has been suggested it is still not clear how progesterone 
influences the development of functional CLs. 
 
1.5.2 Defective CL 
 
Defective luteal function has been attributed as one of many causes of infertility 
(Yaniz et al., 2008) and is of relatively common occurrence in livestock 
reproduction. At puberty and following post-partum and seasonal anoestrous, the 
first oestrous cycle observed in the majority of animals is often of short duration with 
a short lived CL (Mann and Lamming, 2000, Crowe, 2008, Bulman and Lamming, 
1978).  
Most cyclic and progesterone primed seasonally anoestrous ewes induced to 
ovulate with multiple GnRH injections are capable of showing normal luteal 
function. Normal luteal function is determined by an elevation in plasma 
progesterone concentration for at least 9 days; the progesterone rise should start 
within 3 to 4 days of the LH surge and reach a maximum of more than 1.5 ng/ml 
(Southee et al., 1988b, McLeod et al., 1982b). On the other hand, abnormal luteal 
function is defined as progesterone concentrations below 1 ng/ml during the same 
period in animals in which luteolysis is blocked by hysterectomy (Southee et al., 
1988b).  
The abnormal CLs developed by entire non-primed anoestrous ewes show a 
transient increase in progesterone concentration (0.5 – 1 ng/ml) between day 1 and 2, 
similar to those of cyclic ewes or progesterone primed ewes, before returning to base 
line levels by day 6 after ovulation (Hunter et al., 1988, Southee et al., 1988b). This 
transient rise in progesterone, however, is enough to ensure a subsequent normal 
function of the next cycle CL (Southee et al., 1988b). 
Although most animals that do not receive progesterone pre-treatment develop 




day 4 but differences become apparent on day 5 after ovulation (Southee et al., 
1988b, Hunter et al., 1988). While functional CL increase in weight, defective CLs 
either stop growing altogether or show signs of regression, and also show 
disorganized morphological appearance and significantly lower progesterone content 
(Hunter et al., 1989). It has been suggested that the defective production of 
progesterone is due to inadequate supply of substrate. This, however, may be a 
consequence of luteal regression rather than its cause (Hunter et al., 1988). Luteal 
functionality is related to the existing ratio between small and large luteal cells. 
Although abnormal CL seem to have less overall amount of luteal cells (Bramley et 
al., 2005) the small:large luteal cells ratio remains the same as that found in 
functional CLs (Hunter et al., 1988).  
By day 4 after ovulation, defective CL show reduced number of gonadotrophin 
binding sites and an increased sensitivity to luteolytic agents (Hunter et al., 1988, 
Southee et al., 1988b). It is important to note that the reduced number in 
gonadotrophin binding sites in defective CL is not due to a decrease in receptor 
concentration but rather a failure of the receptor numbers to increase, suggesting that 
the lack of gonadotrophin receptors is not the fundamental cause of luteal 
abnormality (Hunter et al., 1988). Abnormal CL also show significantly lower 
vascular surface (Bramley et al., 2005) and appear pale in comparison to dark pink 
normal CL (Hunter et al., 1988). The number of CL developed per animal also does 
not influence luteal functionality: in animals with more than one ovulation, either 
both are normal or both are abnormal (Southee et al., 1988b). 
Another luteal defect observed in non-primed ewes was a lack of follicular 
development at the time of ovulation. It has been suggested that inadequate priming 
of the pre-ovulatory follicle by oestradiol results in lutein abnormality of granulosa 
cells (Murdoch and Van Kirk, 1998). 
Regression of abnormal CL is thought to be PGF-2α dependent as that of a 
normal CL, as non-primed hysterectomized animals show persistent but defective CL 
(Mann and Lamming, 2000). Oxytocin binding sites are present and PGF-2α is 
released in luteolytic pulses after 2 to 3 days of slightly elevated progesterone in 
contrast to 7 to 10 days of cyclic ewes (Hunter et al., 1989). The premature luteolysis 




progesterone action in the uterus but rather from an indirect effect mediated through 
an inadequate level of pre-ovulatory oestrogen production. It has been proven that in 
the absence of progesterone, oestrogen has the ability to cause a decrease in 
endometrial oxytocin receptor numbers. Reduced secretion of oestrogen by the pre-
ovulatory follicle in non-primed animals, therefore, leads to an impaired inhibition of 
endometrial oxytocin receptors and binding of oxytocin to these receptors results in 
the premature luteolytic episodes of PGF-2α by the uterus leading to early luteolysis 
(Mann and Lamming, 2000). 
 It has also been suggested that the premature luteolysis that occurs in the 
abnormal CL is due to an increased sensitivity of the tissue to luteolysins and/or 
inadequate protection (Hunter et al., 1988, Southee et al., 1988a). However, the 
reasons for this possible increased sensitivity in abnormal CL have yet to be fully 
determined. The regression of the short-lived CL is dependent on uterine PGF-2α 
release, however, the abnormality of the CL is not. Defective luteal function, 
therefore, is not due to premature regression but possibly inadequate follicular 
development and inadequate microvasculature of the pre-ovulatory follicle and 






Two blood vessel development processes have been identified in animals and 
humans, vasculogenesis and angiogenesis. 
Vasculogenesis consists of the initial differentiation of embryonic mesenchymal 
cells into hemangioblasts, and angiogenesis is the formation of new blood vessels by 
sprouting from an already existent endothelium (Ferrara et al., 1992, Berisha and 
Schams, 2005, Kaczmareck et al., 2005). Whereas vasculogenesis is restricted to 
embryonic development, angiogenesis continues to operate throughout life when new 
vascularisation is required. Although angiogenesis can be present in pathological 




relatively stable and physiological angiogenesis during adult life is mainly restricted 
to wound healing and the female reproductive tract (Korpelainen and Alitalo, 1998). 
The process of angiogenesis is essential for tissue growth and development and 
has been demonstrated to be a critical component during follicular and luteal 
function and development (Tamanini and De Ambrogi, 2004). Angiogenesis consists 
of 3 main steps: 1) degradation of the basement membrane of a local blood 
microvessel after the release of proteases, 2) migration of endothelial cells and 3) 
proliferation of endothelial cells (Ferrara et al., 1992, Redmer et al., 2001, Berisha 
and Schams, 2005, Kaczmareck et al., 2005). 
Vascular remodelling involves establishment of directional flow and association 
with mural cells such as pericytes and vascular smooth muscle cells. When new 
blood vessels are formed, pericytes migrate from existing arterioles along the side 
branch of the preformed endothelial plexus leading to a progressive coverage of the 
vascular tree (Benjamin et al., 1998). Pericytes can be found at and in front of the 
advancing tips of endothelial cell sprouts, possibly supporting endothelial cell 
outgrowth (Nehls et al., 1992). Initially, the vascular density exceeds the nutritional 
requirements of the tissue but is later adjusted by regression of unnecessary vessels. 
It has been suggested that after the acquisition of a pericyte coating no further 
vascular remodelling takes place (Benjamin et al., 1998).  
Pericytes are surrounded by a basement membrane and intimately associated with 
endothelial cells (Benjamin et al., 1998). They are long, slender, polymorphic cells 
with an elongated body from which branches arise. Pericytes incompletely surround 
endothelial cells and the microvascular basement membrane of capillaries. The same 
basal lamina that envelops cell bodies and cytoplasmatic processes of endothelial 
cells also envelops those of pericytes except for where these two cells make direct 
contact. Pericyte-endothelial cell contact are by adhesion plaques and gap junctions, 
possibly making up a structural mechanism in which they respond to signals 
generated by other cells. Pericytes express typical contractile cell protein like that 
found in vascular smooth muscle cells. A gradual transition can be observed from the 
pericytes to smooth muscle cells, indicating that pericytes are precursors of the latter 
(Diaz-Flores et al., 1991). It is said that pericytes are a transition between vascular 




functions have been attributed to pericytes, including: contractibility and 
permeability regulator, integrity maintenance, endothelial cell growth modulator and 
cell progenitor (Diaz-Flores et al., 1991, Benjamin et al., 1998).  
 
1.6.2 Angiogenesis and folliculogenesis 
 
Adequate ovarian vasculature is essential for follicular development and 
ovulation (Shimizu et al., 2007). As the follicles mature, primary follicles develop 
into secondary follicles containing two layers of cells: the theca layer with its own 
vascular supply and the granulosa layer, which is avascular (Tamanini and De 
Ambrogi, 2004). The establishment of the theca layer precedes angiogenesis, and the 
first endothelial cells become detectable when more than four granulosa layers 
become established (Wulff et al., 2001a).  These newly formed ovarian blood vessels 
provide an increasing supply of gonadotrophins, growth factors, oxygen, steroid 
precursors, as well as other substances to the growing follicle. In the theca layer, 
blood vessels increase in number and size as the follicle develops but do not 
penetrate the basal membrane separating the theca interna from the granulosa cell 
layer (Kaczmareck et al., 2005). 
As the antrum develops, the theca layer acquires two capillary networks located 
in the theca interna and extena. To support the increasing blood flow during 
follicular development, theca capillaries undergo angiogenesis and vasodilatation 
(Tamanini and De Ambrogi, 2004, Hunter et al., 2004). 
Although angiogenesis takes place in the theca layer, the granulosa cells are 
responsible for significant production of angiogenic factors, which will act on the 
theca layer (Tamanini and De Ambrogi, 2004). In pigs, medium sized antral follicles 
show two concentric vascular networks: an inner network near the basal membrane 
and an outer network within the theca externa (Mattioli et al., 2001). It has been 
hypothesised that angiogenic factors accumulate in the follicular cavity, diffuses to 
the theca compartment and create an angiogenic gradient attracting blood vessels to 
the granulosa layer. The basal membrane, however, proves to be a physical barrier 
for this migration, and these blood vessels develop within the theca interna in strict 




source of nutrients for the avascular granulosa. The persistence of this inner capillary 
network is directly dependent on VEGF accumulation in the follicular fluid and 
when levels are low (as in atretic follicles) it undergoes dramatic reduction (Mattioli 
et al., 2001). 
The acquisition of adequate vascular supply is said to be a limiting step in the 
selection and maturation of the main follicle (Hunter et al., 2004), and the 
development of a microvasculature is essential for the delivery of hormones and 
nutrients to developing follicles prior to ovulation and CL development (Tamanini 
and De Ambrogi, 2004).  
Dominant follicles have a higher percentage of blood vessels in the theca layer 
than smaller antral follicles within the same ovary or in the contralateral ovary 
(Acosta et al., 2003). There is a positive relationship between blood flow in the 
follicular wall and plasma oestrogen and LH concentrations. The first detectable 
increase in plasma oestrogen concentrations is coincident with an increase in 
vascularisation in the follicular wall (Acosta et al., 2003, Hunter et al., 2004). 
Dominant follicles have significantly higher oestrogen:progesterone ratio in their 
follicular fluid than non-dominant follicles (Jiang et al., 2003). Follicles with high 
oestrogen:progesterone ratio present well developed capillaries with active 
angiogenesis and a more uniform vessel network distribution than follicles with low 
oestrogen:progesterone ratio (atretic) (Jiang et al., 2003). It has been observed that 
increased vascularisation of individual follicles result in preferential delivery of 
gonadotrophins and therefore individual blood flow may play an essential role in the 
selective maturation of the pre-ovulatory follicle(s) (Zeleznik et al., 1981, Hunter et 
al., 2004, Kaczmareck et al., 2005, Acosta et al., 2003). 
The onset of follicular vascularisation in the primate begins at the early 
secondary stage, increases during follicular development and decreases during 
follicular atresia (Wulff et al., 2001a). In humans, dominant follicle blood flow 
during the late follicular phase and just before the LH surge are the same. However, 
after the LH surge there is an increase in blood flow to the base of the follicle and a 
decrease in blood flow to the apex (Acosta et al., 2003). Vasoactive factors, besides 
regulating local vascularisation, also modulate local secretion of prostaglandin and 




Around the time of the pre-ovulatory LH surge the basal membrane between the 
granulosa and theca interna layers of the developing follicles dissolves. The theca 
capillaries expand and sprout into the avascular granulosa layer to form a dense 
network (Shimizu et al., 2007). 
 
1.6.3 Angiogenesis and luteogenesis 
 
Soon after ovulation the collapsed follicle undergoes extensive changes including 
the luteinisation of the theca and granulosa cells, tissue growth and remodelling and 
increasing progesterone production. In order to meet these demands a well 
established vascular supply is essential (Robinson et al., 2007).  
The early CL consists of tissue infolding formed from the collapsed follicular 
wall. The early CL also has a central cavity which is the remnant of the follicular 
antrum. Most of the blood vessels of the early CL are present at the base of these 
infoldings which probably derive from the theca layer and are composed of 
connective tissue. Towards the end of the early luteal phase, the infoldings expand 
towards the centre of the CL, obliterating the central cavity, and the base of these 
infolding expansions become less prominent but give the CL a lobulated aspect and 
continue to contain the majority of the microvessels. However, numerous capillary 
sprouts can be seen invading the luteinised derived parenchyma (Zheng et al., 1993). 
The early luteal phase is characterized by the invasion of capillaries derived from 
the theca layer and rapid proliferation of endothelial cells (Zheng et al., 1993). 
Endothelial cells represent 85% of the proliferating cells found in the early ovine CL 
(Reynolds et al., 1994, Schams and Berisha, 2004). The sprouting endothelial cells 
invade the cavity of the newly formed CL and establish a vascular bed between the 
luteal cells, which will result in a dense network of fully differentiated capillaries by 
the mid-luteal phase. Luteal blood flow gradually increases from days 2 to 5 after 
ovulation. The high proliferation of endothelial cells in the early luteal phase is 
responsible for the increased vascularity of the mature CL. The presence of a dense 
capillary network is essential for optimal delivery of nutrients and progesterone 
precursors and for the secretion of progesterone itself (Al-zi'abi et al., 2003, Schams 




 During the mid luteal phase a dense network of capillaries can be observed 
surrounding the luteal parenchyma with many of the parenchymal cells being 
adjacent to at least one capillary. Vascular distribution during this stage appears to be 
heterogeneous, with some areas showing high capillary density and others low 
capillary density (Zheng et al., 1993).  
At this stage endothelial cells represent more than 50% of the cells present in the 
ovine CL (Schams and Berisha, 2004, Reynolds et al., 1994). During the mid luteal 
stage the area and density of microvessels are significantly greater than those 
observed in the early luteal phase (Al-zi'abi et al., 2003). 
The late luteal phase is characterized by the regression of the vascular network, 
an increase in connective tissue and the loss of luteal parenchymal cells. Although a 
significant reduction in the number of capillaries can be seen, large microvessels 
remain proeminent (Zheng et al., 1993). By the late regression stage the extensive 
vascular network observed during the mid luteal phase has regressed (Al-zi'abi et al., 
2003). 
In equine CL, total cell proliferation index is highest in the early luteal phase and 
declines by 70% during the mid-luteal and early regression phase (Al-zi'abi et al., 
2003). However, during the late regression phase a significant increase in the 
proliferation index can be observed when compared to early regression. Endothelial 
cell proliferation follows this index very closely, showing highest proliferation rate 
during the early luteal phase and significantly decreasing in number by the mid-luteal 
phase and early regression. However, during the late regression phase very few 
endothelial cells undergo proliferation, suggesting that the increase in the total cell 
proliferation index at this time is probably due to other cell types such as leucocytes 
and fibroblasts. During the early and mid stages of luteal development; endothelial 
cells correspond, respectively, to approximately 95% and 80% of the total cell 
proliferation taking place. However, these levels significantly decrease to 33% by the 
early and to 6% by the late stages of luteal regression (Al-zi'abi et al., 2003). 
Sheep CL exhibit high rates of cellular proliferation from days 2 to 12 of the 
oestrous cycle (day 0 = oestrus). Both parenchymal (steroidogenic) and non-
parenchymal (endothelial cells, fibroblasts, smooth muscle cells) luteal cells 




the CL is completed by day 8, luteal growth and cellular proliferation continues up to 
day 12 after ovulation. The rate of tissue growth is greater than that of the fastest 
growing tumour. The estimated number of luteal cells proliferating increases 3.5 fold 
between day 2 and 4, remains high through to day 12 and decreases between day 12 
and 15 after ovulation. By day 8, a 14 fold increase can be observed in the number of 
luteal cells, and steroidogenic cells correspond to the minority of proliferating cells. 
From day 8 to 12, even though the proliferation rate remains high, the number of 
luteal cells only increases by 1.3 fold, and on day 15 the number of luteal cells is 
similar to those observed on day 12 after ovulation (Jablonka-Shariff et al., 1993). 
Plasma progesterone concentration has a similar profile to that of luteal cell content, 
with an increase from early to mid luteal phase. The increase in plasma progesterone 
and content are associated with increased luteal weight (Jablonka-Shariff et al., 
1993). 
Although there is no doubt that pituitary gonadotrophins are essential for normal 
ovarian function, factors that may regulate the exposure of ovarian cells to the 
gonadotrophins may play an important role in follicular maturation and CL 
development (Ravindranath et al., 1992). As mentioned previously, pre-ovulatory 
follicles have a higher blood supply and gonadotrophin exposure than smaller 
follicles and angiogenic factors are thought to indirectly regulate follicular selection 
by regulating blood vessel formation.  
Many factors have been implicated as positive regulators of angiogenesis, 
including the acid Fibroblast Growth Factor (aFGF), basic FGF, Transforming 
Growth Factor (TGF), Vascular Endothelial Growth Factor (VEGF) and 
Angiopoietins (Ferrara et al., 2003b, Kaczmareck et al., 2005, Bramley et al., 2005). 
Even though individual factors are nevertheless important, angiogenesis seems to 
depend on an interaction between these factors acting at different levels of blood 









1.7 The VEGF family 
 
1.7.1 Molecular biology of VEGF 
 
The VEGF family comprises of a group of growth factors denoted VEGF-A 
(referred to as VEGF), Placenta Growth Factor (PIGF), VEGF-B, VEGF-C , VEGF-
D and VEGF-E, a VEGF-like protein encoded by the Orf virus  (Ferrara, 2001). 
Deletion of both or a single VEGF allele is lethal during foetal development as is 
overexpression (Tamanini and De Ambrogi, 2004, Scheidegger et al., 1999). 
This family of growth factors is responsible for regulating the growth and 
differentiation of multiple components of the vascular system. VEGF-A is 
responsible for regulating blood vessel angiogenesis, while VEGF-C and VEGF-D 
regulate lymphatic angiogenesis (Ferrara et al., 2003b). VEGF has 3 main roles in 
angiogenesis: (1) stimulating endothelial cell proliferation and migration, (2) 
maintaining immature blood vessel viability and (3) facilitating the process of 
pericytes recruitment (Benjamin et al., 1998). 
VEGF also acts as a mitogen for vascular endothelial cells and there is strong 
evidence that it is also essential for the survival of these cells by inducing the 
expression of anti-apoptotic proteins in human endothelial cells (Ferrara, 2001). 
VEGF is also known as vascular permeability factor due to its ability in promoting 
vascular leakage and the formation of fenestrations in certain endothelial cells 
inducing protein extravasion necessary for endothelial cell growth (Ferrara et al., 
2003b, Hunter et al., 2004). VEGF permeability potency is 50,000 fold higher than 
histamine (Tamanini and De Ambrogi, 2004) and its permeability is thought to allow 
large molecules, like LH, to penetrate the endothelium and reach the theca cells 
(Wulff et al., 2001a). 
 Although VEGF seems to act mainly on endothelial cells, it has also been 
reported that, in vitro, VEGF has a mitogenic effect on some non-endothelial cells 
such as retinal pigment epithelial cells and pancreatic duct cells (Ferrara, 2001). 
Furthermore, VEGF promotes growth and multiplication of vascular endothelial cells 




When cells are exposed to low oxygen or nutrients, as in growing tumors, VEGF 
secretion rate is enhanced (Scheidegger et al., 1999, Neulen et al., 1998). Tumour 
cells also produce bFGF that further stimulates VEGF production in vascular smooth 
cells and endothelial cells. Fibroblasts are also stimulated to produce VEGF when 
serum leaks from blood vessels (Scheidegger et al., 1999). On the other hand, natural 
vascular pruning is induced by transient hyperoxia around the newly formed arterial 
vasculature. Hyperoxia causes excessive regression of capillaries from the immature 
vasculature. This vessel regression occurs due to down regulation of VEGF beyond 
the required level to sustain newly formed vessels. Hyperoxia refractoriness is 
determined by pericyte coating of the vessel. Local VEGF injection accelerates the 
process of pericyte coating and completely prevents vessel regression. This pericyte 
coating prevents deleterious vessel regression in mature animals in occasional cases 
of transient fluctuations of tissue oxygen. It has been suggested that in some tissues, 
like the retina, pericytes are unlikely to play a role in initial formation of blood 
vessels but, instead, appear to influence maturation and remodelling of these vessels 
(Benjamin et al., 1998). 
VEGF stimulates nitric oxide (NO) synthase expression in endothelial cells, thus 
increasing NO synthesis. Initially NO has a positive feedback on VEGF expression 
by vascular smooth muscle cells and pericytes (Beckman et al., 2006), however, 
large quantities of NO markedly reduces VEGF production. Basic FGF helps 
stimulate angiogenesis by blocking the negative feedback that NO has on VEGF 
production (Grasselli et al., 2002). 
 
1.7.2 VEGF isoforms 
 
VEGF is a glycoprotein encoded by a single gene (Wiesmann et al., 1997, 
Scheidegger et al., 1999) and alternative splicing of the VEGF gene results in the 
formation of different isoforms that vary according to the number of amino acids 
present after signal sequence cleavage (VEGF121, VEGF165, VEGF189 and VEGF206)  
(Ferrara et al., 2003b, Houck et al., 1991). 
Human VEGFs are longer by one residue in the N-terminal region than most 




VEGF amino acid sequence displays only 4.8% changed residues compared to the 
human sequence. Based on these sequences it has been assumed that canine and 
human VEGFs are structurally almost identical. None of the differences seem to be 
located in positions thought to be relevant for the biological action of VEGF.  It also 
has been demonstrated that the biological properties of canine VEGF are identical to 
those of humans (Scheidegger et al., 1999). 
 The human VEGF gene comprises 8 exons (Tischer et al., 1991). Exons 1-5 of 
the VEGF gene encode the domain responsible for the recognition of the receptors 
fms-like tyrosine kinase (Flt-1 or VEGFR-1) and fetal liver kinase-1/kinase insert 
domain-containing receptor (Flk-1/KDR or VEGFR-2) and are present in all VEGF 
isoforms (Keyt et al., 1996). The amino acids encoded by exon 8 can also be found in 
all VEGF variants. The difference between the various VEGF isoforms is therefore 
due to the presence or absence of the amino acids encoded by exons 6 and 7 
(Poltorak et al., 1997, Tischer et al., 1991). The peptide encoded by exon 7 seems to 
affect receptor recognition of the different isoforms. VEGF121 (lacking this peptide) 
recognises a single VEGF receptor (VEGFR-2) in endothelial cells while VEGF165 
(which contains exon 7 encoded peptide) binds to VEGFR-2 but recognises two 
other receptors (Poltorak et al., 1997). Endothelial cell proliferation and angiogenesis 
are not dependent on the presence of either exon 6 or 7 and seem to be more 
associated with limited VEGFR-2 binding (Poltorak et al., 1997). 
The most abundant product of the VEGF gene, in humans, is the mRNA 
transcript encoding VEGF165, with the exception of the placenta where VEGF121 
transcript is more abundant (Ferrara et al., 1992). 
 VEGF121 lacks exons 6 and 7 (Poltorak et al., 1997) and is a 34 to 36 kDa 
homodimer peptide which is weakly acidic, fails to bind to heparin and can be found 
in its freely diffusible form (Poltorak et al., 1997). 
 Purified VEGF165 has a molecular weight of approximately 46 kDa and 
dissociates upon reduction into two identical 23 kDa subunits (Tischer et al., 1991, 
Houck et al., 1992). VEGF165 contains the amino acids encoded by exon 7 (Poltorak 
et al., 1997) and is a basic heparin-binding protein of which, although secreted freely, 
a significant fraction remains bound to the cell surface and extracellular matrix 




contains many basic residues, thus giving it a more basic characteristic and an 
isoelectric point (pI) of approximately 8.5. The same can be further observed with 
VEGF189 since 12 of the 24 amino acids inserted are basic residues. VEGF189 
contains both exons 6 and 7 encoded peptides (Poltorak et al., 1997), adding 24 
amino acids at position 116 (Houck et al., 1992). 
Recently, other VEGF isoforms have been reported, including VEGF145 and 
VEGF 183 (Ferrara, 2001). VEGF145 contains exons 1-6 and exon 8 with a total of 145 
amino acids. This isoform is usually found as a homodimer of approximately 41 kDa 
but small amounts of monomeric forms can be found. VEGF145 dimers can be 
dissociated into monomers upon reduction. VEGF145 has a heparin binding affinity 
similar to VEGF165, it induces proliferation of human umbilical vein-derived 
endothelial cells (HUVECs) but VEGF165 is 6-fold more effective. It has also been 
shown that this isoform is capable of inducing angiogenesis in vivo. VEGF145 binds 
to VEGFR-2 but not to other receptors. The presence of exon 6, despite conferring 
heparin-binding properties, does not seem to be sufficient to enable efficient binding 
of VEGF145 to those receptors. Several cell lines do not express VEGF145 mRNA, 
indicating that this isoform expression may be more restricted than that of the other 
isoforms (Poltorak et al., 1997).  
In 1991, a new isoform, VEGF206, was found. This isoform comprises a 41 amino 
acid insertion relative to VEGF165 and the highly basic 24 amino acid insertion found 
in isoform 189 (Houck et al., 1991). VEGF206 is identical to VEGF189 with an 
additional 17 amino acid sequence (Houck et al., 1992). Like VEGF189, VEGF206 is 
more basic than acidic and binds to heparin with greater affinity than the VEGF165 , 
isoform thus suggesting that exon 6 might contribute to this binding. These variants 
are almost completely sequestered in the ECM (Ferrara, 2001). Once released from 
the cell membrane or extracellular matrix, VEGF189 has been proven to stimulate 
endothelial cell growth in vitro (Houck et al., 1992). VEGF206 is predominantly cell-
associated and secreted only in very low levels despite the presence of signal peptide 
in the same concentration as for VEGF121 and VEGF165 (Houck et al., 1991). 
Isoforms 121, 145 and 165 are secreted by producing cells and found free in the 
medium (Poltorak et al., 1997). A significant percentage of VEGF165 (Houck et al., 




However, VEGF145 binds to the ECM by a mechanism independent of ECM-
associated heparin sulphates. It seems that simultaneous presence of both exons 6 
and 7 is required for efficient binding of VEGF to cell surfaces, whereas the presence 
of each of these exons on its own does not confer this property (Poltorak et al., 
1997).  
VEGF165, 189 and 206 are found mainly in the extracellular matrix forming a 
complex with heparin sulphate-containing proteoglycans (Wiesmann et al., 1997). 
(Poltorak et al., 1997). 
These large isoforms bind to heparin containing compounds on the cell surface or 
in the extracellular matrix. Heparin competes with VEGF189 for binding sites and can 
result in higher availability of unbound VEGF189 isoform in vitro. Heparinase 
treatment also results in higher free VEGF189 levels, confirming the affinity of this 
isoform for heparin containing compounds. Heparin sulphate-containing 
proteoglycans are the constituents of the ECM that are responsible for binding the 
growth factors in the matrix or cell surface. It is thought that cell surface associated 
heparin-like molecules are necessary for VEGF binding to its receptor on endothelial 
cells. The binding of VEGF to heparin sulphate proteoglycans could possibly have 
the function of providing a reservoir of biologically active VEGF available to 
endothelial cells (Houck et al., 1992) and may be the means of generating a high 
local gradient of active growth factor (Scheidegger et al., 1999).  
Heparin-binding isoforms that are bound to cell surfaces or ECM can be released 
in soluble form by heparin or heparinase. The long isoforms may also be released by 
plasmin following cleavage at the COOH terminus. These findings suggest that 
VEGF can become available to endothelial cells as diffusible proteins (VEGF121 and 
VEGF165) or by following protease activation and cleavage of the longer isoforms 
(Ferrara, 2001). As VEGF189 strongly interacts with heparin it has been suggested 
that this variant binds tightly to cell surface and ECM localized heparin sulphates. 
This was supported by the fact that heparin can dissociate VEGF189 from ECM 
(Poltorak et al., 1997). 
On the other hand, VEGF165 interacts weakly with cell surface heparin sulphates. 
As VEGF145 binds to heparin with the same strength as VEGF165 it was expected also 




to ECM from corneal endothelial cells much better than VEGF165. In addition, the 
VEGF145 bound to ECM is biologically active, being able to induce endothelial cell 
proliferation (Poltorak et al., 1997). 
Heparin binding ability does not seem to be related to receptor binding since 
VEGF145 and  VEGF165 bind to heparin with the same affinity but differ in their 
ability to recognise the receptors as VEGF145 recognizes only VEGFR-2, like 
VEGF121, whilst VEGF165 recognizes two other receptors (neurophilin-1 and -2) 
besides VEGFR-2 (Poltorak et al., 1997). There is also an inverse relationship 
between heparin affinity and diffusability. VEGF121 has the lowest affinity to heparin 
and the highest bioavailability. Loss of heparin binding results in substantial loss of 
mitogenic activity for vascular endothelial cells (Ferrara, 2001). 
Vascular permeability activity has been observed in all isoforms (VEGF121, 
VEGF165, VEGF189 and VEGF206); however, endothelial cell mitogenic activity has 
only been apparent in cell cultures treated with VEGF121 and VEGF165 (Houck et al., 
1991). VEGF 121 and VEGF165 promote angiogenesis, induce permeabilization of 
blood cells and proliferation of vascular endothelial cells. It is suggested that 
VEGF189 may induce endothelial cell proliferation. VEGF145 is the main isoform 
expressed by cell lines derived from carcinomas of the female reproductive system 
(Poltorak et al., 1997).  
 
1.7.3 VEGF Receptors 
 
VEGF binds to two tyrosine kinase receptors: VEGFR-1 (Flt-1) and VEGFR-2 
(Flk-1/KDR), which are expressed almost exclusively on endothelial cells 
(Korpelainen and Alitalo, 1998) and are very important in embryo blood vessel 
formation.  It has been reported that VEGF binds to both receptors with high affinity. 
A higher affinity has been observed for VEGFR-1, however, there is evidence that 
VEGFR-2 is the key signalling receptor for VEGF (Ferrara, 2001). Although 
VEGFR-1 exhibit higher affinity for some VEGF isoforms when compared to 
VEGFR-2, its function in the adult vasculature remains poorly understood (Gille et 




Both receptors are composed of seven immunoglobulin (Ig)-like domains in the 
extracellular domain, a single transmembrane region and a tyrosine kinase (TK) 
domain which is interrupted by a kinase insert domain. VEGF binds to the second Ig-
like domain of the receptors and deletion of this domain abolishes VEGF binding 
completely (Ferrara, 2001). 
VEGFR-1 and –2 have different signal transduction properties. VEGFR-2 
undergoes strong ligand-dependent tyrosine phosphorylation in endothelial cells 
while VEGFR-1 reveals weak responses. VEGF mutants that bind selectively to 
VEGFR-2 are able to induce normal mitogenesis and chemiotaxis in endothelial 
cells, angiogenesis and permeability. In contrast, VEGFR-1 selective VEGF mutants 
are devoid of such activities. PIGF binds with high affinity to VEGFR-1 and not 
VEGFR-2 and lacks direct mitogenic or permeability-enhancing properties (Ferrara, 
2001, Gille et al., 2001). However, high concentrations of PIGF that are expected to 
saturate VEGFR-1 sites are able to potentiate VEGF activity in vitro and in vivo. 
These findings lead to the hypothesis that VEGFR-1 may not be the main signalling 
receptor for VEGF but a “decoy” receptor able to regulate VEGF activity by making 
the ligand less available for VEGFR-2 (Ferrara, 2001). 
It has been proven that VEGFR-1 is essential for the organization of embryonic 
vasculature but not essential for endothelial cell differentiation (Fong et al., 1995). 
VEGFR-1 is said to be involved in organization of endothelial cell morphology 
(Scheidegger et al., 1999) and critical for VEGF induced tube formation (Tamanini 
and De Ambrogi, 2004). Mice embryos lacking VEGFR-1 show differentiation of 
endothelial cells with disruptions at later stages of vasculogenesis resulting in thin-
walled vessels of large diameter and embryo death at 9 days (Folkman and D'amore, 
1996). VEGFR-1 contains a repressor sequence in its juxtamembrane region that 
inhibits VEGF dependent signal transduction. Deletion of such repressor confers 
VEGFR-1 the ability to mediate VEGF dependent endothelial migration. These 
results suggest that VEGFR-1 plays a role in angiogenesis by binding to the ligand 
rather than transducing a signal after the binding (Ferrara, 2001).  VEGFR-1 can be 
found as a full-length membrane–bound receptor and as a soluble truncate form 
containing the extracellular VEGF-binding domain but lacking the transmembrane 




splicing and it is thought to negatively control VEGF action. In the majority of 
tumours VEGFR-1 is overexpressed 2 to 6-fold when compared to healthy tissues. 
Over expression of the truncated form might be useful as an anti-angiogenic protein 
in selected tumours (Scheidegger et al., 1999). 
VEGFR-2 is expressed by endothelial cells and its phosphorylation stimulates 
mitogenesis and migration of endothelial cells while VEGFR-1 has no significant 
effect (Gille et al., 2001, Scheidegger et al., 1999, Tamanini and De Ambrogi, 2004). 
Mice embryos deficient in VEGFR-2 die during early embryological 
development (day 8.5 – 9.5) and showed no blood islands or organized blood vessels 
thus proving the importance of VEGFR-2 in embryo vasculogenesis (Shalaby et al., 
1995). The lack of VEGFR-2 is thought to interfere with the differentiation of 
endothelial cells (Folkman and D'amore, 1996). It has been proven that VEGFR-2 is 
effective in inducing in vivo angiogenesis while VEGFR-1 was unable to do so. 
Therefore, only VEGFR-2 appears capable of promoting angiogenesis in vivo. It has 
been suggested by some authors that VEGFR-2 is the sole mediator of VEGF 
induced migration, angiogenesis and permeability in endothelial cells (Gille et al., 
2001). 
Some VEGF isoforms also bind selectively to two neurophilin type 1 
transmembrane receptors, NP-1 (VEGF165) and NP-2 (VEGF165 and VEGF145) 
(Tamanini and De Ambrogi, 2004). Neurophilin-1 is an isoform specific VEGF 
receptor that presents VEGF165 to its signalling receptor in a manner that enhances 
the effectiveness of the signal transduction cascade. VEGF121 fails to bind to this 
receptor thus partially explaining its lower bioactivity when compared to that of 
VEGF165. Inhibition of VEGF165 binding to neuropilin-1 inhibits its binding to 
VEGFR-2 and its mitogenic activity for endothelial cells. Although the role of 
VEGFR-1 is unclear in adult angiogenesis, VEGFR-2 is essential for VEGF 
biological responses (Ferrara, 2001). 
Another existing receptor, VEGFR-3 (Flt-4), appears to be primarily involved in 
lymphatic angiogenesis. It binds to VEGF-C and –D but not to VEGF-A. PIGF and 
VEGF-B only bind to VEGFR-1 and appear to have little angiogenic activity. VEGF-




VEGF-A, as mentioned before, binds to VEGFR-1 and –2 but not to VEGFR-3 
(Ferrara, 2001). 
 
1.7.4 Role of VEGF in reproduction 
 
1.7.4.1 Role of VEGF during follicular development  
 
Follicular and CL growth and development, as well as endocrine function, are 
dependent on blood vessel proliferation. It has been suggested that VEGF may act as 
mediator of blood vessel growth that occurs in the female reproductive tract (Ferrara 
et al., 2003a). 
 VEGF is essential for follicular development, as suppression of VEGF inhibits 
the development of pre-ovulatory follicles. The lack of VEGF is also known to cause 
a decrease in theca layer vascularity, granulosa cell proliferation, antral formation 
and steroidogenesis. Absence of VEGF disrupts ovulation and subsequent CL 
development and function (Hunter et al., 2004, Ferrara et al., 2003a). 
In response to FSH, granulosa cells are the main source of VEGF in the follicle 
and its expression increases as follicles mature, but theca cells are also able to 
express VEGF. The VEGF produced by the granulosa cells accumulate in the 
follicular fluid and this is believed to be the source of stimuli for blood vessel 
extension towards the granulosa layer around the time of ovulation in cattle, primates 
and pigs (Robinson et al., 2007,  Hunter et al., 2004, Mattioli et al., 2001). 
VEGF receptors, on the other hand, are found mainly in endothelial cells of the 
theca layer, suggesting that VEGF acts in a paracrine fashion to stimulate 
vascularisation of the theca layer (Hunter et al., 2004, Wulff et al., 2001a). Both 
theca and granulosa cells express VEGF mRNA in healthy porcine follicles; 
however, the granulosa compartment expresses more intense hybridisation signals 
(Boonyaprakob et al., 2003, Tamanini and De Ambrogi, 2004). 
An active cycle of angiogenesis can be seen during follicular development 
(Ferrara et al., 1992), and numerous studies have shown that the manipulation of the 
VEGF system can influence follicular development at all stages (Hunter et al., 2004). 




very weak or undetectable (Ferrara et al., 2003a, Tamanini and De Ambrogi, 2004). 
In secondary follicles VEGF protein and mRNA expression is still very weak within 
the granulosa layer, while intense binding can be observed within vessels of the theca 
layer (Tamanini and De Ambrogi, 2004, Ferrara et al., 1992, Ferrara et al., 2003a). 
However, in primates, VEGF mRNA can first be detected in late secondary follicles 
and appear to be in equal quantities in granulosa and theca layers (Wulff et al., 
2001a). 
As the follicle matures, VEGF mRNA expression progressively increases and 
antral follicles show intense granulosa cell signal with moderate VEGF mRNA 
expression in the theca layers (Ferrara et al., 2003a, Mattioli et al., 2001, 
Ravindranath et al., 1992, Tamanini and De Ambrogi, 2004, Wulff et al., 2001a). In 
ovine pre-ovulatory follicles, VEGF mRNA expression is only detectable in the 
theca interna (Tamanini and De Ambrogi, 2004). This mRNA correlates quite well 
with the vascular changes taking place within the developing follicle (Ferrara et al., 
1992).  An increase in both VEGF and VEGFR levels in tertiary follicles is probably 
responsible for follicular growth and antrum formation (Wulff et al., 2001a) as 
VEGF permeabilization action is thought to be essential for antrum formation 
(Tamanini and De Ambrogi, 2004). 
VEGF is thought to play an important role in the selection of the dominant 
follicle as VEGF concentrations in follicular fluid were found to be associated with 
increased vascular density and oestrogen concentrations (Hunter et al., 2004). 
In pig follicles, VEGF production is regulated according to follicular size and 
functional status. Small follicles (<4 mm) have low levels of VEGF while large 
follicles (>5 mm) are able to produce substantial amounts of VEGF (Mattioli et al., 
2001). The same can be observed with VEGFR-1 and -2 expressions in the theca 
layer (Tamanini and De Ambrogi, 2004). Medium follicles (4 to 5 mm), however, 
may or may not produce high amounts of VEGF and are classified as high or low-
VEGF producers. The border line for significant VEGF production seems to be 4 to 5 
mm since it has been observed that follicles bigger than that produce high levels of 
VEGF. This suggests that under gonadotrophin stimulation follicles bigger than 4mm 
become capable of stimulating angiogenesis and probably creating the required 




Medium sized porcine follicles show 2 concentric vascular networks that are 
positively related to VEGF levels found in follicular fluid. Follicles with high levels 
of VEGF have a total vascular area greater than those with low levels of VEGF. The 
increase in vascular area involves both the inner (within theca interna by the basal 
membrane) and outer (within the theca externa) vascular networks. It has also been 
observed that there is a positive relation between VEGF and oestrogen levels in 
follicular fluid.  High levels of oestrogen observed in follicular fluid when high 
levels of VEGF are present suggest that VEGF producing follicles are those that will 
effectively grow and ovulate or will at least reach the pre-ovulatory stage. The 
positive relation between VEGF and oestrogen levels suggest a possible cause-and-
effect relationship, although,  it has been shown that oestrogen does not stimulate 
VEGF production in vitro (Mattioli et al., 2001). Activation of steroidogenesis 
requires an increased supply of nutrients, and VEGF is known to create these 
conditions and also to increase vascular permeability, facilitating the delivery of 
lipoproteins for steroid production. Therefore, it is possible that VEGF stimulates 
oestrogen production by providing steroidogenic cells with the required nutrients 
(Mattioli et al., 2001). 
Many factors are thought to regulate follicular VEGF production. 
Gonadotrophins stimulate granulosa cell production of VEGF and hypoxia is a potent 
inducer of VEGF expression in a number of tissues (Hunter et al., 2004). IGF-I acts 
as stimulant to VEGF as well as directly acting on endothelial cell proliferation and 
differentiation (Schams and Berisha, 2004). 
As follicles mature angiogenesis slows down and blood vessels stabilize. 
However, it is known that VEGF upregulates vascular permeability, thus during this 
period VEGF might be present at high levels to enhance vascular permeability rather 
than to promote angiogenesis (Hayashi et al., 2003). In the peri-ovulatory period, 
VEGF levels increase markedly in follicular fluid and peptide can be detected in 
granulosa-derived luteinized cells of the early CL (Tamanini and De Ambrogi, 2004, 
Ferrara et al., 1992). 
Degradation of the capillary bed interrupts metabolite supply and leads to 
follicular atresia. In follicular atresia in cattle, apoptosis is first observed in the outer 




due to basal VEGF production by the theca layer (Tamanini and De Ambrogi, 2004). 
During follicular atresia in primates, VEGF can be reduced up to 55% in granulosa 
and is no longer detectable in the theca layer. A decrease in 50 to 70% of VEGFR-1 
can be seen in atretic follicles when compared to secondary or tertiary follicles 
(Wulff et al., 2001a). In humans, VEGF mRNA is only weakly expressed in residual 
theca cells (Ferrara et al., 2003a). 
Blocking of VEGF decreases endothelial and non-endothelial cell proliferation. 
This effect on non-endothelial cells could be due to the lack of nutrients, hormones 
and growth factors that reach these cells due to the reduced local permeability caused 
by the absence of VEGF (Tamanini and De Ambrogi, 2004). In some species such as 
pigs, hypoxia can induce VEGF production. As the follicle matures, the pressure of 
oxygen (pO2) gradually decreases in follicular fluid, acting as an angiogenic 
stimulus. In cows, in vitro exposure to low pO2 stimulates VEGF mRNA expression. 
However, in primates, hypoxia does not interfere with VEGF expression in granulosa 
cells (Tamanini and De Ambrogi, 2004). 
In pigs, equine Chorionic Gonadotrophin (eCG) administration increases VEGF 
mRNA expression in granulosa cells, VEGF levels in follicular fluid and VEGFR-1 
and –2 in theca but no difference can be observed in VEGF mRNA expressed in the 
theca layer. It has been observed that in some species fasting increases VEGF 
expression in theca cells while reducing it in granulosa cells. LH and IGF-1 stimulate 
VEGF expression in bovine and primate cultured granulosa cells. Gonadotrophins, in 
the primate, stimulate VEGF secretion in pre-ovulatory follicles (Tamanini and De 
Ambrogi, 2004).  
Local injection of VEGF gene fragments increases the population of large 
follicles and the vascular density in the theca interna. Plasma VEGF concentrations 
are directly proportional to number of oocytes recovered, indicating that enhancing 
VEGF expression during follicular development can increase the number of follicles 
destined to ovulate.  Gonadotrophin administration could be used to enhance VEGF 
production and therefore promote the development of a higher number of oocytes. In 
humans, VEGF concentration in follicular fluid is related to pure FSH administration 





1.7.4.2 Role of VEGF during luteal development 
 
After ovulation, the endothelial vessels invade the ruptured follicle and form a 
network of microvessels that supply the developing CL (Ferrara et al., 1992). VEGF 
can be found during all stages of the CL life-span: development, function and 
regression (Schams and Berisha, 2004). 
Suppression of VEGF causes a significant reduction in endothelial cell 
proliferation, with a 75% reduction in the area occupied by these cells. It also leads 
to increased cell apoptosis and a 50% reduction in plasma progesterone concentration 
(Wulff et al., 2001b, Ferrara, 2001, Dickson et al., 2001). The lack of VEGF 
increases VEGF gene expression, probably as compensation and is likely associated 
with the stimuli caused by local hypoxia due to lack of vascularisation. Decreased 
levels in VEGF also result in decreased levels of VEGFR-1 mRNA, indicating that 
VEGF regulates its own receptor expression (Wulff et al., 2001b). 
Although the lack of VEGF has no apparent effect on the pre-existing vasculature 
(Ferrara, 2001), indicating a certain independence of the other angiogenic factors 
from VEGF, luteal angiogenesis is primarily driven by VEGF and a proportion of 
endothelial cells are dependent on VEGF support (Dickson et al., 2001, Wulff et al., 
2001b). 
VEGF is usually detected in theca derived luteinized cells of early CL. However, 
in primates all luteal cells express VEGF mRNA (Tamanini and De Ambrogi, 2004). 
In primates VEGF mRNA is highly expressed in steroidogenic luteal cells while no 
expression has been observed in endothelial cells. On the other hand, VEGFR-1 was 
found exclusively in endothelial cells of primates CL (Wulff et al., 2001b). 
In pigs CL, VEGF165 and both receptors have been detected (Tamanini and De 
Ambrogi, 2004). VEGF mRNA prevails in large luteal cells (granulosa derived) and 
pericytes, while VEGFR-1 and -2 mRNA can be found mainly in the theca derived 
cells (Tamanini and De Ambrogi, 2004, Boonyaprakob et al., 2003). In mares, VEGF 
mRNA is expressed in luteal cells and absent in endothelial cells. VEGF protein is 
mainly found in the cytoplasm of luteal cells (Tamanini and De Ambrogi, 2004, Al-




Isoforms 121, 165 and 189 have been identified in both ovine and bovine CL. 
While bovine CL express predominantly isoforms 121 and 165 (Schams and Berisha, 
2004), isoform 121 corresponds to 1/3 of total luteal VEGF found in sheep. 
Steroidogenic luteal cells are active VEGF producers, alongside pericytes and 
vascular smooth muscle cells (Tamanini and De Ambrogi, 2004). Vascular smooth 
muscle cells have been shown to synthesize VEGF mRNA and secrete biologically 
active VEGF isoforms 121, 165 and 189 (Tischer et al., 1991). Pericytes are the first 
cells to migrate to the hypoxic granulosa after ovulation, and to produce VEGF to 
initiate angiogenesis. In bovine CL both VEGFR-1 and -2 mRNA are only expressed 
by endothelial cells (Tamanini and De Ambrogi, 2004). 
VEGF levels are high during early luteal phase and decrease as the oestrous cycle 
reaches an end (Kaczmareck et al., 2005, Ribeiro et al., 2006). During the mid-luteal 
phase high levels of VEGF can be seen in luteal cells (Robinson et al., 2007) but tend 
to be confined to those cells adjacent to the tuberculae (Al-zi'abi et al., 2003). During 
early and mid luteal phases intense VEGF mRNA expression can be seen and early 
luteal VEGF mRNA expression resembles the pattern seen in late pre-ovulatory 
follicles with granulosa derived cells intensely expressing VEGF mRNA. VEGF 
mRNA expression appears to be stronger during initial recruitment and capillary 
development during the early luteal phase (Ferrara et al., 2003a) with constant levels 
throughout the mid-luteal phase and a significant decrease as it reaches an end 
(Ribeiro et al., 2006, Tamanini and De Ambrogi, 2004). Besides being produced by 
steroidogenic luteal cells VEGF is also produced by pericytes. Although pericytes 
are still present at mid-cycle many of them are not producing VEGF. This probably 
occurs because at this stage the CL has obtained its maximum size, functionality and 
vascular supply (Redmer et al., 2001). 
By early luteal regression, luteal cells express very little VEGF protein and 
mRNA expression decreases markedly. However, during late regression VEGF 
protein and mRNA expression are significantly increased in non-luteal cells such as 
macrophages and neutrophils. The number of immune cells expressing VEGF 
mRNA increases during regression. It is thought that VEGF at this stage is only 
required to maintain the remaining microvessels involved in clearing degenerating 




VEGFR-2 levels follow a similar pattern to that of VEGF protein (Robinson et 
al., 2007, Boonyaprakob et al., 2003) but high levels of VEGF and VEGFR-2 are 
only maintained during the late luteal phase in cases of pregnancy (Tamanini and De 
Ambrogi, 2004).  
The peak expression of VEGF mRNA and protein during the early luteal phase 
shows a direct association with high endothelial cell proliferation and the 
establishment of a dense capillary network, indicating a close association with 
angiogenesis. During the early luteal phase, when new capillaries are being formed 
throughout the CL, VEGF expression is diffused amongst cells. When this capillary 
network has been established by the mid-luteal phase, VEGF levels are high only in 
cells bordering the tuberculae, where blood vessels enter the luteal tissue (Al-zi'abi et 
al., 2003, Ferrara et al., 1992). 
Endometrial PGF-2α-induced luteolysis consists of functional and structural 
luteolysis (Niswender and Nett, 1994). PGF-2α exerts a significant impact on the 
VEGF system, significantly reducing mRNA expression of VEGF and its receptor.  
However, soon after PGF-2α release VEGF mRNA levels rise, probably due to the 
acute hypoxia created by the death of endothelial cells. By 24 hours after PGF-2α 
release, a decrease in VEGF mRNA can be observed, and it is hypothesised that this 
initiates the definite loss of capillary endothelial cells (Vonnahme et al., 2006). 
Recently, another endothelial growth factor has been identified, the Endocrine 
Gland-derived Vascular Endothelial Growth Factor (EG-VEGF). This factor has 
been shown to be expressed in the primate and human ovaries. EG-VEGF is able to 
induce a strong angiogenic response in the ovary but fails to do so in other organs 
such as skeletal muscle. Similar to VEGF, EG-VEGF mRNA expression is up-
regulated by hypoxia. EG-VEGF mRNA has been found to be expressed at times 
when VEGF mRNA expression is weak or absent, during both follicular and luteal 
phases. EG-VEGF mRNA is expressed in primary follicles when VEGF mRNA is 
barely detectable (Ferrara et al., 2003a). 
EG-VEGF is structurally different from VEGF but has a similar function. VEGF 
and EG-VEGF mRNA are largely similar in their localization in the CL, 
predominantly in large luteal cells. However, it has been observed that, in humans, 




late luteal phase while EG-VEGF progressively increases throughout the luteal 
phase. EG-VEGF is predominantly localized within large luteal cells, with uniform 
distribution throughout the CL. During the early luteal phase EG-VEGF mRNA is 
weakly expressed in granulosa-derived cells and at a lower level in theca-derived 
ones. By the mid-late luteal phase granulosa-derived cells express intense mRNA 
expression and theca-derived cells are negative (Fraser et al., 2005). 
 
1.8 The Angiopoietin family 
 
1.8.1 Molecular biology of Angiopoietins 
 
Angiopoietins are angiogenic factors which act in association with VEGF to 
regulate blood vessel formation and maturation (Davis et al., 1996). In mice three 
types of angiopoietins have been detected: Angiopoietin (Ang)-1, -2 and -3, while 
Ang-4 has also been found to be present in humans (Tamanini and De Ambrogi, 
2004, Wang et al., 2006). 
Ang-1 is a 497-amino acid glycoprotein with a molecular weight of 
approximately 55 kDa under reducing conditions. Although Ang-1 is not capable of 
mediating endothelial cell growth of tubule formation, like VEGF, it is nevertheless 
essential for vascular development (Davis et al., 1996, Suri et al., 1996, Koblizek et 
al., 1998). The lack of Ang-1 results in less complex vasculature with less distinction 
between small and large vessels, as well as reduced number of large vessels and 
defects in vascular remodelling. The absence of Ang-1 causes endothelial cells to 
poorly associate with the underlying matrix of blood vessels and not properly recruit 
pericytes and vascular smooth muscle cells. This poor association with the 
underlying cells leads to the defects in vascular organization observed in animals 
lacking Ang-1 (Suri et al., 1996). 
Ang-1 is believed to regulate vascular maturation after the initial stages of blood 
vessel formation (Davis et al., 1996), and it has been shown to be essential for 
embryo survival (Suri et al., 1996). Its expression in the vicinity of developing 
vessels suggest that Ang-1 plays an important role in assembling  non-endothelial 




will ensure blood vessel stabilization and maturation (Tamanini and De Ambrogi, 
2004, Folkman and D'amore, 1996). 
Ang-1 binds to the endothelial specific TIE-2 receptor tyrosine kinase and 
activates the production and release of recruiting signals for mesenchymal cells. The 
endothelium TGF-β induces differentiation of these mesenchymal cells into pericytes 
and smooth muscle cells. TIE-2 activation by Ang-1 inhibits endothelial cell 
proliferation and stimulates matrix deposition (Folkman and D'amore, 1996). 
Although Ang-1 is mainly involved in vessel maturation, low levels of Ang-1 act 
synergistically with VEGF to induce the formation of new capillaries by sprouting 
from pre-existing vessels (Koblizek et al., 1998). 
Ang-2 is a 496-amino acid protein of approximately 65 kDa (Geva et al., 2002) 
that binds to TIE-2 receptors with a similar affinity to Ang-1. Although both factors 
bind to the same receptor, they have different physiological roles. While Ang-1 
causes TIE-2 phosphorylation in endothelial cell lines, Ang-2 has no such activity, 
even at high levels. However, in non-endothelial cell lines, Ang-2 is capable of 
inducing TIE-2 phosphorylation as much as Ang-1, suggesting that endothelial cells 
contain unique components that interact with TIE-2, allowing functional 
discrimination between the two angiopoietins (Maisonpierre et al., 1997). 
Ang-2 destabilizes existing vessels, loosening the supporting cell matrix and 
allowing VEGF to stimulate endothelial cell proliferation and migration to result in 
new blood vessel formation (Tamanini and De Ambrogi, 2004). 
Ang-2 in high concentration blocks Ang-1 activity in endothelial cells.  Over-
expression of Ang-2 causes widespread vessel discontinuity and loss of normal 
dendritic patterns of the vascular network, giving it a “moth appearance”. 
Characteristic vessels are frequently absent and endothelial cells are present in 
abnormal small clusters in the vicinity of the vessels which are present. This finding 
supports the notion that Ang-2 is an antagonist to Ang-1 in endothelial cells 
(Maisonpierre et al., 1997). As Ang-2 is unable to cause TIE-2 phosphorylation in 
endothelial cells, it antagonises Ang-1 activity by competing for the same receptor. 
As the affinities of both ligands to TIE-2 are similar, higher levels of Ang-2 result in 




The Ang-2:Ang-1 ratio is considered as an index of destabilization of blood 
vessels (Shimizu et al., 2007). However, whether this destabilization will lead to the 
formation or regression of blood vessels is highly dependent on VEGF levels. When 
Ang-2:Ang-1 ratio and VEGF levels are high, angiogenesis results in the formation 
of new blood vessel networks. However when Ang-2:Ang-1 ratio is high but VEGF 
levels are low, regression of blood vessels can be observed. Furthermore, low Ang-
2:Ang-1 ratio and relative low levels of VEGF result in stabilization of blood vessels 
(Hayashi et al., 2003), as illustrated in Figure 3. 
 
 
Figure 3. Diagram illustrating the interactions between angiogenic factors and their 
influence on angiogenesis. 
 
1.8.2 TIE Receptors 
 
The TIE receptor family consists of TIE-1 and TIE-2 (Tek) and is critically 
involved in angiogenesis. These receptors play a critical vessel remodelling role 
subsequent to the actions of VEGF (Folkman and D'amore, 1996). These two 
tyrosine kinase receptors, however, seem to have distinct roles in the formation of 
blood vessels (Sato et al., 1995). 
TIE-2 is an 1122-amino acid glycoprotein of approximately 140-145 kDa, with 
an extracellular domain and an intracellular tyrosine kinase domain (Vikkula et al., 
1996,  Runting et al., 1993). The overall amino acid homology between TIE-2 and 
TIE-1 is approximately 46%. However, this similarity varies in the different 
domains, reaching as high as 84% in the kinase domain (Iwama et al., 1993). 
 TIE-2, when phosphorylated, recruits surrounding stromal cells to stabilize 
vessel structure, and is necessary for capillary fluid exchange (Tamanini and De 
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Ambrogi, 2004) and is essential for embryonic survival (Suri et al., 1996). 
Overexpression of TIE-2 receptor results in venous malformations, with extremely 
distended blood vessels that show abnormal distribution of smooth muscle cells 
(Vikkula et al., 1996). 
 Even though TIE-2 binds with the same affinity to Ang-1 and Ang-2, it has been 
shown that Ang-1 is the primary physiological ligand for this receptor (Suri et al., 
1996). Previous studies have suggested that the number of TIE-2 receptors is 
regulated by the availability of Ang-1 and not the other way around, or that this 
regulation is performed indirectly as TIE-2 levels could depend on the degree of 
vascular organization and not on the availability of the ligand (Suri et al., 1996, 
Folkman and D'amore, 1996). 
The TIE-1 receptor, like TIE-2, is expressed predominantly in endothelial cells 
(Maisonpierre et al., 1997). Animals deficient in TIE-1 fail to establish structural 
integrity of vascular endothelial cells, and develop oedema and localized 
haemorrhage. Although involved in different aspects of vascular maturation, TIE-1 is 
essential for embryo survival (Sato et al., 1995). Curiously, neither Ang-1 nor Ang-2 
is known to bind to this receptor (Maisonpierre et al., 1997). 
 
1.8.3 Role of Angiopoietins in reproduction 
 
In adult human tissues, Ang-1 is widely expressed while Ang-2 is restricted to 
predominant sites of physiological vascular remodelling: ovary, placenta and uterus. 
It has been observed that in the rat ovary Ang-1 transcripts were associated with 
blood vessels and coincided with vessel in-growth into the early CL, rather than 
preceding it as does VEGF. These findings are in agreement with the hypothesis that 
Ang-1 has a later role in angiogenesis than VEGF, probably involving vessel 
maturation and stabilization. Ang-2 pattern, on the other hand, suggests that this 
factor plays an early role at the sites of vessel invasion, collaborating with VEGF by 
blocking the stabilizing or maturing function of Ang-1 and thus allowing vessels to 
remain more plastic and better responsive to sprouting signals from VEGF (Tait and 





1.8.3.1 Role of Angiopoietins during follicular development 
 
Ovarian follicle development depends on the balance between vascular 
outgrowth and regression (Maisonpierre et al., 1997). 
The theca interna of mature bovine follicles expresses mRNA encoding Ang-1, 
Ang-2, TIE-1 and TIE-2 while the granulosa layer only signals for mRNA encoding 
Ang-1 and Ang-2. Ang-1 mRNA expression does not vary between developing and 
mature follicles, but on the other hand, Ang-2 mRNA expression is significantly 
lower in mature follicles than in developing ones (Hayashi et al., 2003, Tamanini and 
De Ambrogi, 2004, Shimizu et al., 2007). Thus, the Ang-2:Ang-1 ratio is lower in 
the theca interna layer of mature follicles when compared to that of developing ones. 
This shows that as follicular maturation progresses, the Ang-2:Ang-1 ratio shifts 
from high (destabilized vessels) to low (stabilized vessels). A reduction in the Ang-
2:Ang-1 ratio in mature follicles indicate blood vessel maturation and reduced 
angiogenesis despite high levels of VEGF. TIE-1 and TIE-2 mRNA expression 
remain unchanged throughout follicular development (Hayashi et al., 2003). 
In the theca layer of tertiary follicles, Ang-1 mRNA is expressed at low levels 
and some authors report that Ang-2 mRNA cannot be detected at any stage of 
follicular development. TIE-2 mRNA, on the other hand, has been detected in as 
early as primordial follicles. Unlike in other species, TIE mRNA expression in 
primates is present in the granulosa layer of primary and secondary follicles. These 
levels, however, decrease by the late secondary stage and are barely detectable in the 
granulosa of tertiary follicles. TIE-2 mRNA expression can be mainly detected in 
theca cells of tertiary follicles and decrease by 70% as follicles undergo atresia 
(Wulff et al., 2001a). 
It has been shown that Angiopoietins are associated with the changes in follicular 
capillaries at the time of the LH surge. Ang-1 mRNA is highly expressed before the 
LH surge, followed by a significant decrease at the time of the LH surge. A slow and 
consistent rise is observed after the LH surge, followed by a slow decrease at peri-
ovulatory time and early CL development. It is believed that the reduction in Ang-1 
mRNA expression in peri-ovulatory follicles may be directly regulated by 




and ovulation with lowest levels soon after the LH surge and at peri-ovulatory time 
(Shimizu et al., 2007). 
The Ang-2:Ang-1 ratio is increased at the time of the LH surge. An increase in 
this ratio is associated with blood vessel destabilization, which is essential for 
angiogenesis. Therefore, it is likely that during the LH surge the follicle prepares the 
capillary network for ovulation. The Ang-2:Ang-1 ratio gradually declines by 
ovulation time and is significantly increased in early CL development. TIE-2 mRNA 
is found at its highest levels prior to the LH surge and at early stages of CL 
development, while lower levels are observed at peri-ovulatory time (Shimizu et al., 
2007). 
Ang-1 is associated with an increase in oestrogen secretion by the dominant 
follicle as well as in stimulating, in synergism with Ang-2, early luteinisation and 
progesterone release from peri-ovulatory follicles after the LH surge (Hayashi et al., 
2003). 
During follicular atresia, when large follicles fail to ovulate, there is no invasion 
of vessels into the granulosa and those vessels present in the theca interna recede as 
the follicle regresses. VEGF mRNA is virtually undetectable in atretic follicles 
whereas Ang-2 mRNA is present in large amounts within the granulosa 
(Maisonpierre et al., 1997). In the theca layer, Ang-1 and Ang-2 mRNA expression 
do not change throughout follicular atresia but Ang-2 expression seems to be always 
higher than Ang-1. High Ang-2:Ang-1 ratio and low VEGF turns blood vessels 
towards regression in atretic follicles (Maisonpierre et al., 1997, Hayashi et al., 2003, 
Tamanini and De Ambrogi, 2004). 
TIE-1 and TIE-2 mRNA expression are also higher in early atretic follicles but 
TIE-2 mRNA levels decrease markedly by the mid and late stages of atresia 
(Tamanini and De Ambrogi, 2004, Hayashi et al., 2003). 
 
1.8.3.2 Role of Angiopoietins during luteal development  
 
The VEGF and Angiopoietin-TIE signalling systems are essential for follicular 
and luteal angiogenesis (Shimizu et al., 2007). Ang-1 levels are mainly associated 




suggests that it plays an earlier role than Ang-1 at the sites of vessel formation. Ang-
2 clusters are abundant in the front of the vessels invading the newly formed CL 
(Maisonpierre et al., 1997). 
 During early CL development high Ang-2 and low Ang-1 expression result in 
a high Ang-2:Ang-1 ratio. This ratio is mainly dictated by Ang-1 level variation as 
Ang-2 levels are thought to remain stable throughout CL development. Ang-1 levels 
increase during the mid luteal phase resulting in a low Ang-2:Ang-1 ratio followed 
by higher Ang-2:Ang-1 ratio due to decreasing Ang-1 levels during the late luteal 
phase (Schams and Berisha, 2004, Sugino et al., 2005). The different levels of VEGF 
will determine if unstable blood vessels are to result in angiogenesis or vascular 
regression (Schams and Berisha, 2004). 
The variations of these angiogenic factors and the vascular network present 
during the different luteal development stages clearly demonstrate the close influence 
of these factors in the formation, stabilization and regression of the luteal vascular 
network (Sugino et al., 2005). 
Degenerating CLs show similar patterns of VEGF and Angiopoietins as atretic 
follicles. PGF-2α shows no effect on Ang-1 mRNA expression levels but increases 
Ang-2 mRNA when VEGF mRNA starts to decline (Vonnahme et al., 2006). 
Therefore degenerating CLs show small amounts of Ang-1 and VEGF mRNA 
expression while Ang-2 mRNA is expressed in large amounts (Maisonpierre et al., 
1997). 
Although blood flow has been long recognized as an important factor in ovarian 
function, recent data indicate that angiogenic factors and their receptors may play a 
major role in regulating follicular development and maintenance of progesterone 











1.9 Hypothesis and objective of the study 
 
It has been repeatedly proven that small-dose multiple injections of GnRH are 
capable of consistently inducing ovulation in seasonally anoestrous ewes (McLeod et 
al., 1982b, McLeod et al., 1982a, McLeod et al., 1983, McNatty et al., 1982, Southee 
et al., 1988b, Southee et al., 1988a), and that a defective CL is formed as a result in 
the majority (approximately 75%) of animals (Southee et al., 1988a, Southee et al., 
1988b, McLeod et al., 1982b). Defective luteal function, however,  is not only 
observed in seasonally anoestrous ewes induced to ovulate with small-dose multiple 
injections of GnRH but is also a common phenomenon after the first ovulation at 
puberty, or following parturition over a range of species and is therefore considered 
to affect the fertility adversely. 
These observations provide a controlled in vivo model of defective luteal function 
caused by GnRH-induced ovulation in the seasonally anoestrous ewe. This enables 
what is normally observed after the first ovulation at puberty, or following parturition 
or seasonal anoestrus to be reproduced. 
It has also been extensively shown that progesterone priming of seasonally 
anoestrous ewes for as early  as 3-5 days prior to GnRH treatment results in 100% 
normal luteal function against only 25% of non-primed animals (McLeod et al., 
1982b, Keisler and Buckrell, 1997, Hunter et al., 1988, Husein and Kriddli, 2003, 
Haresign et al., 1996, Hunter et al., 1989, Southee et al., 1988b, Southee et al., 
1988a, Bartlewski et al., 2001, Pearce et al., 1987). However, it is not known how 
progesterone priming eliminates defective luteal function. Previous studies, as cited 
in this literature review, excludes the effect of progesterone priming through the 
gonadotrophins release from the pituitary gland and/or PGF2-α release from the 
endometrium. Collectively, it seems that progesterone given prior to induction of 
pre-ovulatory follicle maturation can affect what happens after ovulation.  
 It is also well documented that an adequate vascular bed is essential for normal 
follicular and luteal development and that angiogenic factors such as VEGF and 
Angiopoietins and their receptors are essential for blood vessel formation and 
maturation (Maisonpierre et al., 1997, Shimizu et al., 2007, Berisha and Schams, 




et al., 2005, Nett et al., 1976). A question arises: is there any possibility that 
progesterone priming can eliminate the defective luteal function by affecting the 
vascular development either in the pre-ovulatory follicle and/or early corpus luteum? 
Indeed there is some, although limited, information to support this as progesterone 
has been shown to stimulate the expression of VEGF and VEGFR-2 in the bovine 
granulosa cells when cultured in vitro (Shimizu and Miyamoto, 2007). It is, 
therefore, hypothesized that  progesterone priming of seasonally anoestrous ewes, 
administered with small dose multiple injections of GnRH eliminates defective luteal 
function by altering the angiogenic system of the selected follicle and early CL.    
In order to test this hypothesis both protein and mRNA expression of VEGF, 
Angiopoietins and their receptors were measured in the follicular layers of pre-
ovulatory follicles before and after the LH surge and in the luteal cells of 1, 2 and 4 
day old CL of seasonally anoestrous ewes treated with small-dose multiple injections 














































2.1 Experimental Animals, progesterone priming and GnRH treatment 
 
Fifty seasonally anoestrous Welsh Mule ewes were divided into 10 groups (1 to 
10). Each ewe had its jugular vein cannulated to facilitate pulsatile GnRH 
(Luteinizing Hormone Releasing Hormone human acetate salt, Sigma-Aldrich, L-
7134, Lot 053K1109) injections and blood sampling. 
Animals from Groups 2, 4, 6, 8 and 10 received a single dose of 20 mg of 
progesterone (Sigma-Aldrich) in corn oil (i.m.) three days before the start of GnRH 
treatment while animals in Groups 1, 3, 5, 7 and 9 received oil vehicle alone. 
Each animal received injections of 500 ng GnRH (diluted in 2 ml of normal 
saline solution) given intravenously every 2 hours for 28 hours to induce LH pulses, 
followed by a bolus injection of 300 g GnRH at 30 hours after the start of GnRH 
treatment. The bolus injection was designed to synchronize the onset of the pre-
ovulatory LH surge at a time when it is shown it to occur in similarly treated animals 
(Khalid et al., 1997). This allowed collection of the ovaries at precise times in 
relation to the LH surge. 
Animals from Groups 1 (n = 5) and 2 (n = 5) were slaughtered 24 hours after the 
start of the pulsatile GnRH treatment (6 hours before the expected LH surge) so that 
pre-ovulatory follicles prior to the LH surge could be analysed. These animals did 
not receive GnRH bolus injection. 
Animals from Group 3 (n = 5) and Group 4 (n = 5) were slaughtered 46 hours 
after the beginning of the GnRH treatment (16 hours after GnRH bolus injection) so 
that pre-ovulatory follicles after the LH surge but prior to ovulation could be 
analyzed.  
Animals from Group 5 (n = 5) and Group 6 (n = 5) were slaughtered 80 hours 
after the beginning of the GnRH treatment (50 hours after GnRH bolus injection) so 
that newly formed CL could be analysed (1 day old CL).  
Animals from Group 7 (n = 5) and Group 8 (n = 5) were slaughtered 104 hours 
after the beginning of the GnRH treatment (74 hours after GnRH bolus injection) so 
that 2 day old CL could be analyzed. 
Animals from Group 9 (n = 5) and Group 10 (n = 5) were slaughtered 152 hours 




days old CL) around the time of regression of the defective CL in animals that were 
not primed with progesterone (Hunter et al., 1988, Hunter et al., 1989). 
The time of the start of pulsatile GnRH treatment and the slaughter times of the 
different treatment groups of seasonally anoestrous ewes primed or non-primed with 
progesterone are illustrated in Figure 4. 
 
 
Figure 4. Diagram illustrating slaughter times of Groups 1 to 10 of progesterone 




To collect the ovaries animals were killed with an overdose injection of 
Pentobarbital Sodium (Euthatal®, Merial Animal Health Ltd) in accordance to the 
Code of Practice for the Humane Killing of Animals under Schedule 1 of the 
Animals (Scientific Procedures) Act 1986. 
The reproductive soundness of the animals used was confirmed by the fact that 
all ewes had lambed earlier in the year (April). The breeding season for Welsh 
Mountain ewes start in mid October (Webster and Haresign, 1983), therefore, by 
performing this experiment in late August it was almost certain that animals were in 
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seasonal anoestrus with no possible negative interference of prolactin on 
gonadotrophin stimulation (Webster and Haresign, 1983) as weaning of lambs took 
place in late June. 
 
 
2.2 Blood sampling for LH quantification and ovulation monitoring 
 
Animals were blood sampled (3 ml) every 2 hours, just before each GnRH 
injection, from the start of GnRH treatment until slaughter (Groups 1 and 2) or until 
16 hours after GnRH bolus injection (Groups 3 and 4) to monitor the timing of the 
pre-ovulatory LH peak. Additional samples from ewes in Groups 1 to 4 were taken at 
30 minute intervals starting at 6 hours after the start of GnRH treatment for a period 
of 4h to confirm that injections induced LH pulses (Figure 5).   
 
 
Figure 5. Blood sampling timeline diagram of Groups 1 to 4 of progesterone primed 
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Blood samples were collected into heparinised tubes (L.I.P. Ltd) and centrifuged 
at 2,500 rpm for 10 minutes at 4 °C. Plasma was carefully transferred into labelled 
tubes (VWR International) and kept at -20 °C until analysed. 
 
2.3 Tissue Collection 
 
The ovaries from all the animals were collected immediately after euthanasia and 
washed in 1x Phosphate Buffered Saline (PBS, BDH). Ovaries containing follicles 
only (Groups 1 to 4) were fixed in 40% v/v neutral buffered formalin for in situ 
hybridization (ISH) and immunohistochemistry (ICH) analysis. If both ovaries had 
CL, one CL was dissected (for Western Blotting analysis) and rest of the ovary along 
with the other CL were fixed in 40% v/v neutral buffered formalin (National 
Diagnostics) for ISH and ICH analysis. If a CL was present in only one ovary, the 
ovary was sliced in half through the CL and one half of the CL was dissected and 
used for Western Blotting and the other half along with remaining ovarian tissue was 
fixed in neutral buffered Formalin for ISH and ICH. Dissected CLs were stored at -
80 °C for Western Blotting analysis.  For ISH and ICH analysis the ovaries were 
fixed in formalin for 24 hours then transferred to 70% v/v ethanol (BDH) until 
embedded in paraffin wax. 
 
2.4 Western Blotting Technique 
 
Western Blotting analysis was done to determine the presence and relative 
quantity of VEGF, VEGFR-2 (Flk-1), Angiopoietin-1 and -2 and TIE-2 receptor in 
early corpora lutea (1, 2 and 4 days old). The indirect Western Blotting technique 
consists mainly of 5 steps: separation of proteins by electrophoresis, transfer of 
proteins to a membrane, primary antibody probing, enzyme-labeled secondary 








2.4.1 Sample preparation and protein estimation 
 
Frozen corpora lutea samples were taken from the -80 °C freezer and placed on 
dry ice. The frozen tissues were ground and the powdered CL was placed in a 2 ml 
microtube. Approximately 5 μg of CL was processed with 300 μl of lysis buffer [ 0.7 
mM Tris (Bio-Rad), 0.02% Sodium Dodecyl Sulphate (SDS, Sigma-Aldrich), 2mM 
Sodium Orthovandate (Sigma-Aldrich), 1% v/v Glycerol (BDH), 1% v/v Protease 
Inhibitor Cocktail Set I (Calbiochem) and 4% v/v distilled water]. Samples were 
homogenized and vortexed until no large pieces of tissue remained. Samples were 
then spun at 13,000 rpm for 5 minutes at 4 °C. The supernatant was transferred to a 
clean microtube and heated in a water bath for 5 minutes at 100 
o
C and vortexed 
prior to protein estimation.  
Detergent cell lysis is often used in conjuction with tissue homogenization to 
disrupt cell membranes. Detergents such as SDS break lipid:lipid, protein:protein and 
lipid:protein interactions disrupting the lipid barrier surrounding cells and 
solubilising membrane proteins (Pierce Perbio Science Applications Handbook and 
Catalog 2005/2006). By including SDS in the lysis buffer preparation, both 
cytoplasmatic (VEGF, Ang-1 and Ang-2) and transmembrane (VEGFR-2 and TIE-2) 
proteins were freed and able to be analysed.  
A 2 μl aliquot of sample lysate was used to determine protein concentration by 
spectophotometry (NanoDrop® ND-1000 Spectophotometer, NanoDrop 
Technologies Inc., Wilmington, Delaware, USA). Once the total protein 
concentration of the sample had been determined, dilution with Lysis Buffer was 
carried out to achieve a final concentration of 2 μg protein/μl of solution. To each 
diluted sample 2% bromophenol blue (Sigma-Aldrich) and β-mercaptoethanol 
(Sigma-Aldrich) were added at a final concentration of 2% and 5%, respectively. 
 In order to achieve satisfactory protein detection levels it is important to observe 
that samples must go through purification steps such as denaturation and reduction, 
amongst others, which aim to make the target protein more accessible to the 
antibodies being employed. The denaturating temperature for most existing proteins 
is below 100 °C, therefore submitting the samples to a temperature of 100 °C should 




polypeptic chain. The SDS used in the lysis buffer aids the denaturation of the 
proteins by breaking the hydrophobic interactions within the molecules and thus 
destroying the protein’s native form (Marzzoco and Torres, 1999). β-
mercaptoethanol added in excess will denature the protein by reducing disulphide 
bonds thus overcoming some tertiary protein folding and breaking up quaternary 
protein structure (Sigma-Aldrich, 2-Mercaptoethanol Product Information Sheet).  
Samples were kept at -20 
o
C until needed for gel electrophoresis.  
 
2.4.2 Gel electrophoresis 
 
The principle of electrophoresis is based on the fact that under the same pH level 
different proteins have different charges, which will make them migrate at different 
speeds when submitted to an electric field. Agarose and acrylamide gels enable 
proteins to be separated by their molecular weight as well as by their charge 
(Marzzoco and Torres, 1999, Scientific, 2009). Acrylamide is the substance of choice 
for the preparation of gels and, when in contact with ammonium persulphate, forms a 
cross-linked polymer network that works as a sieve separating the molecules. The 
size of the pores formed in a gel is inversely related to the amount of acrylamide 
used. Therefore, high percentage gels have smaller pores than low percentage ones 
and are thus better suited for separating small proteins (Scientific, 2009). 
Polyacrylamide gel electrophoresis (PAGE) is commonly used to characterize 
proteins in a specific sample. There are different types of PAGE but the most widely 
used is the SDS-PAGE technique which separates proteins mainly according to their 
mass. On the SDS-PAGE system the detergent SDS binds to the hydrophobic 
radicals of the protein in a pattern of one SDS molecule for every two amino acid 
residues. The SDS molecules mask the original charge of the native protein by 
providing a negative charge. This results in a long amino acid complex with negative 
charge density that is proportional to the length of the polypeptic chain, no matter the 
protein. This method therefore allows proteins to be separated exclusively by their 
molecular weight (Marzzoco and Torres, 1999, Scientific, 2009) 
Mini one dimension (1D) gels were used for the Western Blotting assays and 




resolving gel varied in percentage concentration according to the protein being 
analysed. High percentage gels were used for smaller proteins and lower percentage 
gels for heavier proteins, as described in Chapter 4. The resolving gels were 
composed of a variable concentration of 30% Acrylamide (Protogel®, National 
Diagnostics), distilled water, Tris (Bio-Rad), SDS (BDH), ammonium persulfate 
(Sigma-Aldrich) and TEMED (1,2-bis(dimethylamino)-ethane, Sigma-Aldrich). 
The composition of resolving and stacking gels used in this project can be found 
in Table 2. The resolving gel buffer consisted of 1.5M Tris (electrophoresis graded) 
in distilled water whilst the stacking gel buffer consisted of 0.5M Tris in distilled 
water, pH adjusted with HCl (BDH Analar®) to 8.4 and 6.8, respectively.  The 
resolving gel was left to set for at least 15 minutes before the stacking gel was added. 
Stacking gel at 4% was used to create wells into which the samples were loaded. 
Combs 1.5 mm thick were used to shape wells and the stacking gel was left to set for 
at least 30 minutes. 
 










10% w/v SDS 
(ml) 
4% 6.1 1.3 2.5 0.1 
6% 5.4 2.0 2.5 0.1 
8% 4.7 2.7 2.5 0.1 
10% 4.1 3.3 2.5 0.1 
12% 3.4 4.0 2.5 0.1 
14% 2.7 4.7 2.5 0.1 
16% 2.1 5.3 2.5 0.1 
For resolving gel add 50 μl of 10% Amonium persulfate and 5 μl TEMED 
For stacking gel add 50 μl of 10% Amonium persulfate and 10 μl TEMED 
Bio-Rad Mini-Protean 3 Cell Instruction Manual 
 
Equal amounts of extracted protein were loaded into the acrylamide mini gels (8 
x 10 cm) and separated by SDS-PAGE. The total amount of protein added varied 
according to the protein of interest and is further detailed in Chapter 4.  For each 
electrophoresis a negative control (72.5% v/v distilled water, 0.5M Tris-HCl at pH 
6.8, 10% v/v glycerol,  5% v/v  β-mercaptoethanol, 0.1% w/v bromophenol blue and 




Invitrogen) and a positive control (an experimental sample used repeatedly) were 
also loaded into each gel. 
Electrophoresis was performed using 1x Tris/Glycine/SDS tank buffer (National 
Diagnostics) at 150v and 400mA for 60-100 minutes or until samples ran through. 
Under the effect of an electric current the proteins migrate down the gel matrix 
creating lanes of protein bands at different molecular weights.   
 




Once the electrophoresis was done the stacking gel was cut off and the remaining 
gel containing the proteins was soaked in Transfer Buffer (39mM glycine, 48mM 
Tris, 0.037% w/v SDS and 20% v/v methanol in distilled water) for 15 minutes. One 
cut to size polyvinyl difluoride (PVDF) membrane (Immobilon-P® transfer 
membranes, pore size 0.45μm, Millipore Corporation) per gel was soaked in 100% 
methanol (BDH) for 5 minutes then washed in water for a further 5 minutes and left 
in contact with Transfer Buffer for 15 minutes prior to the blotting process. PVDF 
membranes are hydrophobic in nature and proteins bound to this type of membrane 
can be used in most immunodetection protocols and can also be detected by most 
dyes (Hames, 1998). 
Thick filter paper (Bio-Rad) was cut to size and soaked in Transfer Buffer 
alongside the mini gels. A filter paper – membrane – gel - filter paper sandwich was 
placed in a Semi-Dry Blotting machine (Trans-Blot® semi-dry transfer cell, Bio-Rad 
Laboratories) and electrophoretic elution was performed at 25v and 33mA/gel 
(0.8mA per cm² gel) for 45 to 90 minutes. Semi-dry blotting is considered to be a 
quick and complete transfer method (Harlow and Lane, 1988).  
 
2.4.3.2 Blocking and Comassie Blue staining 
 
Transfer of protein was quickly verified by the presence of the prestained 




luminescent darkroom labeling tape, Sigma-Aldrich) were placed where the 
molecular weight markers were to facilitate visualization at the end of the process 
when films were to be revealed. To better check that proteins were satisfactorily 
transferred, some membranes were stained with Ponceau S (Sigma-Aldrich). The 
stain reversely binds to the proteins in the membrane and the presence of bands show 
a successful transfer. Ponceau S can be quickly washed away with distilled water 
without significant interference with membrane quality. 
Membranes were then placed in blocking solution of 10% milk or 5 to 10% 
Bovine Serum Albumin (BSA, Sigma-Aldrich) in TBST [50mM Tris, 150mM 
Sodium Chloride (NaCl, Sigma-Aldrich), 0.02% v/v Tween 20 (BDH), dissolved in 
water and pH adjusted to 7.4] . Blocking was performed for 2 hours or overnight, in a 
shaker, depending on the protein of interest. The blocking step is essential to 
minimize background staining. The milk proteins or BSA saturate the binding sites 
(pores) of the membrane that do not contain the proteins from the gel, thus 
preventing primary and secondary antibodies becoming trapped in the pores and 
sending non-specific signals when the detection step is performed (Hames, 1998).  
One other way of checking the transfer rate of the proteins was to stain the gels 
with Comassie Blue solution [0.25% w/v of Comassie Brilliant Blue (Sigma-
Aldrich), 2% v/v Methanol (BDH) and 1% v/v Acetic Acid (BDH)] for 1 hour after 
blotting was over. Comassie blue is an organic dye and consists of one of the 
simplest methods of protein detection. It is believed that a strong bond is formed 
between the dye and the protein molecules, especially basic amino acid residues in 
the proteins (Hames, 1998). After 1 hour the excess dye was washed off by placing 
gels in a de-staining solution of 10% v/v acetic acid (BDH) and 10% v/v methanol 
(BDH) in water overnight with an absorbent paper. Blue bands could clearly be seen 






       
Figure 6. Comassie Blue stained gels before (left) and after (right) semi-dry blotting 
for 90 minutes. Even though very small amounts of protein can still be seen in the gel 




2.4.3.3 Primary antibody probing  
 
After blocking, membranes were incubated with 5 ml/membrane of primary 
antibody solution in a sealed bag at high agitation. Polyclonal antibodies specific to 
the proteins of interest were used at 1:150 to 1:500 concentration in 5% w/v milk in 
TBST. Membranes were then washed 4 times in 1x TBST for 15 minutes to remove 
excess primary antibody. Optimal concentration and incubation period with primary 
antibody for each protein of interest can be found detailed in Chapter 4. 
This project used indirect immunodetection of proteins in which a primary 
antibody is directed specifically against the protein of interest and is then detected 
using a secondary labelled antibody directed against the primary antibody (Hames, 
1998).  This enhances the signal intensity during the detection step, providing better 
results than the direct method. 
 
2.4.3.4 Secondary antibody probing 
 
Washing was followed by probing with a Horseradish Peroxidase (HRP) labelled 
secondary antibody, specific to the primary antibody used, for 1 hour at slow 
agitation. Further details on the secondary antibody used for each protein assay can 




minutes each time, prior to detection, to remove excess secondary antibody and thus 
avoid non-specific background staining. 
 
2.4.3.5 Enhanced chemiluminescence detection method 
 
Membranes were placed in Saran wrap and 4 ml of 1:1 ECL solution n°1 and n°2 
(ECL™ Western Blot detection reagents, GE Healthcare) was carefully poured onto 
each membrane and left to incubate for 1 minute. The excess ECL reagent was 
drained and membranes wrapped in clean Saran wrap and placed in a film cassette. 
In a dark room, membranes were put in contact with a film sheet (Hyperfilm®, 
Amersham Biosciences). 
Enhanced chemiluminescence is based on the emission of light during the 
horseradish catalyzed oxidation of luminol. The horseradish peroxidase present in the 
secondary-primary antibody-protein complex oxidises the substrate quantitatively 
and the light emitted is captured on film (Figure 7).  
The films were exposed to the membranes for 1 to 10 minutes depending on the 
protein being detected. Further information can be found in Chapter 4. Films were 
removed from the cassette, placed in developer for 1-2 minutes, rinsed in distilled 
water and placed in fixer (GBX developer and fixer, Kodak Processing Chemicals 
for Autoradiography films) for approximately 1 minute. Excess fixer was removed 
by placing the film in water and films were then hung to dry at room temperature. 
 
            A          B           C      D 
 
Figure 7. Autoradiograph image of the β-actin band from CL lysate samples (A, B, 
C and D) at a molecular weight of approximately 50 kDa. Molecular weight markers 





2.4.4 Western Blotting analysis 
 
Semi-quantitative analysis of protein content was done by optical densitometry 
through computer software Quantity One® (Bio-Rad Laboratories). For each sample 
an area of analysis was drawn around the band and on an area of the background, 
including the control. The value obtained for each band had the background of its 
lane subtracted so that any background interference was removed from the analysis. 
The obtained values were divided by the value of the control and were then 
compared based on how much of the control they corresponded to. The control 
sample remained the same for each and every gel, at the same concentration. 
 
2.5 ELISA Immunoassay 
 
Plasma LH quantification was done using a sandwich type Enzyme Linked 
Immuno Sorbent Assay (ELISA, LH DETECT®, INRA Centre de Tours-PRC, 
Nouzilly, France) to monitor time of pre-ovulatory LH peak and to monitor LH 
pulses. 
ELISA immunoassays are considered quick and reliable and can be used to 
determine relative or absolute levels of most protein antigens (Harlow and Lane, 
1988). In this ELISA type sandwich assay two polyclonal antibodies produced 
against the same antigen (LH) were used. The microplate used was sensitized with a 
purified anti-LH antibody (AC1) prior to use. The LH from the experimental samples 
binds to the AC1 and is later bound by a second anti-LH antibody (AC2). Reaction 
intensity is amplified by a peroxidase conjugated antibody (AC3) which binds to the 
immunocomplex formed. Enzymatic activity is measured using a chromogenic 
substrate and the reaction intensity is measured by spectophotometry. Reaction 
intensity is proportional to LH concentration in sample (LH DETECT® instruction 
manual).  
The major advantages of this assay are its specificity and the speed in which it 
can be performed, as well as the fact that the antigen does not need to be purified. 




Microplates were removed from the -20 °C freezer and allowed to reach room 
temperature for about 30 minutes. Meanwhile experimental plasma samples were 
diluted 1:5 with dilution buffer (provided in the kit) and the standards, positive 
control and antibody solutions left to thaw at room temperature. 
Once at room temperature standards (0, 0.06, 0.12, 0.25, 0.5, 1.0, 2.0 and 3.0 
ng/ml) were loaded in duplicate into the first two rows of the microplate. One 
hundred μl of diluted samples and positive controls were loaded in duplicate to the 
remaining wells. The plate was covered with adhesive strip and left to incubate for 1 
hour at room temperature.  
The plates were emptied by inverting onto an absorbent paper and washed 5 
times with 0.1% v/v Tween 20 (BDH) in PBS (BDH). Plates were turned and tapped 
on absorbent paper between washes. To each well 100 μl of anti-LH antibody (AC2) 
was added and left to incubate for 1 hour at 37 °C. Plates were emptied and washed 
as described above. After that, peroxidase-conjugated antibody (AC3) was added 
(100 μl/well) and left to incubate at 37 °C for 1 hour, followed by washing. One 
hundred μl of substrate solution (TMB) was added to each well and blue colour was 
left to develop for 10 minutes. One hundred μl of stopping solution was added 
turning the solutions from blue to yellow (Figure 8) so that measurements using the 
spectrophotometer could be performed at wavelength of 450nm within 30 minutes of 
the stopping solution being added. 
The concentrations obtained for the experimental samples were based on the 
comparison with those obtained from the standards and the concentration adjusted by 
the dilution factor. 
 
 
Figure 8. Illustrative LH ELISA Immunoassay microplate following the addition of 










The process of fixation is essential to preserve cells and tissues in a reproducible 
and life like manner. In addition to altering the chemical nature of cells, fixatives can 
also cause variable degree of porosity in the tissue allowing penetration of various 
sized molecules. Non-coagulative fixatives such as formalin result in smaller pore 
sizes than the coagulant ones. Most fixative solutions are designed to stabilize 
proteins thus best preserving cellular structure. 
Formalin based fixatives are usually well tolerated by cells and have a good 
tissue penetration which is greatly related to tissue preservation. Some shrinkage and 
distortion may occur, as can be observed in some follicles, especially those placed 
close to the ovary border. Formaldehyde fixes by reacting primarily with amino acids 
to form cross-linking methylene bridges. This results in low permeability to 
macromolecules and minimal alteration in intracytoplasmatic protein structure. Since 
the formalin-fixing paraffin-embedding technique has been proven to be superior for 
preserving cell and tissue morphology, it is one of the most commonly used methods 
of tissue preservation and preparation for research analysis (Boenisch et al., 2001). 
Formalin has been the fixer of choice for many ISH and ICH studies using human 
(Fraser et al., 2005, Ferrara et al., 2003a), equine (Al-zi'abi et al., 2003) and ovine 
ovaries (Vonnahme et al., 2006, Redmer et al., 2001, Campbell et al., 2004) and, 
therefore, was the fixer used in this project. 
Sheep ovaries were washed in PBS pH 7.4 (BDH) solution at room temperature, 
fixed in 40% v/v Neutral Buffered Formalin (National Diagnostics) solution for 24 









2.6.1.2 Tissue processing and embedding 
 
 The preparation of tissues for histology requires infiltration and embedding of 
the specimens in a firm matrix, like paraffin, for microtomy. As paraffin is 
immiscible with aqueous solutions, fixed tissue samples must be dehydrated prior to 
paraffin embedding (Wishe et al., 1980).  
Ovaries were individually placed in small labelled embedding cassettes (Taab 
Laboratories) and placed in an automatic tissue processor (Shandon Citadel 2000). 
The samples were submitted to increasing ethanol concentration (1 hour in 70% v/v 
ethanol, 1 hour in 90% v/v ethanol, 1 hour and 30 min in the first two washes of 
100% ethanol and 1 hour and 45 minutes for the last two 100% ethanol washes) and 
then placed in CNP30 (Taab Laboratories) for 3 hours, twice. CNP30 is an organic 
solvent made from a blend of 1,1,1-trichloroethane with perchloroethylene and some 
additives (Lake, 1980). Paraffin solvents are organic compounds miscible with 
paraffin at 56 
o
C as well as with dehydrating agents at room temperature (Wishe et 
al., 1980). Samples were then embedded in Paraffin Wax (Paraplast®, Leica, Taab 
Laboratories) at 60-65 
o
C for 4 hours and 30 minutes. This final step impregnates the 
tissue with molten wax for the final stage, embedding, when tissues are placed in 
paraffin wax blocks ready to be cut. 
Ovaries were placed in stainless steel cassette moulds and covered with molten 
wax. Whole ovaries were placed with the longest side facing the bottom of the block. 
Ovaries containing corpora lutea were placed with CL facing down to facilitate 
cutting. Blocks were allowed to cool before being removed from the mould and then 
stored at room temperature before sections were cut. 
 
2.6.2 Slide preparation 
 
 Prior to sectioning, wax blocks were melted into wooden blocks for support 
with the tissue surface facing upwards (cutting surface). Six micrometer sections 
were made using a steel blade microtome (HM 360 Microtome, Microm) and then 
placed in a water bath at 45 
o
C to prevent wrinkling. Sections were placed on glass 




to their ability to adhere the sections even under hot conditions for long incubation 
periods as those found in the in situ hybridization protocol.  Slides were dried using a 
hot plate (temperature just below wax melting point) and air dried overnight.  
 Ovaries from pre-ovulatory animals were serially sectioned whilst ovaries 
containing CLs only had sections made from the corpora lutea. Two sections were 
put on each slide and every 25
th
 slide (25, 50, 75, 100, 125
th
 and so on) of serially 
sectioned ovaries was stained with Hematoxylin-Eosin (HE) to be used for mapping 
and follicle identification. Ovaries from pre-ovulatory animals (Groups 1 to 4) 
yielded roughly 300 slides each, resulting in a total of 6,000 serially sectioned slides. 
Approximately 30 slides were made from each CL containing ovary. These slides 
were used for both ICH and ISH assays. 
 
2.6.3 Ovary mapping 
 
2.6.3.1 Hematoxylin-Eosin Staining 
 
 Slides were placed in CNP30 (Taab Laboratories) for at least 30 minutes for 
dewaxing and rehydrated through a series of ethanol solutions (100%, 90%, 70% and 
50% v/v), 2 minutes in each. Slides were quickly washed in distilled water for 1 
minute and placed in Mayer’s Haematoxylin (Haemalum-Mayer –Taab Laboratories) 
for 15 minutes. Slides were then placed under gently running tap water for 5 minutes 
or until sections appeared blue.  Slides were then placed in 1% w/v Eosin (Taab 
Laboratories) for 3 minutes and washed gently in tap water for 10 seconds following 
dehydration through graded ethanol solutions (50% and 70% v/v for 1 minute, 90% 
v/v and 100% for 2 minutes) and placed in CNP30 for at least 5 minutes. Slides were 
cleaned and mounted using DePex Mounting Medium (BDH) and covered with a 
glass coverslip (VWR International). The result was a section which had nuclei 
stained blue with a cytoplasm of various shades of pink. This type of staining 





            
Figure 9. Paraffin-embedded ovarian section from seasonally anoestrous ewes 
treated with pulsatile GnRH, stained with Hematoxylin-Eosin for mapping. Ovary 
displaying different size follicles (left) and the different follicular layers (right): 





2.6.3.2 Ovary Mapping 
 
 Ovary mapping comprised of identifying and measuring follicles bigger than 
2 mm in diameter in every 25
th
 slide that had been stained with HE. Slide analysis 
was done using a bright field microscope with a measuring eyepiece. A picture of the 
section was drawn and the follicles identified with numbers (Figure 10).  
As sheep follicles become gonadotrophin dependent when they reach 2mm in 
diameter (Driancourt, 2001) follicles smaller than 2mm were not selected for this 
project. Based on our own observations, the largest follicles detected in animals from 
Groups 1 to 4 did not exceed 6-7 mm in diameter. As the difference between the 
dominant follicle and the largest subordinate follicle in sheep is 2-3 mm (Driancourt, 
2001), the largest subordinate follicles that could be observed in the experimental 
animals would have approximately 3-4 mm. Therefore, follicles bigger than 2 mm in 
diameter were selected for in situ hybridization and immunohistochemistry analysis 
and then further classified into small (2-2.5 mm in diameter) and large (≥2.5 mm in 








    
Figure 10. Ovary mapping illustrating follicle distribution on the 50
th
 (left) and 75
th
 
(right) Hematoxylin-Eosin stained slide from a progesterone primed seasonally 
anoestrous ewe treated with pulsatile GnRH slaughtered prior to the LH surge. 
  
 
2.6.4 Immunohistochemistry assay 
 
 Slides of interest were dewaxed in CNP30 (Taab Laboratories) for at least 30 
minutes, rehydrated through graded ethanol solutions (100%, 70% and 50% v/v) for 
2 minutes each and then washed in deionised water for a further 2 minutes. 
 Slides were then incubated in 3% v/v Hydrogen Peroxide (Sigma-Aldrich) in 
Methanol (BDH) for 15 minutes to ensure that any endogenous peroxidase activity 
was blocked.  Peroxidase activity is a common property of many proteins, including 
haemoglobin, myoglobin and catalases (Boenisch et al., 2001). If endogenous 
peroxidase activity is not suppressed, peroxidase substrates used at the end of the 
immunohistochemistry procedure to develop colour may interact with tissue proteins 
and result in a false positive reaction. Therefore, incubation of slides in Hydrogen 
peroxide/Methanol solution is done to minimize non-specific results, also known as 
background staining. This step would not be necessary if Alkaline Phosphatase 
substrates were used to develop colour at the end of the immunohistochemistry 
procedure.  
Slides were washed twice for 5 minutes in 1x PBS pH 7.4 (BDH) prior to a 10 
minute incubation in boiling hot 0.01M Sodium Citrate (Sigma-Aldrich), adjusted to 
pH 6.0.  This step, also known as antigen or epitome retrieval, is done in order to 
improve immunoreactivity of formalin-fixed tissue antigens. Each antigen may 
contain from one to many epitopes and each of these may be composed of five or 
more amino acids. Although some epitopes are formalin-resistant and remain 




structure and binding capability or cross-linking with unrelated proteins thus 
“masking” the antigen and making it unavailable for binding (Boenisch et al., 2001). 
This heat-induced antigen retrieval step allows more epitomes of the protein of 
interest to be available for binding with the primary antibody to be used. 
Slides were dried and sections circled using a water proof pen (ImmEDGE® pen, 
Vector Laboratories) to avoid spillage of solution. 
Sections were incubated in 300 μl of Blocking Solution containing 1% v/v 
Normal Goat Serum (Vector Laboratories), 20% v/v Avidin D (Vector Laboratories) 
in PBS pH 7.4 (BDH) for 30 minutes in an humidified chamber.  The addition of 
normal serum will lead to hydrophobic binding between serum proteins and tissue 
proteins.  Due to the similarity of serum proteins and IgG they compete for the same 
hydrophobic binding sites in the tissue. Therefore when the biotinilated IgG (2
nd
 
antibody) is added to the sections there will be less tissue proteins for it to non-
specifically bind to. The secondary antibody should bind mostly to the primary 
antibody thus reducing background staining. Normal serum should be different from 
the species in which the primary antibody is raised in to further avoid non-specific 
binding of the secondary antibody,  
Slides were drained and probed with 200 μl/section of primary antibody in 20% 
v/v Biotin (Vector Laboratories) in PBS pH 7.4 (BDH). Antibodies for the different 
proteins analysed were used at different concentrations and are further specified in 
Chapters 3 and 4. 
Biotin, a vitamin (B7) and coenzyme, can be found distributed in a variety of 
tissues where it is bound to other proteins. Biotin once in contact with Avidin forms 
a strong and stable compound. When Avidin is added to the blocking solution it 
binds to the Biotin found in the tissue. Biotin can only bind to one molecule of 
Avidin, however, Avidin has 4 binding sites to Biotin (Boenisch et al., 2001). 
Therefore, incubation with Biotin after incubation with Avidin is essential for the 
blocking process to be complete. This will reduce any non-specific binding of the 
Avidin-Biotinilated enzyme complexes (ABC) that are used to enhance the 
immunohistological response. The use of Avidin/Biotin blocking is essential when 




For VEGFR-2 assays, a slightly different approach was used for the blocking and 
primary antibody probing, but which led to similar results. For this specific protein 
slides were blocked for 30 min in 1% v/v Normal Goat Serum (Vector Laboratories) 
in PBS, drained, had a drop of Avidin D (Vector Laboratories) added to each section 
and incubated for 15 minutes, then drained and a drop of Biotin (Vector 
Laboratories) added to each section and incubated for a further 15 minutes. Slides 
were then drained and probed with primary antibody diluted in PBS alone.  
For every 3 positive sections 1 control/negative section was used. The control 
section was a similar tissue section to the positive ones and was treated in the same 
way except that instead of primary antibody, Normal Rabbit IgG (Santa Cruz 
Biotechnologies) was used in the same concentration and diluted in a similar 1% v/v 
Normal Goat Serum (Vector Laboratories) in PBS solution with biotin (or without in 
the case of VEGFR-2 assays). Control sections were incubated for as long as the 
positive ones. Normal IgG used in control slides should be from the same species in 
which the primary antibody is raised in. 
Once the incubation time was over, slides were washed thrice in PBS (BDH) for 
5 minutes. This washing step should have been able to remove all excess and 
unbound primary antibody reducing the chances of a false positive reaction. The 
Rabbit IgG should not have been able to bind to the tissue as there was no specific 
antigen or binding site for it and it should have been washed away once the 
incubation time was over. All sections were then incubated with 200 μl of 
biotinylated anti-rabbit IgG secondary antibody (ABC Kit, Vector Laboratories) 
diluted 1:25 in 2% v/v Normal Goat Serum (Vector Laboratories) in PBS for 30 
minutes.  
The method used in this protocol is the two-step indirect staining method in 
which an unconjugated primary antibody first binds to the protein of interest in the 
tissue and a labelled secondary antibody directed to the primary antibody is applied 
followed by the substrate solution. This procedure is more sensitive than direct 
methods as several secondary antibodies bind to a number of epitopes of the same 
primary antibody amplifying the response. The biotynilated secondary antibody used 





Slides were washed twice in PBS (BDH) for 5 minutes to remove excess and 
unbound secondary antibody.  Sections were incubated in 200 μl ABC solution [2% 
v/v solution A (Avidin DH), 2% v/v solution B (Biotinilated peroxidise enzymes) 
(ABC Kit, Vector) in PBS] for 30 minutes at room temperature. ABC solution was 
left to stand at room temperature for 30 minutes prior to being added to the slides. 
During the 30 minutes pre-incubation period Avidin DH (solution A) binds to the 
biotynilated peroxidase (solution B) forming a three-dimensional complex. As 
previously mentioned, Avidin has a strong affinity for Biotin but whilst one molecule 
of biotin can only bind to one molecule of Avidin, one molecule of Avidin can bind 
to as many as four biotin molecules. However, due to the molecular orientation of the 
binding sites in the Avidin molecule, fewer than four molecules of biotin will 
actually bind, leaving at least one binding site free (Boenisch et al., 2001, Vector 
Laboratories catalogue 2007-2008).  
Once this pre-incubated solution is added to the slides the avidin-biotinylated 
enzyme complexes bind to the biotinylated secondary antibody found in the tissue 
through the binding site that was left free in the three dimensional complex. 
Therefore, to every protein of interest several primary antibodies can be found 
attached. To every primary antibody several secondary antibodies can be found 
attached and to every secondary antibody several avidin-biotinylated enzyme 
complexes can be found attached. This should guarantee a good amplification of the 






    Vector Laboratories Catalogue 2007-2008 
 
Figure 11. Simplified diagram illustrating the indirect detection method followed by 
ABC amplification signal used in immunohistochemistry assays. 
 
 
Slides were washed twice in PBS (BDH) to remove any excess of ABC solution. 
ImmPACT® DAB (Vector Laboratories) was used as substrate to develop colour. 
DAB is a diaminobenzidine-based peroxidase substrate which reacts with the 
enzymes from the ABC solution producing a brown colour in positive slides (Figure 
12). Sections were left in contact with DAB for different lengths of time, according 
to optimized time determined for each protein as detailed in the relevant chapters.  
Excess DAB was removed by briefly washing slides in deionised water and 
counterstaining was done by immersing slides in Hematoxylin (Vector Laboratories) 
for 1 minute. Slides were washed under running tap water for 5 minutes. 
After dehydration though a series of graded ethanol solutions (50%, 70%, 100%) 
slides were placed in CNP30 for at least 5 minutes and mounted with Vectamount 
Permanent Mounting Medium (Vector Laboratories) using a glass cover slip (VWR 
International). Slides were air dried overnight and kept away from direct light until 





        
Figure 12. VEGF Immunohistochemistry negative (left) and positive (right) slide 
following colour development using DAB (brown) and Hematoxilin counterstaining. 
The granulosa (G) and theca (T) follicular layers are indicated. Bright field 
microscopy at 400X magnification. 
 
 
2.7 In situ hybridization 
 
In situ hybridization is a technique that allows specific nucleic acid sequences to 
be detected in morphologically preserved tissue sections. As the name suggests, the 
detection is done by hybridization of probe and nucleic acid sequence of interest in 
the exact place that it is found in the cell. The technique provides microscopic 
topological information and semi-quantitative comparison of DNA and/or mRNA 
activity (Eisel et al., 2002). 
The technique was developed in 1969 by Pardue and Gall and (independently) by 
John et al. in the same year. At the beginning, radioisotope labels and 
autoradiography were used to detect hybridized sequences. Nowadays, however, 
non-radioactive methods of ISH are most commonly employed in association with 
colorimetric analysis. There are two types of non-radioactive ISH methods: direct 
and indirect. In the direct method a reporter molecule is bound to the probe thus 
allowing visualization of probe-target immediately after hybridization. The main 
advantage of the direct method is the shorter time taken to perform the assay. 







and washing conditions and the interference of reporter molecule in the hybridization 
process far outweigh the benefits. Indirect methods require a reporter molecule to be 
chemically or enzymatically introduced into the probe so that a specific antibody to 
the reporter molecule can be used. One of the most used systems is the Digoxigenin 
(DIG) System (Eisel et al., 2002) (see section 2.7.1.11)    
The significant advantage of ISH when compared to methods like Southern and 
Northen Blotting is that it permits the localization of the hybridization material 
within a cell or tissue. The major disadvantage of ISH is that maintaining the 
morphology and structures of the cell potentially introduces inhibitory elements. To 
overcome such conditions pre-hybridization treatment of tissues are essential 
(Baumgart et al., 2001) 
 
2.7.1 Riboprobe synthesis 
 
RNA probe sysnthesis involves various steps which follow on from one another. 
These steps include: (1) RNA extraction, (2) Complimentary DNA (cDNA) 
synthesis, (3) Polymerase Chain Reaction (PCR), (4) Gel extraction, (5) Ligation, (6) 
Transformation, (7) Bacterial selection, (8) Bacterial growth, (9) DNA extraction, 
(10) Restriction Digest and Linearization and (11) Probe synthesis and label. 
Not all steps were performed in this project as bacteria containing the plasmid of 
interest were supplied. Thus only steps 2.7.1.8 to 2.7.1.11 were performed for the 
work in this project. Steps 2.7.1.1 to 2.7.1.7 were performed in our laboratory by Dr 
Waliul Chowdhury, and will not be discussed in detail in this thesis. 
 
 
2.7.1.1 RNA extraction 
 
In order to make riboprobes that will detect ovine mRNA, sheep tissues such as 
liver, ovary and muscle had their RNA extracted. The extraction process basically 
consists of homogenizing the tissue and RNA isolation using phenol ethanol and a 
number of centrifugation steps. The total RNA extracted is composed of messenger 




2.7.1.2 Complimentary DNA synthesis 
 
A DNA sequence is synthesised based on the extracted mRNA. Incubation of 
RNA, nucleotide bases (A, T, G and C) and M-MLV enzyme at 37 °C for 1 hour 
results in the production of a strand of DNA complimentary to the RNA available. 
 
2.7.1.3 Polymerase Chain Reaction 
 
Messenger RNA sequence of the protein/factor of interest is identified and PCR 
primers are designed so that only specific cDNA is amplified. This process 
guarantees that the cDNA from the mRNA of interest is present in a much greater 
number than any other cDNA. 
 
2.7.1.4 Gel extraction  
 
 PCR samples are run on agarose gel and, based on the number of base pairs 
of the cDNA of interest, the band of the product is identified on the gel and extracted 
using a series of buffers and centrifugation. 
   
2.7.1.5 Ligation 
 
This process consists of inserting the extracted cDNA into a linear vector. When 
the cDNA is added the DNA binds to both ends of the vector forming a circular 





Competent Escherichia coli are used in this step. These bacteria have already 
perforated membranes enabling substances, such as the plasmid, to pass into the cell. 
PGEM-T Easy Vector (Promega) containing the DNA sequence of interest was 




2.7.1.7 Bacterial selection or blue and white screening 
 
The bacterial cells are spread on agar plates containing a selective broth. 
Following overnight incubation both blue and white bacterial colonies can be 
identified. Blue colonies are those that contain the vector but not the DNA of 
interest. The white colonies, on the other hand, contain the plasmid. These white 
colonies are picked from a plate, grown in broth and kept at -80 °C for further use.  
 
2.7.1.8 Bacterial growth 
 
Approximately 10 ml of autoclaved 25% w/v LB Broth (Merk) in water was 
pipetted into a 50 ml sterile falcon tube and left to reach room temperature for 
approximately 30 minutes. One tube was used as a control and two other tubes to 
grow the bacteria of interest. To each tube (except control) 50 μl of the bacterial 
culture containing the plasmid of interest was added and all tubes were incubated  in 
a shaker at 37 °C for 6 hours. 
After this first incubation period, the control and bacteria cultures were added to 
a sterile glass conical flask containing 90 ml of LB broth. By this stage it was 
possible to observe if there was bacterial growth in the falcon tubes by the opaque 
aspect of the broth. The flasks were covered with aluminium foil and incubated in a 
shaker, at 37 °C, overnight.  
If by the next day the control flask had signs of contamination the cultures would 
be disposed of and procedure repeated. However, if the control flask was clear, 
cultures would be used for cDNA extraction. In order to have a stock of these 
bacteria containing the plasmid of interest, 500 μl of bacteria culture in broth was 
added to 500 μl of glycerol (BDH) and stored in 2 ml microtubes at -20 °C. 
 
2.7.1.9 DNA extraction 
 
Complimentary plasmid DNA extraction was performed using Qiagen® Plasmid 
Kit (Qiagen). The protocol and reagents used were those provided with the product 




Bacterial culture was put into 50 ml falcon tubes and the bacteria cells harvested 
by centrifugation at 6,000 x g for 15 minutes at 4 °C. All traces of supernatant were 
carefully removed by inverting the tube. Bacterial pellets were re-suspended in 4 ml 
of Buffer P1 with RNAse A by vortexing until a homogeneous solution was 
obtained. To each tube 4 ml of Buffer P2 was added and mixed gently by inverting 
the tubes 4-6 times. Lysis reaction was performed for 5 minutes at room temperature. 
The precipitation of genomic DNA was achieved by adding 4 ml of chilled Buffer P3 
and incubating in ice for 15 minutes, after gently mixing. A fluffy white material 
formed and the lysate became viscous. The precipitated material contained genomic 
DNA, proteins, cell debris and SDS. 
Samples were centrifuged at 20,000 x g for 30 minutes at 4 °C. Supernatant 
containing plasmid DNA was removed and transferred to a clean falcon tube. 
Samples were centrifuged at 20,000 x g for a further 15 minutes. Supernatant was 
removed and kept for filtration. 
Qiagen Tips were equilibrated by applying 4 ml of buffer QBT and column was 
allowed to empty by gravity flow. Supernatant containing plasmid DNA was applied 
to the Qiagen Tip and allowed to enter the resin by gravity flow. If the process is 
successful cDNA should be completely bound to Qiagen resin in tip. Tips were 
washed twice with 10 ml of Buffer QC to remove the majority of contaminants in the 
plasmid DNA preparation. Using new tubes, DNA was eluted by adding 5 ml of 
Buffer QF to the Qiagen Tip. DNA was precipitated by adding 10.5 ml of room 
temperature isopropanol to the eluted DNA. Samples were mixed and centrifuged at 
20,000 x g for 30 minutes at 4 °C. The supernatant was carefully removed and the 
DNA pellet was further washed with 5 ml of 70% v/v ethanol and centrifuged at 
20,000 x g for 10 minutes. The supernatant was removed and the pellet air-dried for 
5-10 minutes prior to dilution in 100 μl of Nuclease Free Water (NFW, Ambion). 
This solution will be referred as Midi-prep solution from now on. Tubes were 








2.7.1.10 Restriction digest and linearization 
 
Prior to sample preparation, the work bench was disinfected with 70% v/v 
ethanol (BDH) and RNAse free cleaning wipes (RNAseZap®, Ambion). The 
reagents used in this protocol were thawed in ice prior to being used. 
Two 200 μl RNA free microtubes were used for cDNA linearization. To each 
tube 59 μl of NFW (Ambion), 1 μl of BSA (10 μl/ml – Promega) and 10 μl of Midi-
prep solution were added. One of the tubes was used as a precursor for producing 
anti-sense (AS, positive) probes whilst the other as precursor for sense (S, negative) 
probes. 
AS probes are made from a complimentary sequence to the mRNA of interest 
found in the tissue. Therefore, under hybridization conditions it binds to the mRNA 
and this results in a positive response. The Sense probe, on the other hand, has 
exactly the same sequence as the mRNA found on the tissue and does not bind to the 
sequence of interest, thus working as a negative control to monitor hybridization 
procedure.  
To AS microtubes 10 μl of Buffer A and 10 μl of restriction enzyme Apa I 
(Promega) were added. The solution was mixed thoroughly by pippetting up and 
down several times, and the microtubes placed in RNAse-free water bath at 37 °C 
overnight. To S tubes 10 μl of Buffer D and 10 μl of restriction enzyme Sal I 
(Promega) were added and the solution incubated as stated above. 
Restriction enzymes recognize a short, specific DNA sequence. They cleave 
double stranded DNA at specific sites (restriction sites). Each enzyme has a specific 
requirement for optimal activity, thus the use of different reaction buffers for each 
enzyme (Product Information sheet, Promega). Apa I enzymes cleave the DNA of 
interest on one side whilst Sal I cleaves it at the opposite side.  
After 16 hours incubation the cDNA concentration in the tubes was determined 
by 1% w/v agarose gel/ethidium bromide electrophoresis. For each gel, 1.5 g agarose 
(BDH) was added to 150 ml TAE (Promega). The mixture was microwaved for 2-3 
minutes until the agarose dissolved. The flask was left to cool down at room 
temperature for approximately 20 minutes when 10 μl of ethidium bromide (Sigma-




commonly used as DNA/RNA stain for agarose gel electrophoresis (Sigma product 
information sheet). The solution was mixed and left to cool down at room 
temperature for a further 10 minutes. 
Agarose mixture was poured into an RNAse-free horizontal gel cassette and left 
to polymerize for 30 minutes. Once set, the gel was placed in chamber and covered 
with 1x TAE buffer prior to sample loading. 
Apa and Sal testing samples were prepared by adding into 200 μl RNAse-free 
microtubes 2 μl of Apa or Sal linearized solution, 1.5 μl Blue/Orange 6x loading dye 
(Promega) and 6.5 μl NFW. These test tubes were kept on ice until loading, and the 
original Apa and Sal solutions were stored at -20 °C until needed. 
To the first well of the agarose gel, 5 μl of 100bp DNA ladder (Promega) was 
added and 10 μl of test samples were loaded into the remaining wells. 
Electrophoresis was performed at 125v, 400mA for 50 minutes. DNA concentrations 
were roughly estimated by placing the agarose gel under an Ultra-violet (UV) box 
and comparing intensity of the bands found in the samples with those of the 500bp 






Figure 13. Agarose/ethidium bromide gel image used to estimate Angiopoietin-2 
cDNA concentration in four Apa samples (B) based on the 500bp band (arrow) from 





The Apa bands illustrated in the figure above showed fluorescence intensity over 
twice that of the 500pb band. As the intensity of the 500bp band corresponds to 150 
ng, the total cDNA concentration of the Angiopoietin-2 Apa bands was estimated at 
approximately 400 ng. Considering 2 μl of solution was used to estimate cDNA 
concentration, the final concentration of these Ang-2 Apa solutions was 200 ng/μl. 
 From this point onwards the linearized cDNA solutions will be reffered to as 
either  Sal (for S probes) or Apa (for AS probes). 
 
2.7.1.11 Probe synthesis and label 
 
This final step in probe making was done using Megascript SP6 polymerase kits 
(Ambion) for AS probes and Megascript T7 polymerase kits (Ambion) for S probes. 
Each kit contained ATP, CTP and GTP nucleotides, unlabelled UTP, 10x Reaction 
Buffer, Nuclease Free Water, Polymerase Enzyme mix, DNAse and Lithium 
Chloride (LiCl). The DIG-11-UTP label used was supplied by Roche (Roche). 
During this step the DNA of interest is amplified time and time again. However, 
rather than synthesising DNA the nucleotides used result in RNA being synthesised 
instead. RNA probes are generated by in vitro transcription from a linearized 
template (linearized cDNA). A promoter for RNA polymerases must be available on 
the vector DNA containing the template of interest. The synthesised transcripts are 
an exact copy of the sequence from the promoter site to the restriction site used for 
linearization. Riboprobes are inherently single-stranded (Eisel et al., 2002).       
The DIG labelling method is based on a steroid isolated from Digitalis purpurea 
and D. lanata. As these plants are the only natural source of digoxigenin, the 
antibody used in the indirect method does not bind to other biological materials. The 
DIG-labelled UTP nucleotides can be incorporated randomly by DNA or RNA 
polymerase, however, for most reactions DIG labelled nucleotide is incorporated 
every 20 to 25
th
 nucleotide (Eisel et al., 2002).  
All reagents were removed from the -20 °C freezer and thawed in ice before 
being used. For every 20 μl of probe labelling solution, 1-3 μg of linearized cDNA 




cDNA concentration determined in the previous step. The concentrations of the 
reagents used to prepare 20 μl of AS and S probe solutions are detailed in Table 3. 
 
Table 3. Reagents concentration for making a 20 μl solution of sense or anti-sense 
probe for in situ hybridization assays. 
Reagents (μl) Sense Anti-sense 
ATP 2 2 
CTP 2 2 
GTP 2 2 
unlabelled UTP 1.3 1.3 
DIG-11-UTP 5.2 3.5 
10x Reaction Buffer 2 2 
Enzyme mix 2 2 
cDNA 1-3 μg 
NFW make up to 20 μl 
 
 
Reagents were mixed thoroughly and placed in a water bath at 37 °C for 6 hours 
or overnight. Tubes were then removed from the water bath and placed on ice for 5-
10 minutes. To each 20 μl solution 1 μl of DNAse was added and tubes placed in 
water bath, at 37 °C, for 30 minutes. This step should ensure that the template DNA 
used to make the riboprobe is digested leaving only RNA probes in the solution. 
To every tube 30 μl of NFW, 25 μl of LiCl and 150 μl of ice cold 100% ethanol 
(BDH) was added. Microtubes were placed in a -20 °C freezer overnight for 
precipitation of riboprobes into a white pellet. The next day, samples were removed 
from the freezer and immediately centrifuged at 13,000 rpm for 30 minutes at 4 °C. 
The supernatant was discarded and the pellet washed with 150 μl of ice cold 70% v/v 
ethanol (BDH) followed by 10 minutes centrifugation at 13,000 rpm at 4 °C. The 
supernatant was discarded and the pellet allowed to air dry in ice for a further 5-10 
minutes. The pellet was re-suspended in 20 μl of NFW and 1 μl of the solution was 
taken to test the probe concentration. Probes were kept at -20 °C until needed for ISH 
assays. 
To the 1 μl of probe solution 7 μl of NFW and 2 μl of Blue/Orange dye 
(Promega) were added. Concentration was estimated by agarose gel/ethidium 
bromide electrophoresis followed by UV fluorescence of gel (Figure 14), as 








Figure 14. Agarose/ethidium bromide gel image used to estimate Angiopoietin-2 




2.7.2 In situ hybridization assay 
 
Ovarian slides were placed in racks and dewaxed in CNP30 (Taab Laboratories) 
or Histosol (National Diagnostics) for approximately 30 minutes followed by 
rehydration through a series of ethanol solutions (100%, 70%, 50% and 25% v/v) for 
2 minutes. Slides were placed for 5 minutes in autoclaved deionised water prior to 5 
minutes incubation in Neutral Buffered Formalin (National Diagnostics). This step 
should help prevent sections becoming loose from slides further along the assay. 
Slides were washed twice in 1x PBS pH 7.0 (BDH) for 5 minutes and then placed 
in boiling hot 0.01 M Sodium Citrate (Sigma-Aldrich) for 35 minutes. Slides were 
then washed for 2 minutes in PBS and placed in 1mM EDTA (Sigma-Aldrich) in 
PBS for 5 minutes. EDTA inactivates metal dependent enzymes which could damage 
DNA/RNA (Eisel et al., 2002). Slides were transferred to a solution comprising 1mM 
EDTA, 0.1% w/v Proteinase K (Sigma-Aldrich) in PBS and were kept at 37 °C, 




accessibility by digesting the protein surrounding the nucleic acid, thus allowing the 
designed probe to reach the mRNA of interest more easily (Eisel et al., 2002). 
Slides were incubated in 0.2% w/v Glycine (Sigma-Aldrich) in PBS for 5 
minutes at room temperature to stop the Proteinase K reaction. Incubation in 20% v/v 
Acetic Acid (BDH) in Methanol (BDH) was performed at room temperature for 40 
minutes. The acid treatment leads to protein extraction and partial hydrolysis of the 
target improving the signal-to-noise ratio (Eisel et al., 2002) 
Slides were washed in PBS for 5 minutes, drained and sections individually 
circled using ImmedgePen® (Vector Laboratories). This was performed to avoid loss 
of solutions that are placed directly on the sections, such as hybridization buffer, and 
also avoid AS probes mixing with S probes due to direct contact of solutions from 
adjacent sections. Hybridization buffer consisting of 10% w/v Dextran Sulphate 
(Sigma-Aldrich), 50% v/v Deionised Formamide (QBiogene), 8.4% v/v autoclaved 
deionized  water, 25% v/v of 2x SSC solution (17.5% w/v NaCl and 8.82% w/v 
Sodium Citrate in water, pH adjusted to 7.0), 1% v/v denaturated DNA from herring 
sperm (Sigma-Aldrich) and 5% of Denhart’s solution (Sigma-Aldrich) was heated in 
a water bath at 55 °C. 
Both S and AS probes were diluted in Hybridization Buffer (HB) to a final 
concentration of 1 ng/μl. Approximately 50 μl of HB was added to each section 
resulting in 50 ng probe/section. Hybridization was performed in a humidified 
chamber at 60 °C overnight. Incubation times were optimized for each probe/mRNA 
of interest and further information can be found in the following chapters. 
Hybridization depends on the ability of denaturated RNA (in tissue) to reanneal with 
complimentary strands (AS probes) just below their melting point. Renaturation of 
DNA/RNA occurs roughly between 16-32 °C (Eisel et al., 2002). Incubation of 
slides at 60 °C allows target RNA to remain denaturated and allow the probe to bind 
to it. Also, the use of high temperatures reduces the risk of mismatching of base 
pairs, thus increasing hybridization rate and stability of hybrids. Monovalent cations 
(such as sodium ions) interact with nucleic acids causing the electrostatic repulsion 
between strands to decrease with increasing salt concentration, therefore, the higher 




al., 2002). The high levels of sodium found in the HB should contribute towards 
stabilization of target-probe complex. 
On the following day HB was drained and slides washed twice in warm (60 °C) 
2x SSC solution. During hybridization, duplexes form not only between perfectly 
matched sequences but also between imperfectly matched ones. It is important to 
remove background associated with non-specific hybrids and this can be achieved by 
washing slides in a diluted solution of salt at a relatively high temperature (Eisel et 
al., 2002). 
Slides were incubated in 0.01% w/v RNAse (ABgene) in 2x SSC at 37 °C for 30-
35 minutes. This digests any unbound RNA probe removing high background and 
non-specific signals. Slides were further washed once at room temperature with 2x 
SSC for 2 min and twice in warm (60 °C) 2x SSC for 10 minutes followed by 10 
minutes in warm (60 °C) 1x SSC. 
Slides were washed for 5 minutes in TBS containing 0.8% w/v NaCl (Sigma-
Aldrich), 0.02% w/v Potassium Chloride (KCl, BDH), 0.3% w/v tris-base (BDH) in 
water, pH adjusted to 7.4. Slides were placed for 5 minutes in AP1 solution [ 0.1M 
tris (BDH) HCl added to adjust pH to 7.5, 0.1M NaCl (Sigma-Aldrich), 2mM 
Magnesium Chloride (MgCl2, Sigma-Aldrich) in water]. Slides were drained and 
placed on tray. Approximately 500 μl of 3% w/v BSA (Sigma-Aldrich) in AP1 was 
added to each section and allowed to incubate for 30-40 minutes. The BSA binds to 
the tissue in almost every place except those sites that already contain the hybrid. 
This step should significantly reduce non-specific binding of antibody. 
An Alkaline Phosphatase labelled anti-digoxigenin antibody (Roche) was diluted 
in 3% w/v BSA (Sigma-Aldrich) in AP1 to a final concentration of 1:500. Slides 
were drained and 100 μl of antibody solution was added to each section and left to 
incubate for 2 hours. As the digoxigenin used in labelling the probes can only be 
found in the Digitalis spp plants, the anti-digoxigenin antibody is extremely specific 
and should not bind to any other biological material. 
Slides were drained and washed 3 times in AP1 for 5 minutes followed by a 5 
minute wash in AP2 ( 0.1M tris HCl added to adjust pH to 9.5, 0.1M NaCl and 




Colour developing solution was prepared using 0.35% v/v NBT (Roche Applied 
Science), 0.35% v/v BCIP (Roche Applied Science), 1% v/v Levamisole (Vector 
Laboratories) in AP2. Approximately 500 μl of colour developing solution was 
added to each section and slides were left to develop colour overnight in the dark. 
Developing colour times were optimized for each probe/mRNA of interest and 
further details can be found in the following chapters. The Alkaline Phosphatase 
from the antibody reacts with the NBT/BCIP to form a stable precipitate. 
Colorimetric detection methods have the advantage of being easy to locate within the 
tissue, high sensitivity and good stability of precipitates. Levamisol is added to the 
solution to inactivate any endogenous alkaline phosphatase activity. This step is 
performed more out of precaution than necessity as most alkaline phosphatase 
activity is usually lost during hybridization (Eisel et al., 2002). 
On the next day slides were washed for 5 minutes in TBS to remove excess 
colouring solution. Slides were mounted using warm glycerol gelatin (Sigma-
Aldrich) and glass coverslips. Slides were kept protected from direct light to prevent 
fading of colouring. An illustrative image of an ovarian slide after in situ 
hybridization can be seen in Figure 15. 
 
 
    
Figure 15. Follicular image from seasonally anoestrous ewe treated with small-dose 
multiple injections of GnRH with progesterone priming, following in situ 
hybridization with VEGF sense (left) and anti-sense probes (right). The granulosa 












2.7.3 Analysis of slides 
 
Slides from ISH and ICH assays were analysed visually under bright field 
microscopy at 200 and 400x magnification for better visualization of luteal and 
follicular cell layers, respectively. The granulosa, theca interna and theca externa cell 
layers were analysed separately. Each follicle was analysed in 3 different sections, at 
3 randomly selected areas in each section, resulting in a total of 9 areas analysed per 
cell layer/follicle. CL were analysed in 3 different sections at 3 randomly selected 
areas.  
 
2.7.3.1 Expression Index scoring and Visual Appraisal method  
 
For every cell layer the percentage of positively stained cells and the intensity of 
the staining were recorded.  As intensity of the staining was categorized into weak 
(1), medium (2) or strong (3), as illustrated in Figure 16, therefore, the proportion 
(percentage) of the specifically stained cells to which each intensity staining 




Figure 16. In situ hybridization illustrating weak (1), medium (2) and strong (3) 
intensity staining of mRNA expression for Angiopoietin-2 in the corpus luteum of 







The percentage of a specific staining was multiplied by its value (1, 2 or 3) and 
an Expression Index for each cell layer was calculated based on the values for each 
stain intensity (Figure 17). The Expression Index (EI) for each cell layer / section 
was calculated as follows: 
 
 EI = % total stain x [(1 x % weak) + (2 x % medium) + (3 x % strong)]/100 
 
For example, if the total area stained in a section is 80% and from that weak 
staining corresponds to 60% whilst medium and strong correspond to 20% each then 
the EI would be: 
 
EI = 80 x [(1x60)+(2x20)+(3x20)] /100 =  80 x (60 + 40 + 60)/100 = 128 
 
The Mean Expression Index of each cell layer was calculated based on the mean 
values obtained from all areas of all sections (9 values). Both ISH and ICH analysis 


















Index 1 1xn 2 2xn 3 3xn 
G 0 - - - - - - 0 
TI 90 20 20 40 80 40 120 198 
TE 30 80 80 20 40 - - 36 
 
Figure 17. Example of semi-quantitative assessment of VEGF immunostaining in 
different follicular layers (G = granulosa, TI = theca interna, TE = theca externa) in a 
seasonally anoestrous ewe treated with small-dose multiple injections of GnRH 
without progesterone priming . The Expression Index is calculated based on the 
overall percentage of staining and the different intensities of staining where 1 = 




2.7.3.2 Visual Appraisal and Image Software Analysis methods 
 
 The Visual Appraisal method (Expression Index scoring), although relatively 
subjective, proved to be a much quicker method of analysis than any done with the 
aid of a computer software analysis system, facilitating analysis of very large 
numbers of slides within the current study.   
 However, the Visual Appraisal method of analysis was compared with results 
obtained using image analysis software, by correlation and a regression analysis. 
Pictures were taken from a variety of follicles, and 50 areas of positive staining 
representing a range of staining intensities were selected for analysis. These areas 







using the image analysis software ImageScope version 9.1.19.1571 (Aperio 
Technologies).   
 Both Pearson’s correlation and regression analysis were performed using 
SPSS® statistical software programme version 15.0 (SPSS Inc., Chicago, Illinois, 
USA). There was a significant (P<0.01) correlation of 0.915 between the Visual 
Appraisal and the Image Software Analysis methods and a regression coefficient (R
2
) 
of 0.837 was obtained (Figure 18). These results clearly indicate a very high degree 
of homology between the subjective Expression Index scores and those obtained 
from the use of relatively more objective image analysis software, confirming that 
the more rapid Visual Appraisal method is suitable for quantitative estimation of ICH 
and ISH results.  
 
 
Figure 18. Regression coefficient graph illustrating the relationship between the 
Visual  Appraisal (Expression Index, Y axis) and the Image Software Analysis 
(Software Score, X axis) methods used to analyse 50 ovarian images following 
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 Ovine follicular vascular development initiates during the mid to late secondary 
stage when the stromal cells that surround the follicle develop into the theca interna 
and theca externa layer (Stevens and Lowe, 1993, Fortune, 2003). Under appropriate 
stimulation angiogenesis continues throughout follicular growth until ovulation 
(Kaczmareck et al., 2005). 
 Ovine follicles become gonadotrophin dependent when they reach approximately 
2 mm in diameter (Driancourt, 2001). FSH stimulates initial follicular development, 
but as the follicle matures there is a switch from FSH to LH dependency (Hunter et 
al., 2004). FSH induces general follicular development and the expression of LH 
receptors in the granulosa cells of mature follicles (Stabenfeldt and Edquist, 1996) 
while LH stimulates dominant follicle growth and indirectly influences oestrogen 
production (Driancourt, 2001), which in turn stimulates GnRH pulses that induce the 
pre-ovulatory LH surge. Prior to the LH surge, locally produced inhibitors prevent 
the granulosa cells from becoming prematurely luteinized. However, after the LH 
surge the granulosa cells become responsive to LH and begin to secrete progesterone 
and intrafollicular substances that cause follicular rupture and ovulation (Stabenfeldt 
and Edquist, 1996). 
 It is widely accepted that pulsatile GnRH treatment alone is sufficient to cause 
ovulation in seasonally anoestrous ewes (Stabenfeldt and Edquist, 1996, Southee et 
al., 1988b, McLeod et al., 1983, McLeod et al., 1982a). However, unless primed with 
progesterone prior to GnRH-induced ovulation most ewes develop a defective CL 
(Husein and Kriddli, 2003, Haresign et al., 1996, Southee et al., 1988a). 
 As vascularity and normal tissue function are closely related (Kaczmareck et al., 
2005, Berisha and Schams, 2005, Redmer et al., 2001) it is possible that the lack of 
progesterone priming may lead to inadequate vascularity of the newly formed CL 
and consequently result in defective luteal function. Although limited vascularity 
may not interfere with the capability of the dominant follicle to ovulate it may 
influence its development and cell layer constitution. 
 Angiogenesis is essential for tissue growth and development and is a critical 




Ambrogi, 2004). Antral follicles show two concentric vascular networks, an inner 
network in the theca interna and an outer network within the theca externa layer. The 
theca interna vascular network is, however, the main source of nutrients for the 
follicle (Mattioli et al., 2001). 
 Follicular angiogenesis is mainly regulated by the VEGF-Angiopoietin system. 
VEGF is essential for follicular development regulating theca layer vascularity, 
granulosa cell proliferation, antral formation and steroidogenesis (Hunter et al., 2004, 
Ferrara et al., 2003a). Both theca and granulosa cells are able of expressing VEGF, 
however, as the follicle develops the granulosa layer becomes the main source of 
VEGF (Hunter et al., 2004, Robinson et al., 2007). VEGFR-2, on the other hand, is 
found mainly in endothelial cells of the theca layer (Wulff et al., 2001a, Hunter et al., 
2004). 
 VEGF production varies according to follicular size. Small follicles have 
significantly lower levels of VEGF than large ones (Mattioli et al., 2001). VEGFR-2 
expression in the theca layer seems to follow a similar pattern to that of VEGF 
protein (Tamanini and De Ambrogi, 2004). LH has been shown to stimulate VEGF 
production (Driancourt, 2001) and in the peri-ovulatory period VEGF levels increase 
markedly in follicular fluid and can be detected in granulosa derived luteinized cells 
(Ferrara et al., 1992, Tamanini and De Ambrogi, 2004). 
 Angiopoietins act in association with VEGF to promote blood vessel formation, 
maturation or regression (Davis et al., 1996). Both theca and granulosa cells are able 
to express Ang-1 and Ang-2 mRNA while TIE-2 mRNA expression seems to be 
restricted to the theca cells. Ang-1 expression does not seem to vary between 
developing and mature follicles. On the other hand, Ang-2 is found to be 
significantly lower in mature than developing follicles (Hayashi et al., 2003, Shimizu 
et al., 2007, Tamanini and De Ambrogi, 2004). It has been shown that Angiopoietins 
are associated with the changes in follicular capillaries at the time of the LH surge. 
Ang-1 mRNA is highly expressed before the LH surge followed by a significant 
decrease at the time of the LH surge. A slow and constant rise is, however, observed 
soon after the LH surge. Although Ang-2 levels are steady throughout most of 
follicular development, it reaches its lowest level soon after the LH surge. The Ang-




ovulation time (Shimizu et al., 2007). TIE-2 expression remains unchanged 
throughout follicular development (Hayashi et al., 2003) but reaches its highest just 
prior to the LH surge (Shimizu et al., 2007). 
 CL formation consists of changes in the theca and granulosa cells of the pre-
ovulatory follicle that occurs after the LH surge (Kaczmareck et al., 2005). Under the 
influence of LH theca and granulosa cells differentiate into small and large luteal 
cells, respectively, forming the steroidogenic parenchyma of the newly developed 
CL (Berisha and Schams, 2005, Schams and Berisha, 2004, Sawyer, 1995). In order 
to meet the demands of the extensive changes that take place in the follicular cell 
layer after the LH surge, a well established vascular supply is essential for normal 
luteal development (Robinson et al., 2007).   
 Around the time of the LH surge the basal membrane between the theca interna 
and the granulosa layer dissolves and theca capillaries expand and invade the 
avascular granulosa to form a dense network (Shimizu et al., 2007). Therefore, 
adequate development of follicular vascularity may be the key for an adequate luteal 
blood supply to be established. Furthermore, poor follicular blood supply could 
affect the initial stages of luteinisation of the theca and granulosa layers that occur 
soon after the LH surge and throughout early luteal development (Stabenfeldt and 
Edquist, 1996, Robinson et al., 2007). 
 It has been suggested that abnormal luteal function is due to inadequate follicular 
development before ovulation (Southee et al., 1988b, McLeod et al., 1982b) and 
inadequate development of the microvasculature of the pre-ovulatory follicle and 
subsequent CL (Southee et al., 1988a). 
Multiple small-dose injections of GnRH has been shown to successfully induce 
ovulation in seasonally anoestrous ewes (Southee et al., 1988b, McLeod et al., 1983, 
McLeod et al., 1982a). However, unless primed with progesterone prior to GnRH 
treatment, the vast majority of animals develop a defective CL (Haresign et al., 1996, 
Husein and Kriddli, 2003, Hunter et al., 1988). This provides us with a reliable in 
vivo model to study the differences in late follicular and early luteal development of 
functional and defective CL. 
 One working hypothesis is that the lack of progesterone priming prior to 




during late follicular development and early luteal formation.  Defective production 
of these factors could lead to the formation of an inadequate vascular bed and limited 
development of the dominant follicle prior to the LH surge. This deficient blood 
supply to the dominant follicle could lead to the formation of a poor and unstable 
vascular network, during early luteal development, incapable of supporting the newly 
formed CL and thus resulting in defective luteal function. Furthermore, abnormal 
production of angiogenic factors after the LH surge could result in restricted 
sprouting of blood vessels from the theca into the granulosa layer after the basal 
membrane dissolves. This could further interfere with the luteinisation process taking 
place as well as compromising angiogenesis during the early luteal phase. 
The current experiment was designed to test this hypothesis and investigate the 
effects of progesterone priming on the expression of angiogenic factors in ovine 
follicles, both before and after the LH surge. 
  
 
3.2 Material and Methods 
 
 Seasonally anoestrous ewes were allocated into four treatment groups (Groups 1 
to 4) of which two received an i.m. injection of 20 mg of progesterone 3 days prior to 
the start of GnRH treatment (Groups 2 and 4) while the remaining received oil 
vehicle alone (Groups 1 and 3). Small-dose GnRH injections were given every 2 
hours for 28 hours followed by a bolus injection at 30 hours, as described in detail in 
Chapter 2. 
In order to determine angiogenic factors levels in the follicular cell layers prior to 
the LH surge, ovaries from Groups 1 and 2 were collected 24 hours after the start of 
GnRH treatment (6 hours prior to GnRH bolus injection and expected pre-ovulatory 
LH surge). In order to analyse angiogenic factor levels post-LH surge, ovaries from 
Groups 3 and 4 were collected 46 hours after the start of GnRH treatment (16 hours 
after GnRH bolus injection and approximately 14 hours prior to expected ovulation). 
Animals that happened to ovulate (1/10 from progesterone primed and 2/10 from 




 Blood samples were taken every 2 hours to monitor the timing of the pre-
ovulatory LH surge. The samples were collected just prior to GnRH injections, from 
the start of GnRH treatment until 6 hours before (Groups 1 and 2) and 16 hours after 
(Group 3 and 4) GnRH bolus injection. For a period of 4 hours, at the beginning of 
GnRH treatment, samples were collected more frequently to monitor if GnRH 
injections were inducing the desired LH pulses. 
 
3.2.1 LH ELISA assays 
 
 In order to confirm the onset of the LH surge, LH ELISA immunoassays were 




Immunohistochemistry assays were performed according to the process described 
in Chapter 2. However, optimized primary antibody concentration and colour 
developing time varied between proteins and are detailed below. 
 For VEGF, slides were incubated in a 1:100 concentration (1 μl of the antibody 
in 99 μl of PBS) of Rabbit polyclonal anti-human VEGF antibody at 200 μg/ml 
(VEGFA-20, Santa Cruz Biotechnologies) overnight for 23 hours and then left in 
contact with DAB solution to develop colour for 1 minute. 
 Rabbit polyclonal anti-mouse FLK-1 (VEGFR-2) at 200 μg/ml (Santa Cruz 
Biotechnologies) was used overnight for 24 hours at a concentration of 1:50. Slides 
were left to develop colour for 2 minutes. 
 For Ang-1, a 1:200 concentration of Rabbit polyclonal anti-mouse Angiopoietin-
1 at 85 mg/ml (Abcam) was used for 1 hour and slides were left to develop colour for 
2 minutes. 
For Ang-2 the antibody concentration used was of 1:100 Rabbit polyclonal anti-





For TIE-2, 1:100 Rabbit polyclonal anti-mouse TIE-2 at 200 μg/ml (C-20, Santa 
Cruz Biotechnologies) was used for 1 hour and slides were left in contact with DAB 
for 30 seconds to develop colour. 
  
3.2.3 In situ hybridization 
 
 For every gene of interest there were 294 positive (AS) and 98 negative (S) 
sections. Enough probe was made to cover that number with a safe margin and also 
to be able to repeat half of the assay if needed. Due to the large number of slides 
involved, each mRNA of interest had slides divided into 2 assays. Each assay 
contained slides from animals belonging to each group, in equal numbers. In situ 
hybridization was performed according to the technique described in Chapter 2. 
Optimized hybridization and colour development for each mRNA of interest are 
described below. 
  
3.2.3.1 Angiopoietins and their receptor 
 
Ang-1, Ang-2 and TIE-2 hybridization was performed for 19 hours in a 
humidified chamber at 60 °C.   Colour development took place for 20 hours prior to 
mounting. 
  
3.2.3.2 VEGF and VEGFR-2 
 
Professor Dale Redmer (Department of Animal and Range Sciences, North 
Dakota State University, Fargo, ND, USA) kindly provided bacteria containing 
VEGF and VEGFR-2 cDNA as described in Redmer et al. (1996). Bacteria were 
replicated and plasmid successfully extracted. 
VEGFR-2 cDNA linearization proved successful and although S and AS probes 
obtained were extremely low in concentration, after many attempts, there was 
enough probe for CL slides but not enough for follicles. VEGF cDNA linearization 





3.2.4. Statistical analysis 
 
Prior to the analysis follicles were classified into small (2 – 2.5 mm in diameter) 
and large (>2.5 mm in diameter) and analysed separately. For each analysis of a 
factor there was a total of approximately 91 small and 79 large follicles. 
The data on plasma LH concentration were analyzed using One-way ANOVA. 
Both protein and mRNA Expression Indices for different angiogenic factors were 
analyzed using a  Linear Mixed Model within the REML function of GenStat using 
Treatment x Time x Layer as fixed effects and Animal/Follicle number as random 
effects. If data were not normally distributed the best power of transformation to 
normalise the residuals was identified using the Lambda value with maximum 
likelihood. Values were submitted to Log (Ang-1 protein in small follicles and 
VEGF protein in large follicles) or Square Root transformation (Ang-1 and -2 
mRNA in small follicles and Ang-1 mRNA in large follicles). Due to the fact that 
some of the values equaled to zero, Log of Value+1 was used to make the conversion 
possible. For ease of interpretation back transformed mean values are provided in the 
tables. Overall effects of treatment (progesterone priming), time (before or after the 
LH surge) and layer (granulosa, theca interna and theca externa) as well as 3-way 
interactions (treatment x time x layer) were analyzed. All analyses were performed 
using GenStat 9
th
 edition (Version 9.1.0.147, Lawes Agricultural Trust, VSN 




3.3.1 LH profile 
 
Mean plasma LH concentrations in the different experimental groups are 
illustrated in Figure 19. 
Mean LH concentrations did not vary between treatment groups at any time of 
sample collection. LH levels remained low prior to GnRH bolus.  However, from 6 
to 10 hours after the start of pulsatile GnRH treatment when animals were sampled 




concentrations fluctuated and were comparatively higher indicating that each GnRH 
injection was inducing a LH pulse. Values, however, did not exceed 3 ng/ml prior to 
GnRH bolus injection. The GnRH bolus, that was given intravenously 30 hours after 
the beginning of the pulsatile GnRH treatment, successfully induced an immediate 
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Figure 19. Mean plasma LH concentrations of progesterone primed (Groups 2 and 4) 
and non-primed (Groups 1 and 3) seasonally anoestrous ewes at various times after 
start of GnRH treatment. GnRH bolus injection (300 μg) was given intravenously at 
30 hours (*) after the start of pulsatile GnRH treatment. 
 
 
3.3.2 Small follicles 
 
3.3.2.1 VEGF protein 
 
An example of VEGF protein expression in the various follicular layers can be 
seen in Figure 20. Statistical analysis indicated that there was no significant effect (P 
= 0.69) of progesterone priming on VEGF protein levels. However, there were 
significant effects (P<0.05) of time of LH surge and follicular cell layers on VEGF 
protein levels but no significant interaction (P = 0.40) between progesterone priming, 





Overall mean VEGF protein expression was significantly higher (P<0.05) before 
compared with that after the LH surge (Figure 21). The expression in the theca 
interna layer was significantly higher (P<0.05) than in the two other layers, with no 




Figure 21. The overall mean Expression Index of VEGF protein before and after the 
pre-ovulatory LH surge in small follicles of seasonally anoestrous ewes treated with  
small-dose multiple injections of GnRH. s.e.d. = 8.12, standard error of difference 
between means to compare the mean values for VEGF expression before and after 
the LH surge. Different letters on bars indicate significant difference at 5% level. n = 
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Figure 22. The overall mean Expression Index of VEGF protein in the granulosa 
(G), theca externa (TE) and theca interna (TI) layers of small follicles of seasonally 
anoestrous ewes treated with small-dose multiple injections of GnRH. s.e.d. = 6.355, 
standard error of difference between means to compare the mean values for VEGF 
expression between cell layers. Different letters on bars indicate significant 






Table 4. Mean VEGF protein Expression Index values observed in the various cell 
layers of small follicles of the different groups of progesterone primed and non-
primed ewes treated with small-dose multiple injections of GnRH. 
Groups Progesterone Time 
Layer 
Granulosa Theca externa Theca interna 
1 - Pre-LH 55.04 46.60 144.59 
2 + Pre-LH 81.68 58.78 144.82 
3 - Post-LH 22.71 28.76 97.02 
4 + Post-LH 41.76 49.21 123.79 
s.e.d. (14.97) = standard error of difference between means to compare the mean values both within 
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Figure 20. Immunohistochemistry showing follicular VEGF protein expression, after 
the LH surge, in the ovary of a seasonally anoestrous ewe treated with small-dose 
multiple injections of GnRH without progesterone priming. Negative (left) and 
positive (right) staining for VEGF protein is shown.  The granulosa (G) and the theca 
(T) layers are identified. Bright field microscopy, 200X magnification. 
 
 
3.3.2.2 VEGFR-2 protein 
 
An example of VEGFR-2 protein expression in the various follicular layers can 
be seen in Figure 23. Statistical analysis indicated that there was no significant effect 
of progesterone priming (P = 0.34) nor timing of the LH surge (P = 0.93) on 
VEGFR-2 protein levels. However, there was a significant effect (P<0.05) of 
follicular cell layers on VEGFR-2 protein levels but no significant interaction (P = 
0.18) between factors.  
 The theca interna layer of small follicles expressed significantly higher (P<0.05) 
VEGFR-2 protein levels than the other two layers. Furthermore, VEGFR-2 protein 
expression was significantly lower (P<0.05) in the granulosa than in the theca 
externa layer (Figure 24). 
Mean VEGFR-2 protein values, observed in the different cell layers of small 
follicles of progesterone primed and non-primed seasonally anoestrous ewes treated 
with small-dose multiple injections of GnRH, before and after the LH surge are 









Figure 24. The overall mean Expression Index of VEGFR-2 protein in the granulosa 
(G), theca externa (TE) and theca interna (TI) layers of small follicles of seasonally 
anoestrous ewes treated with small-dose multiple injections of GnRH. s.e.d. = 2.516, 
standard error of difference between means to compare the mean values for VEGFR-
2 expression between cell layers. Different letters on bars indicate significant 







Table 5. Mean VEGFR-2 protein Expression Index values observed in the various 
cell layers of small follicles of the different groups of progesterone primed and non-
primed ewes treated with GnRH. 
Groups Progesterone Time 
Layer 
Granulosa Theca externa Theca interna 
1 - Pre-LH 11.77 23.29 69.83 
2 + Pre-LH 12.91 23.92 64.72 
3 - Post-LH 7.36 13.97 50.01 
4 + Post-LH 20.46 31.75 74.90 
s.e.d. (10.07) = standard error of difference between means to compare the mean values both within 
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Figure 23. Immunohistochemistry showing follicular VEGFR-2 protein expression, 
after the LH surge, in the ovary of a seasonally anoestrous ewe treated with small-
dose multiple injections of GnRH primed with progesterone. Negative (left) and 
positive (right) staining for VEGFR-2 protein is shown.  The granulosa (G) and theca 
(T) layers are identified. Bright field microscopy, 100X magnification. 
 
 
3.3.2.3 Angiopoietin-1 protein 
 
An example of Ang-1 protein expression in the various follicular layers can be 
seen in Figure 25. As data were not normally distributed, values were submitted to 
Log transformation prior to statistical analysis. There was no significant effect of 
progesterone priming (P = 0.32) nor timing of the LH surge (P = 0.73) on Ang-1 
protein expression. However, there were significant effects (P<0.05) of follicular cell 
layers on Ang-1 protein levels as well as a significant interaction between factors.  
The theca interna layer expressed significantly higher (P<0.05) amounts of Ang-1 
protein than the granulosa and theca externa layers. The theca externa expressed 
significantly higher (P<0.05) levels of Ang-1 protein than the granulosa layer (Figure 
26). 
Mean Ang-1 protein values observed in the different cell layers of small follicles 
before and after the LH surge from progesterone primed and non-primed seasonally 
anoestrous ewes treated with small-dose multiple injections of GnRH are detailed in 
Table 6 and illustrated in Figure 27. Although statistical analysis indicated that there 
was a significant (P<0.05) interaction between the factors there was no consistent 









Figure 26. The overall mean Log Expression Index of Angiopoietin-1 protein in the 
granulosa (G), theca externa (TE) and theca interna (TI) layers of small follicles of 
seasonally anoestrous ewes treated with small-dose multiple injections of GnRH. 
Log s.e.d. = 0.039, standard error of difference between means to compare the mean 
values for Angiopoietin-1 expression between cell layers. Different letters on bars 





Table 6. Back transformed mean values for Angiopoietin-1 protein Expression Index 
(Log values) observed in the various cell layers of small follicles before and after the 
LH surge from progesterone primed and non-primed seasonally anoestrous ewes 
treated with small-dose multiple injections of GnRH. 
Groups Progesterone Time 
Layer 
Granulosa Theca externa Theca interna 
1 - Pre-LH 16.55 (1.219) 25.76 (1.411) 88.30 (1.946) 
2 + Pre-LH 25.35 (1.404) 30.47 (1.484) 67.92 (1.832) 
3 - Post-LH 14.15 (1.151) 13.96 (1.145) 52.48 (1.720) 
4 + Post-LH 22.23 (1.347) 37.58 (1.575) 94.84 (1.977) 
Log s.e.d. (0.2244) = standard error of difference between means to compare the mean values both 
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Figure 27. The mean Log Expression Index of Angiopoietin-1 protein in the 
granulosa (G), theca externa (TE) and theca interna (TI) layers of small follicles from 
progesterone primed and non-primed seasonally anoestrous ewes treated with small-
dose multiple injections of GnRH, prior to and post-LH surge. The Log s.e.d. = 
0.2244, standard error of the difference between means to compare mean values 





                   
Figure 25. Immunohistochemistry showing follicular Angiopoietin-1 protein 
expression, after the LH surge, in the ovary of a seasonally anoestrous ewe treated 
with small-dose multiple injections of GnRH primed with progesterone. Negative 
(left) and positive (right) staining for Angiopoietin-1 protein is shown. The granulosa 


















G TE TI G TE TI 
Pre-LH Post-LH 






































3.3.2.4 Angiopoietin-1 mRNA  
 
An example of Ang-1 mRNA expression in the various follicular layers can be 
seen in Figure 28. As data were not normally distributed, values were submitted to 
Square Root transformation prior to statistical analysis. There was no significant 
effect of progesterone priming (P = 0.98) nor timing of the LH surge (P = 0.62) on 
Ang-1 mRNA expression levels. However, there was a significant effects (P<0.05) of 
follicular cell layers on Ang-1 mRNA expression levels with no significant 
interaction between factors (P = 0.27).  
The granulosa showed significantly higher (P<0.05) Ang-1 mRNA expression 
levels than both theca layers. The expression in theca interna was significantly higher 
(P<0.05) than in the theca externa layer (Figure 29). 
Mean Ang-1 mRNA values observed in the different cell layers of small follicles 
before and after the LH surge from progesterone primed and non-primed seasonally 









Figure 29. The overall mean Square Root Expression Index of Angiopoietin-1 
mRNA in the granulosa (G), theca externa (TE) and theca interna (TI) layers of small 
follicles of seasonally anoestrous ewes treated with small-dose multiple injections of 
GnRH. Square Root s.e.d.=0.1259, standard error of difference between means to 
compare the mean values for Angiopoietin-1 expression between cell layers. 








Table 7. Back transformed mean values of Angiopoietin-1 mRNA Expression Index 
(Square Root values) observed in the various cell layers of small follicles before and 
after the LH surge from progesterone primed and non-primed seasonally anoestrous 
ewes treated with small-dose multiple injections of GnRH. 
Groups Progesterone Time 
Layer 
Granulosa Theca externa Theca interna 
1 - Pre-LH 145.44 (12.06) 105.47 (10.27) 115.56 (10.75) 
2 + Pre-LH 131.10 (11.45) 103.22 (10.16) 120.34 (10.97) 
3 - Post-LH 130.41 (11.42) 102.41 (10.12) 118.81 (10.90) 
4 + Post-LH 136.56 (11.60) 100.80 (10.04) 127.46 (11.29) 
Square root s.e.d. (0.325) = standard error of difference between means to compare the mean values 
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Figure 28. In situ hybridization showing follicular Angiopoietin-1 mRNA 
expression, after the LH surge, in the ovary of a seasonally anoestrous ewe treated 
with small-dose multiple injections of GnRH without progesterone priming. Sense 
(left) and anti-sense (right) probed slides for Angiopoietin-1 mRNA are shown. The 




3.3.2.5 Angiopoietin-2 protein 
 
An example of Ang-2 protein expression in the various follicular layers can be 
seen in Figure 30. Statistical analysis indicated that there was no significant effect of 
progesterone priming (P = 0.54) nor timing of the LH surge (P = 0.60) on Ang-2 
expression levels. However, there were significant effects (P<0.05) of follicular cell 
layers on Ang-2 protein levels as well as of the interaction between factors.  
Significant difference (P<0.05) in Ang-2 protein levels were observed between 
all three follicular layers, with the highest values in the theca interna and the lowest 
levels in the granulosa layer (Figure 31).   
Mean Ang-2 protein values observed in the different cell layers of small follicles 
before and after the LH surge from progesterone primed and non-primed seasonally 
anoestrous ewes treated with small-dose multiple injections of GnRH are detailed in 
Table 8.   
It appears as though the significant interaction was due to the lower levels of 
Ang-2 protein in progesterone primed and non-primed animals before the LH surge 











 Figure 31. The overall mean Expression Index of Angiopoietin-2 protein in the 
granulosa (G), theca externa (TE) and theca interna (TI) layers of small follicles of 
seasonally anoestrous ewes treated with small-dose multiple injections of GnRH. 
s.e.d. = 1.910, standard error of difference between means to compare the mean 
values for Angiopoietin-2 expression between cell layers. Different letters on bars 








Table 8. Mean Angiopoietin-2 protein Expression Index values observed in the 
various cell layers of small follicles before and after the LH surge from progesterone 
primed and non-primed seasonally anoestrous ewes treated with small-dose multiple 
injections of GnRH. 
Groups Progesterone Time 
Layer 
Granulosa Theca externa Theca interna 
1 - Pre-LH 12.62 22.36 45.46 
2 + Pre-LH 6.43 18.44 27.98 
3 - Post-LH 3.49 15.68 31.47 
4 + Post-LH 11.28 23.36 42.77 
Square root s.e.d. (9.92) = standard error of difference between means to compare the mean values 
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Figure 32. The mean  Expression Index of Angiopoietin-2 protein in the granulosa 
(G), theca externa (TE) and theca interna (TI) layers of small follicles from 
progesterone primed and non-primed seasonally anoestrous ewes treated with small-
dose multiple injections of GnRH, prior to and post-LH surge. The s.e.d. = 9.925, 
standard error of the difference between means to compare mean values within and 





         
Figure 30. Immunohistochemistry showing follicular Angiopoietin-2 protein 
expression, before the LH surge, in the ovary of a seasonally anoestrous ewe treated 
with small-dose multiple injections of GnRH primed with progesterone. Negative 
(left) and positive (right) staining for Angiopoietin-2 protein is shown. The granulosa 
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3.3.2.6 Angiopoietin-2 mRNA 
 
An example of Ang-2 mRNA expression in the various follicular layers can be 
seen in Figure 33. As data was not normally distributed, values were submitted to 
Square Root transformation prior to analysis. There was no significant effect of 
progesterone priming (P = 0.54) nor timing of the LH surge (P = 0.82) on Ang-2 
mRNA expression levels. However, there was a significant effect (P<0.05) of 
follicular cell layers on Ang-2 mRNA expression levels with no significant 
interaction between factors (P =0 .99).  
The granulosa layer showed small but significant higher (P<0.05) levels of Ang-2 
mRNA expression than the theca layers, with no significant difference being 
observed between the theca externa and theca interna layers (Figure 34). 
Mean Ang-2 mRNA values observed in the different cell layers of small follicles 
before and after the LH surge from progesterone primed and non-primed seasonally 









Figure 34. The overall mean Square Root Expression Index of Angiopoietin-2 
mRNA in the granulosa (G), theca externa (TE) and theca interna (TI) layers of small 
follicles of seasonally anoestrous ewes treated with small-dose multiple injections of 
GnRH. Square Root s.e.d. = 0.024, standard error of difference between means to 
compare the mean values for Angiopoietin-2 mRNA expression between cell layers. 





Table 9. Back transformed mean values of Angiopoietin-2 mRNA Expression Index 
(Square Root values) observed in the various cell layers of small follicles before and 
after the LH surge from progesterone primed and non-primed seasonally anoestrous 
ewes treated with small-dose multiple injections of GnRH. 
Groups Progesterone Time 
Layer 
Granulosa Theca externa Theca interna 
1 - Pre-LH 105.06 (10.25) 100.00 (10.00) 100.60 (10.03) 
2 + Pre-LH 103.02 (10.15) 100.60 (10.03) 101.20 (10.06) 
3 - Post-LH 105.88 (10.29) 100.00 (10.00) 100.00 (10.00) 
4 + Post-LH 103.02 (10.15) 100.00 (10.00) 100.00 (10.00) 
Square root s.e.d. (0.068) = standard error of difference between means to compare the mean values 
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Figure 33. In situ hybridization showing follicular Angiopoietin-2 mRNA 
expression, after the LH surge, in the ovary of a seasonally anoestrous ewe treated 
with small-dose multiple injections of GnRH primed with progesterone. Sense (left) 
and anti-sense (right) probed slides for Angiopoietin-2 mRNA are shown.  The 




3.3.2.7 TIE-2 protein 
 
An example of TIE-2 protein expression in the various follicular layers can be 
seen in Figure 35. Statistical analysis indicated that there was no significant effect of 
progesterone priming (P = 0.29) nor timing (P = 0.24) on TIE-2 protein levels. There 
were no significant effects (P = 0.12) of follicular cell layers on Ang-2 protein levels 
nor of the interaction between factors (P = 0.15).  
Mean TIE-2 protein values observed in the different cell layers of small follicles 
before and after the LH surge from progesterone primed and non-primed seasonally 


















Table 10. Mean TIE-2 protein Expression Index values observed in the various cell 
layers of small follicles before and after the LH surge from progesterone primed and 
non-primed seasonally anoestrous ewes treated with small-dose multiple injections of 
GnRH. 
Groups Progesterone Time 
Layer 
Granulosa Theca externa Theca interna 
1 - Pre-LH 13.02 15.67 18.26 
2 + Pre-LH 10.46 12.40 10.15 
3 - Post-LH 6.82 9.39 6.89 
4 + Post-LH 5.59 4.88 5.51 
s.e.d. (6.84) = standard error of difference between means to compare the mean values both within 







                
Figure 35. Immunohistochemistry showing follicular TIE-2 protein expression, after 
the LH surge, in the ovary of a seasonally anoestrous ewe treated with small-dose 
multiple injections of GnRH primed with progesterone. Negative (left) and positive 
(right) staining for TIE-2 protein is shown. The granulosa (G) and theca (T) layers 












3.3.2.8 TIE-2 mRNA 
 
An example of TIE-2 mRNA expression in the various follicular layers can be 
seen in Figure 36. Statistical analysis indicated that there was no significant effect of 
progesterone priming (P = 0.19) nor timing of the LH surge (P = 0.87) on TIE-2 
mRNA expression levels. However, there was a significant effect (P<0.05) of 
follicular cell layers on Ang-2 mRNA expression levels with no significant 
interaction between factors (P = 0.37).  
The granulosa expressed significantly higher (P<0.05) levels of TIE-2 mRNA 
than the theca layers, with no significant differences being observed between the 
theca layers (Figure 37). 
Mean TIE-2 mRNA values observed in the different cell layers of small follicles 
before and after the LH surge from progesterone primed and non-primed seasonally 
anoestrous ewes treated with small-dose multiple injections of GnRH are detailed in 
Table 11. 
 
Figure 37. The overall mean Expression Index of TIE-2 mRNA in the granulosa (G), 
theca externa (TE) and theca interna (TI) layers of small follicles of seasonally 
anoestrous ewes treated with small-dose multiple injections of GnRH. s.e.d. = 1.685, 
standard error of difference between means to compare the mean values for TIE-2 
mRNA expression between cell layers. Different letters on bars indicate significant 
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Table 11. Mean TIE-2 mRNA Expression Index values observed in the various cell 
layers of small follicles before and after the LH surge from progesterone primed and 
non-primed seasonally anoestrous ewes treated with small-dose multiple injections of 
GnRH. 
Groups Progesterone Time 
Layer 
Granulosa Theca externa Theca interna 
1 - Pre-LH 121.4 103.3 103.1 
2 + Pre-LH 139.3 123.5 124.1 
3 - Post-LH 123.6 104.6 111.2 
4 + Post-LH 135.6 111.9 117.2 
s.e.d. (12.83) = standard error of difference between means to compare the mean values both within 









                 
Figure 36. In situ hybridization showing follicular TIE-2 mRNA expression, after 
the LH surge, in the ovary of a seasonally anoestrous ewe treated with small-dose 
multiple injections of GnRH without progesterone priming. Sense (left) and anti-
sense (right) probed slides for TIE-2 mRNA are shown.  The granulosa (G) and theca 










3.3.3 Large follicles 
 
3.3.3.1 VEGF protein 
 
As data was not normally distributed, values were submitted to Log 
transformation prior to analysis. Statistical analysis indicated that there was a 
significant effect (P<0.05) of progesterone priming, timing of the LH surge and 
follicular cell layers on VEGF protein expression but no significant interaction (P = 
0.98) between progesterone priming, time and follicular layers.  
Progesterone primed animals showed significantly higher (P<0.05) overall mean 
levels of VEGF protein than non-primed animals (Figure 38). 
Overall mean VEGF protein expression levels were found to be significantly 
higher (P<0.05) prior to the LH surge (Figure 39). 
Overall mean VEGF protein expression levels were significantly higher (P<0.05) 
in the theca interna layer than in the remaining two layers with no significant 
difference being observed between the granulosa and theca externa layers (Figure 
40). 
Mean VEGF protein expression values observed in the different cell layers of 
large follicles before and after the LH surge from progesterone primed and non-







Figure 38. The overall mean Log Expression Index of VEGF protein in large 
follicles of progesterone primed (+P4) and non-primed (-P4) seasonally anoestrous 
ewes treated with small-dose multiple injections of GnRH. Log s.e.d. = 0.058, 
standard error of difference between means to compare the mean values for VEGF 
expression before and after the LH surge. Different letters on bars indicate significant 





Figure 39. The overall mean Log Expression Index of VEGF protein before and 
after the pre-ovulatory LH surge in large follicles of seasonally anoestrous ewes 
treated with  small-dose multiple injections of GnRH. Log s.e.d. = 0.058, standard 
error of difference between means to compare the mean values for VEGF expression 
before and after the LH surge. Different letters on bars indicate significant difference 
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Figure 40. The overall mean Log Expression Index of VEGF protein in the 
granulosa (G), theca externa (TE) and theca interna (TI) layers of large follicles of 
seasonally anoestrous ewes treated with small-dose multiple injections of GnRH. 
Log s.e.d. = 0.066, standard error of difference between means to compare the mean 
values for VEGF expression between cell layers. Different letters on bars indicate 





Table 12. Back transformed mean values for VEGF protein Expression Index (Log 
values) observed in the various cell layers of large follicles before and after the LH 
surge from progesterone primed and non-primed seasonally anoestrous ewes treated 
with small-dose multiple injections of GnRH. 
Groups Progesterone Time 
Layer 
Granulosa Theca externa Theca interna 
1 - Pre-LH 23.83 (1.377) 20.79 (1.318) 92.57 (1.965) 
2 + Pre-LH 53.70 (1.730) 25.40 (1.405) 117.76 (2.071) 
3 - Post-LH 8.79/ (0.944) 14.89 (1.173) 69.02 (1.839) 
4 + Post-LH 29.17 (1.465) 25.40 (1.405) 118.30 (2.073) 
Log s.e.d. (0.136) = standard error of difference between means to compare the mean values both 
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3.3.3.2 VEGFR-2 protein 
 
Statistical analysis indicated that there was no significant effect of progesterone 
priming (P = 0.14) nor timing of the LH surge (P = 0.55) on VEGFR-2 protein 
expression. However, there were significant effects (P<0.05) of follicular cell layers 
on VEGFR-2 protein expression as well as significant interaction between factors.  
The theca interna expressed significantly higher (P<0.05) amounts of VEGFR-2 
protein than the granulosa and theca externa layers, with no significant difference 
being observed between the granulosa and theca externa layers (Figure 41). 
No significant differences in VEGFR-2 protein expression levels could be 
observed in the granulosa and theca externa layers between progesterone primed and 
non-primed animals either prior to or after the LH surge. However, prior to the LH 
surge, non-primed animals expressed significantly higher levels of VEGFR-2 protein 
in the theca interna than primed animals, but after the LH surge progesterone primed 
animals expressed significantly higher levels of VEGFR-2 expression in the theca 
interna layer than non-primed animals (Figure 42). It appears as though the 
significant interaction was due to lower VEGFR-2 expression levels in the theca 
interna of primed animals before the LH surge, but higher levels after the LH.  
Mean VEGFR-2 protein expression values observed in the different cell layers of 
large follicles before and after the LH surge from progesterone primed and non-
primed seasonally anoestrous ewes treated with small-dose multiple injections of 









Figure 41. The overall mean Expression Index of VEGFR-2 protein in the granulosa 
(G), theca externa (TE) and theca interna (TI) layers of large follicles of seasonally 
anoestrous ewes treated with small-dose multiple injections of GnRH. s.e.d. = 2.55, 
standard error of difference between means to compare the mean values for VEGFR-
2 expression between cell layers. Different letters on bars indicate significant 







Table 13. Mean VEGFR-2 protein Expression Index values observed in the various 
cell layers of large follicles before and after the LH surge from progesterone primed 
and non-primed seasonally anoestrous ewes treated with small-dose multiple 
injections of GnRH. 
Groups Progesterone Time 
Layer 
Granulosa Theca externa Theca interna 
1 - Pre-LH 6.73 9.02 48.32 
2 + Pre-LH 9.76 11.38 31.70 
3 - Post-LH 3.93 7.05 31.46 
4 + Post-LH 7.92 18.39 65.18 
s.e.d. (8.22) = standard error of difference between means to compare the mean values both within 
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Figure 42. The mean Expression Index of VEGFR-2 protein in the granulosa (G), 
theca externa (TE) and theca interna (TI) layers of large follicles from progesterone 
primed and non-primed seasonally anoestrous ewes treated with small-dose multiple 
injections of GnRH, prior and post-LH surge. The s.e.d. = 8.227, standard error of 
the difference between means to compare mean values within and between treatment 
groups. Number of animals per treatment per time = 5. 
 
   
3.3.3.3 Angiopoietin-1 protein 
 
Statistical analysis indicated that there was no significant effect of progesterone 
priming (P = 0.19) nor timing of the LH surge (P = 0.95) on Ang-1 protein 
expression. However, there were significant effects (P<0.05) of follicular cell layers 
on Ang-1 protein expression levels as well as significant interaction between factors.  
The theca interna expressed significantly higher (P<0.05) overall mean levels of 
Ang-1 protein than the granulosa and theca externa layers, with no significant 
difference being observed between the granulosa and theca externa layers (Figure 
43). 
The significant interaction was due to the fact that while there was no significant 
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primed animals in the different layers before the LH surge, after the LH surge 
progesterone primed animals showed significantly higher (P<0.05) Ang-1 protein 
expression levels in the theca interna layer when compared to non-primed animals 
(Figure 44).   
Mean Ang-1 protein values observed in the different cell layers of large follicles 
before and after the LH surge from progesterone primed and non-primed seasonally 




Figure 43. The overall mean Expression Index of Angiopoietin-1 protein in the 
granulosa (G), theca externa (TE) and theca interna (TI) layers of large follicles of 
seasonally anoestrous ewes treated with small-dose multiple injections of GnRH. 
s.e.d. = 3.876, standard error of difference between means to compare the mean 
values for Angiopoietin-1 expression between cell layers. Different letters on bars 
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Table 14. Mean Angiopoietin-1 protein Expression Index values observed in the 
various cell layers of large follicles before and after the LH surge from progesterone 
primed and non-primed seasonally anoestrous ewes treated with small-dose multiple 
injections of GnRH. 
Groups Progesterone Time 
Layer 
Granulosa Theca externa Theca interna 
1 - Pre-LH 35.93 23.07 63.78 
2 + Pre-LH 33.28 42.31 68.54 
3 - Post-LH 13.90 17.27 58.64 
4 + Post-LH 37.48 34.18 98.97 
s.e.d. (18.17) = standard error of difference between means to compare the mean values both within 






Figure 44 The mean Expression Index of Angiopoietin-1 protein in the granulosa 
(G), theca externa (TE) and theca interna (TI) layers of large follicles from 
progesterone primed and non-primed seasonally anoestrous ewes treated with small-
dose multiple injections of GnRH, prior and post-LH surge. The s.e.d. = 18.17, 
standard error of the difference between means to compare mean values within and 
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3.3.3.4 Angiopoietin-1 mRNA 
 
As data was not normally distributed, values were submitted to Square Root 
transformation prior to statistical analysis. There was no significant effect of 
progesterone priming (P = 0.17) nor timing of the LH surge (P = 0.40) on Ang-1 
mRNA expression levels. However, there were significant effects (P<0.05) of 
follicular cell layers on Ang-1 mRNA expression levels as well as significant 
interaction between factors.  
The granulosa showed significantly higher (P<0.05) overall mean levels of Ang-1 
mRNA expression than both theca layers, and the theca interna showed significantly 
higher (P<0.05) levels of Ang-1 mRNA expression than the theca externa (Figure 
45). 
While no significant difference was observed in Ang-1 mRNA levels in the 
different cell layers of progesterone primed and non-primed animals before the LH 
surge, progesterone primed animals showed significantly higher (P<0.05) mean 
levels of Ang-1 mRNA than non-primed animals but only in the theca interna layer 
after the LH surge. It was this factor that was responsible for the significant 
interaction (Figure 46). 
Mean Ang-1 mRNA values observed in the different cell layers of large follicles 
before and after the LH surge from progesterone primed and non-primed seasonally 






Figure 45. The overall mean Square Root Expression Index of Angiopoietin-1 
mRNA in the granulosa (G), theca externa (TE) and theca interna (TI) layers of large 
follicles of seasonally anoestrous ewes treated with small-dose multiple injections of 
GnRH. Square Root s.e.d. = 0.120, standard error of difference between means to 
compare the mean values for Angiopoietin-1 mRNA expression between cell layers. 







Table 15. Back transformed mean values for Angiopoietin-1 mRNA Expression 
Index (Square Root values) observed in the various cell layers of large follicles 
before and after the LH surge from progesterone primed and non-primed seasonally 
anoestrous ewes treated with small-dose multiple injections of GnRH. 
Groups Progesterone Time 
Layer 
Granulosa Theca externa Theca interna 
1 - Pre-LH 134.79 (11.61) 100.80 (10.04) 104.65 (10.23) 
2 + Pre-LH 134.56 (11.60) 102.21 (10.11) 104.85 (10.24) 
3 - Post-LH 131.10 (11.45) 101.00 (10.05) 105.26 (10.26) 
4 + Post-LH 140.42 (11.85) 100.20 (10.01) 129.27 (11.37) 
Square Root s.e.d. (0.297) = standard error of difference between means to compare the mean values 
























n = 20 
TI 
































Figure 46. The mean Square Root Expression Index of Angiopoietin-1 mRNA in the 
granulosa (G), theca externa (TE) and theca interna (TI) layers of large follicles from 
progesterone primed and non-primed seasonally anoestrous ewes treated with small-
dose multiple injections of GnRH, prior and post-LH surge. The s.e.d. = 0.297, 
standard error of the difference between means to compare mean values within and 




3.3.3.5 Angiopoietin-2 protein 
 
Statistical analysis indicated that there was no significant effect of progesterone 
priming (P = 0.42) nor timing of the LH surge (P = 0.89) on Ang-2 protein 
expression levels. However, there were significant effects (P<0.05) of follicular cell 
layers on Ang-2 protein expression levels as well as significant interaction between 
factors.  
The theca interna expressed significantly higher (P<0.05) overall mean levels of 
Ang-2 protein than the granulosa and theca externa layers, with no significant 
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The significant (P<0.05) interaction was attributed to the high mean levels of 
Ang-2 protein expression in the theca interna of progesterone primed animals after 
the LH surge, with no significant differences in any other layer before or after the LH 
surge (Figure 48).  
Mean Ang-2 protein values observed in the different cell layers of large follicles 
before and after the LH surge from progesterone primed and non-primed seasonally 
anoestrous ewes treated with GnRH are detailed in Table 16. 
 
 
Figure 47. The overall mean Expression Index of Angiopoietin-2 protein in the 
granulosa (G), theca externa (TE) and theca interna (TI) layers of large follicles of 
seasonally anoestrous ewes treated with small-dose multiple injections of GnRH. 
s.e.d. = 2.393, standard error of difference between means to compare the mean 
values for Angiopoietin-2 expression between cell layers. Different letters on bars 
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Table 16. Mean Angiopoietin-2 protein Expression Index values observed in the 
various cell layers of large follicles before and after the LH surge from progesterone 
primed and non-primed seasonally anoestrous ewes treated with small-dose multiple 
injections of GnRH. 
Groups Progesterone Time 
Layer 
Granulosa Theca externa Theca interna 
1 - Pre-LH 7.53 7.62 26.28 
2 + Pre-LH 10.23 11.73 19.45 
3 - Post-LH 0.93 4.16 13.92 
4 + Post-LH 5.53 14.86 32.95 
s.e.d. (8.94) = standard error of difference between means to compare the mean values both within 






Figure 48. The mean Expression Index of Angiopoietin-2 protein in the granulosa 
(G), theca externa (TE) and theca interna (TI) layers of large follicles from 
progesterone primed and non-primed seasonally anoestrous ewes treated with small-
dose multiple injections of GnRH, prior and post-LH surge. The s.e.d. = 8.943, 
standard error of the difference between means to compare mean values within and 
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3.3.3.6 Angiopoietin-2 mRNA 
 
Statistical analysis indicated that there was no significant effect of progesterone 
priming (P = 0.44) nor timing of the LH surge (P = 0.12) on Ang-2 mRNA 
expression levels. However, there was a significant effect (P<0.05) of follicular cell 
layers on Ang-2 mRNA expression levels but with no significant interaction between 
factors (P = 0.06).  
The granulosa showed significantly higher (P<0.05) overall levels of Ang-2 
mRNA than the theca layers, with no significant difference being observed between 
the theca interna and theca externa layers (Figure 49). 
Mean Ang-2 mRNA values observed in the different cell layers of large follicles 
before and after the LH surge from progesterone primed and non-primed seasonally 




Figure 49. The overall mean Expression Index of Angiopoietin-2 mRNA in the 
granulosa (G), theca externa (TE) and theca interna (TI) layers of large follicles of 
seasonally anoestrous ewes treated with small-dose multiple injections of GnRH. 
s.e.d. = 0.884, standard error of difference between means to compare the mean 
values for Angiopoietin-2 mRNA expression between cell layers. Different letters on 
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Table 17. Mean Angiopoietin-2 mRNA Expression Index values observed in the 
various cell layers of large follicles before and after the LH surge from progesterone 
primed and non-primed seasonally anoestrous ewes treated with small-dose multiple 
injections of GnRH. 
Groups Progesterone Time 
Layer 
Granulosa Theca externa Theca interna 
1 - Pre-LH 111.8 100.5 100.5 
2 + Pre-LH 105.0 100.2 100.2 
3 - Post-LH 104.1 100.0 100.0 
4 + Post-LH 104.9 100.0 100.0 
s.e.d. (2.16) = standard error of difference between means to compare the mean values both within 
and between the various treatment groups.  
 
 
3.3.3.7 TIE-2 protein 
 
Statistical analysis indicated that there was no significant effect of progesterone 
priming (P = 0.33) nor timing of the LH surge (P = 0.41) on TIE-2 protein expression 
levels. However, there was a significant effect (P<0.05) of follicular cell layers on 
TIE-2 protein levels but with no significant interaction between factors (P = 0.63).  
The theca externa layer expressed significantly higher (P<0.05) overall mean 
levels of TIE-2 protein than the granulosa, with no significant difference between the 
theca interna and theca externa layers nor between the granulosa and theca interna 
layer (Figure 50). 
Mean TIE-2 protein expression values observed in the different cell layers of 
large follicles before and after the LH surge from progesterone primed and non-
primed seasonally anoestrous ewes treated with small-dose multiple injections of 





Figure 50. The overall mean Expression Index of TIE-2 protein in the granulosa (G), 
theca externa (TE) and theca interna (TI) layers of large follicles of seasonally 
anoestrous ewes treated with small-dose multiple injections of GnRH. s.e.d. = 0.748, 
standard error of difference between means to compare the mean values for TIE-2 
expression between cell layers. Different letters on bars indicate significant 





Table 18. Mean TIE-2 protein Expression Index values observed in the various cell 
layers of large follicles before and after the LH surge from progesterone primed and 
non-primed seasonally anoestrous ewes treated with small-dose multiple injections of 
GnRH. 
Groups Progesterone Time 
Layer 
Granulosa Theca externa Theca interna 
1 - Pre-LH 6.438 8.856 8.536 
2 + Pre-LH 4.134 5.316 2.405 
3 - Post-LH 3.811 5.905 4.785 
4 + Post-LH 4.898 5.181 4.181 
s.e.d. (2.82) = standard error of difference between means to compare the mean values both within 
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3.3.3.8 TIE-2 mRNA 
 
Statistical analysis indicated that there was no significant effect of progesterone 
priming (P = 0.14) nor timing of the LH surge (P = 0.75) on TIE-2 mRNA 
expression levels. However, there were significant effects (P<0.05) of follicular cell 
layers on TIE-2 mRNA expression levels as well as a significant interaction between 
factors.  
The granulosa expressed significantly higher (P<0.05) overall mean levels of 
TIE-2 mRNA than the theca layers, with no significant difference between the theca 
interna and theca externa layers (Figure 51). 
In terms of the significant interaction, TIE-2 mRNA expression before the LH 
surge was significantly higher (P<0.05) in the granulosa and theca externa layers of 
progesterone primed animals compared to non-primed. This difference, however, 
disappeared by the post-LH period (Figure 52).  
Mean TIE-2 mRNA values observed in the different cell layers of large follicles 
before and after the LH surge from progesterone primed and non-primed seasonally 










Figure 51. The overall mean Expression Index of TIE-2 mRNA in the granulosa (G), 
theca externa (TE) and theca interna (TI) layers of large follicles of seasonally 
anoestrous ewes treated with small-dose multiple injections of GnRH. s.e.d. = 2.237, 
standard error of difference between means to compare the mean values for TIE-2 
mRNA expression between cell layers. Different letters on bars indicate significant 







Table 19. Mean TIE-2 mRNA Expression Index values observed in the various cell 
layers of large follicles before and after the LH surge from progesterone primed and 
non-primed seasonally anoestrous ewes treated with small-dose multiple injections of 
GnRH. 
Groups Progesterone Time 
Layer 
Granulosa Theca externa Theca interna 
1 - Pre-LH 119.6 100.7 100.8 
2 + Pre-LH 138.5 119.4 106.1 
3 - Post-LH 122.8 101.9 103.1 
4 + Post-LH 125.8 106.3 112.9 
s.e.d. (8.70) = standard error of difference between means to compare the mean values both within 
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Figure 52. The mean Expression Index of TIE-2 mRNA in the granulosa (G), theca 
externa (TE) and theca interna (TI) layers of large follicles from progesterone primed 
and non-primed seasonally anoestrous ewes treated with small-dose multiple 
injections of GnRH, prior and post-LH surge. The s.e.d. = 8.701, standard error of 
the difference between means to compare mean values within and between treatment 




 A summary of the effects on angiogenic factors levels before and after the LH 
surge in the granulosa, theca interna and theca externa layers of both small and large 
follicles of progesterone primed and non-primed animals treated with small-dose 
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 It has been reported that seasonally anoestrous ewes pre-treated with 
progesterone prior to GnRH-induced ovulation show an LH surge significantly later 
than non-primed animals (39 versus 20 hours after the start of GnRH treatment, 
respectively) when progesterone priming was removed at the start of GnRH 
treatment (McLeod et al., 1982b). However, when progesterone injection is given 5 
or 3 days before the start of GnRH treatment, as in the case of this study, there is no 
delay in the onset of the LH surge (Pearce et al., 1987). Furthermore, it has been 
shown that when given intravenously, a GnRH bolus is able to immediately induce 
an LH surge (Hunter et al., 1988). Progesterone priming has no effect on the duration 
or amplitude of the LH surge (Haresign et al., 1996, Legan et al., 1985), therefore, 
once the pre-ovulatory LH surge is induced there should be no significant variation 
between primed and non-primed animals in the time required for ovulation to occur. 
Ovulation following GnRH bolus injection is expected to occur 30 hours after the 
onset of the LH surge (Stellflug et al., 1997, Bazer et al., 1994), 60 hours after the 
beginning of GnRH treatment in this study. 
 In this project a 300 μg GnRH bolus injection given intravenously 30 hours 
after the start of the GnRH treatment resulted in synchronization of the onset of the 
LH surge in all animals, as reported previously by Khalid et al. (1997). GnRH bolus 
injection was designed at 30 hours after the start of pulsatile GnRH treatment in 
order to expose follicles to a sustained increase in LH for a period long enough for 
their development and maturation. Moreover, the synchronization of the onset of the 
pre-ovulatory LH surge was of extreme importance in order to establish ovary 
collection times and guarantee that follicles were exposed to gonadotrophin 
stimulation for the same length of time in both treatment groups. Based on the LH 
profile for each group it is safe to say that ovaries from Group 1 and Group 2 animals 
were collected prior to the LH surge (24 hours after start of GnRH treatment) and 
ovaries from Group 3 and Group 4 were collected after the LH surge but prior to 
ovulation (46 hours after the start of GnRH treatment). Therefore, post-LH surge 
ovaries were collected 16 hours after the onset of the LH surge but 14 hours prior to 




absence of a corpus haemorrhagicum and/or an ovulation point in the majority of 
animals. The ovulated animals (1/10 from primed and 2/10 from non-primed groups) 
were excluded from any analysis. 
 Adequate ovarian vasculature is essential for follicular development and 
ovulation (Shimizu et al., 2007). Furthermore, the acquisition of adequate vascular 
supply is essential for the delivery of hormones and nutrients to the developing 
follicle prior to ovulation (Tamanini and De Ambrogi, 2004). The theca blood 
vessels are responsible for providing the growing follicles with gonadotrophins, 
growth factors, steroid precursors and other substances essential for adequate 
vascular development (Kaczmareck et al., 2005). Although blood vessels are limited 
to the theca layers, the granulosa cells seem to be responsible for a significant 
production of angiogenic factors  (Tamanini and De Ambrogi, 2004) which can 
diffuse to the theca compartment. These factors are also thought to accumulate in the 
follicular fluid creating an angiogenic gradient attracting blood vessels closer to the 
granulosa layer (Mattioli et al., 2001). 
 VEGF is essential for follicular development (Hunter et al., 2004, Ferrara et al., 
2003a) and the persistence of the theca interna capillary network is directly 
dependent on VEGF accumulation in the follicular fluid (Mattioli et al., 2001). 
VEGF is also necessary for antrum development and for neovascularisation to occur 
(Hayashi et al., 2003). 
 In small follicles there was a significant difference in VEGF protein expression 
by the different cell layers. Although the granulosa layer is said to be the main source 
of VEGF production in the follicle (Hunter et al., 2004, Robinson et al., 2007), in this 
study it was observed that in small follicles of 2-2.5 mm in diameter, the theca 
interna expressed significantly higher levels of VEGF protein than the theca externa 
or the granulosa layer. As the theca interna is the main source of vascular supply to 
the developing follicle (Mattioli et al., 2001), high levels of VEGF are expected to be 
present in such follicles as follicular angiogenesis is still taking place during early 
follicular development. 
 Progesterone priming did not have any significant effect on VEGF expression 




 Although it has been reported that LH stimulates VEGF expression in the 
granulosa layer (Tamanini and De Ambrogi, 2004), VEGF levels in small follicles 
were found to be significantly higher prior to the LH surge. LH receptors are known 
to appear in the granulosa cells of ovine follicles when they reach approximately 3.5 
mm in diameter (Hunter et al., 2004). As all small follicles analyzed in this study 
ranged from 2 to 2.5 mm in diameter, LH receptors may well not have been present 
in the granulosa layer. This observation leads to the conclusion that the LH surge 
does not have a direct influence in upregulating VEGF levels in small follicles. 
Furthermore, after the LH surge, small follicles either have their development halted 
or undergo atresia (Hunter et al., 2004, Driancourt, 2001, Stabenfeldt and Edquist, 
1996). In either case, VEGF levels are expected to decline (Wulff et al., 2001a), as 
observed in this study. 
 VEGFR-2 was found to be expressed mainly by the theca layers of small 
follicles, as previously reported (Wulff et al., 2001a, Hunter et al., 2004). The highest 
levels of VEGFR-2 were found in the theca interna while the lowest was observed in 
the granulosa layer. As with VEGF protein, progesterone priming had no overall 
effect on VEGFR-2 levels, but unlike with VEGF, the LH surge did not significantly 
alter VEGFR-2 levels in small follicles. 
 Angiopoietins act in association with VEGF to regulate blood vessel formation 
and maturation (Davis et al., 1996). In small follicles it was observed that all cell 
layers were capable of expressing Ang-1 protein and mRNA. The theca interna layer 
expressed significantly higher levels of Ang-1 protein than the theca externa or 
granulosa layers. The granulosa showed the lowest amounts of Ang-1 protein of all 
follicular layers. Ang-1 mRNA, on the other hand, was mainly expressed by the 
granulosa layer, followed by the theca interna and last by the theca externa layer. 
These findings are in agreement with previous reports on Ang-1 mRNA expression 
in the follicular layers (Hayashi et al., 2003, Shimizu et al., 2007). This difference in 
protein and mRNA expression by the different follicular layers could possibly be 
explained by the diffusion of the protein from the granulosa to the theca layer 
(Mattioli et al., 2001) or to the follicular fluid. 
 Neither progesterone priming nor the LH surge had any significant effect on 




 Similarly to Ang-1, Ang-2 protein in small follicles was found at its highest in 
the theca interna and lowest in the granulosa layer. Ang-2 mRNA levels were found 
relatively evenly in all three follicular layers, with the granulosa layers showing 
slight but significantly higher amounts of Ang-2 mRNA. These findings are in 
agreement with previously reported data in which both theca and granulosa layers are 
capable of expressing Ang-2 mRNA (Hayashi et al., 2003, Shimizu et al., 2007). 
 Neither progesterone priming nor the LH surge had any overall significant 
effect on either Ang-2 protein or mRNA expression in small follicles.  
 TIE-2 expression did not significantly vary between the follicular cell layers of 
small follicles. Interestingly, TIE-2 mRNA was found to be significantly higher in 
the granulosa than in the theca layers. This difference in TIE-2 mRNA expression, 
but not in protein concentration, in the different follicular layers could be explained 
by the fact that TIE-2 protein produced by the granulosa cells has likely diffused to 
the theca compartment, accounting for the lack of variation in protein levels between 
the follicular layers. It has been reported that in bovine follicles TIE-2 mRNA can 
only be found in the theca layers (Shimizu et al., 2007, Hayashi et al., 2003), 
however, in other species such as primates TIE-2 mRNA was found to be present in 
the granulosa as well as the theca layers (Wulff et al., 2001a). We have observed that 
ovine follicles express TIE-2 mRNA in all 3 follicular layers. 
 Progesterone priming did not have any significant effect on either TIE-2 
protein levels or mRNA expression in small follicles. Furthermore, TIE-2 protein and 
mRNA did not significantly vary before or after the LH surge.  
 These findings lead to the conclusion that LH has no influence on either 
Angiopoietin or their receptor in small follicles and that these relatively low levels 
associated with low VEGF post-LH surge result in regression of vascularity leading 
to a halt in follicular development and/or atresia. 
 Based on these findings it can be concluded that the negative effect that the 
lack of progesterone priming prior to GnRH treatment has on luteal functionality is 
not related to lower production or expression of angiogenic factors or their receptors 
in small follicles before or after the LH surge. This is expected as follicles up to 2.5 




which had already been exposed to an LH surge would certainly undergo atresia and 
halt any further development. 
 The great majority of the large follicles used in this project (62%) were ≥3.5 
mm and therefore would be expected to express LH receptors in the granulosa layer 
(Hunter et al., 2004) and become more susceptible to LH than small follicles. 
 Interestingly, VEGF production by large follicles was highest in the theca 
interna layer, as observed in small follicles. As the majority of the follicles were 
expected to have developed LH receptors in the granulosa layer, it was expected that 
LH would have stimulated enough VEGF production by the granulosa layer to turn it 
into the main source of VEGF protein in the follicle, as reported previously (Hunter 
et al., 2004, Robinson et al., 2007). However, the lower VEGF levels observed in the 
granulosa layer may still accumulate and result in high VEGF levels in the follicular 
fluid which would act as a stimulus for blood vessels to extend towards the granulosa 
around the time of ovulation (Mattioli et al., 2001). Furthermore, VEGF levels 
produced by the granulosa could be diffusing into the theca interna layer and thus 
accounting for the elevated levels of protein observed in that layer. 
 Non-primed animals showed significantly lower overall VEGF levels than 
progesterone primed animals. As the theca capillary network is directly dependent on 
VEGF levels, the lower VEGF levels observed in non-primed animals may lead to 
degradation of the existing vascular bed and poor sprouting around the time of 
ovulation. Low VEGF levels during the late follicular phase have been shown to 
interfere with dominant follicle ovulation and have been associated with the 
development of non-functional CL (Fraser and Duncan, 2009). 
 VEGF levels in large follicles were found to be significantly higher before the 
LH surge, as observed in small follicles. This is in agreement with previously 
reported data in which VEGF levels decreased at peri-ovulatory time (Fraser and 
Duncan, 2009), however,  the levels observed after the LH surge may be sufficient to 
induce angiogenesis. During the peri-ovulatory period VEGF levels are known to 
increase markedly in the follicular fluid (Ferrara et al., 1992, Tamanini and De 
Ambrogi, 2004). Even though lower levels of VEGF were observed in the different 
cell layers, VEGF levels could possibly be found to be high in follicular fluid as 




However, follicular fluid measurements of angiogenic factors were not part of this 
study. 
 VEGFR-2 levels were found to be significantly higher in the theca interna of 
large follicles when compared to the granulosa and theca externa layers. The LH 
surge did not have any significant overall influence on VEGFR-2 protein levels in 
large follicles.  
 No significant change was observed in VEGFR-2 levels in the granulosa and 
theca externa layer of both progesterone primed and non-primed animals before or 
after the LH surge, remaining relatively low. VEGFR-2 expression in the theca 
interna layer, on the other hand, showed dramatic variation. While progesterone 
primed animals showed a significant increase in VEGFR-2 levels after the LH surge, 
non-primed animals showed a significant decrease in receptor levels. Furthermore, 
VEGFR-2 levels observed in the theca interna of progesterone primed animals after 
the LH surge were significantly higher than those observed in non-primed animals. 
 Around the time of the LH surge the basal membrane between the granulosa 
and theca interna layers dissolves and the theca capillaries expand and sprout into the 
avascular granulosa layer to form a dense vascular network which will be the base 
for luteal vascular development (Shimizu et al., 2007). Significantly lower levels of 
VEGF and VEGFR-2 observed in non-primed animals could significantly interfere 
with blood vessel sprouting, thereby limiting early luteal angiogenesis. 
 Progesterone seems to act in synergism with LH to upregulate VEGFR-2 
production by the theca interna cells of large follicles. LH is known to stimulate 
VEGF expression (Tamanini and De Ambrogi, 2004) and this study has shown that it 
has a similar effect on VEGFR-2 production. Although it is not clear why the LH 
surge did not result in an increased expression of VEGF in large follicles, an increase 
in the VEGFR-2 expression by the theca interna cell of progesterone primed animals 
may result into an overall increased effect of VEGF and therefore, a higher degree of 
vascularisation in these animals. 
In large follicles all 3 layers were able to express Ang-1 protein. However, the 
theca interna showed significantly higher levels of Ang-1 than the granulosa and 
theca externa layers. Furthermore, no significant difference was observed in Ang-1 




the granulosa layer of large follicles showed significantly higher levels of Ang-1 
mRNA expression than the theca layers. Ang-1 mRNA was found at its lowest in the 
theca externa layer. 
 In both small and large follicles, Ang-1 protein was mainly produced by the 
theca interna while Ang-1 mRNA was found at its highest levels in the granulosa 
layer. Although both the granulosa and the theca layers have been reported to express 
mRNA for Ang-1 (Shimizu et al., 2007, Hayashi et al., 2003), it is nevertheless 
interesting to observe that protein production did not always reflect mRNA 
expression, whether in concentration or location. 
 Neither progesterone priming nor the LH surge had any significant overall 
effect on Ang-1 protein or mRNA expression. Ang-1 mRNA has been shown to be 
highly expressed in bovine follicles before the LH surge followed by a significant 
decrease at the time of the LH surge and a slow and consistent rise after the LH surge 
(Shimizu et al., 2007). Although there is fluctuation in Ang-1 mRNA expression 
before and after the LH surge, the lack of variation in Ang-1 mRNA levels observed 
in this study could be due to the collecting times coinciding with the high levels of 
Ang-1 mRNA expression by the follicle, both before and after the LH surge. 
 No significant alterations in overall Ang-1 protein levels were observed in any 
of the cell layers before or after the LH surge, however, Ang-1 levels were 
significantly higher in the theca interna of progesterone primed animals after the LH 
surge than those observed in non-primed animals. Interestingly, Ang-1 mRNA levels 
did not vary in any layer of progesterone primed and non-primed animals before or 
after the LH surge. Therefore, although Ang-1 mRNA expression in the theca interna 
of both treatment groups after the LH surge was very similar, they yielded different 
responses in protein production. While non-primed animals showed similar Ang-1 
levels to the pre-LH phase, progesterone primed animals showed significantly higher 
levels than non-primed ones. 
 While in small follicles progesterone priming and the LH surge do not seem to 
affect Ang-1 protein and mRNA expression levels, in large follicles progesterone 
priming seems to upregulate Ang-1 protein expression by the theca interna cells after 
the LH surge, possibly contributing to the early luteinisation process that takes place 




 As with Ang-1, all follicular layers of large follicles were capable of expressing 
Ang-2 protein. However, the highest Ang-2 levels were observed in the theca interna 
with no difference observed between the theca externa and granulosa layer. As in 
small follicles, Ang-2 mRNA was mainly expressed by the granulosa layer. The 
expression of Ang-2 mRNA by all three follicular layers are in agreement with 
previously reported data (Hayashi et al., 2003, Tamanini and De Ambrogi, 2004). 
 Neither progesterone nor the LH surge had any overall significant effect on 
Ang-2 protein and mRNA expression in large follicles. However, Ang-2 protein 
levels in the theca interna of progesterone primed animals after the LH surge were 
significantly higher than those found in non-primed animals. Interestingly, Ang-2 
mRNA in the theca interna after the LH surge did not significantly vary between the 
treatment groups, suggesting that progesterone acts in synergism with LH to 
upregulate Ang-2 protein production. These findings are in agreement with previous 
reports in which Ang-2 mRNA expression levels were shown to be steady 
throughout follicular development and ovulation (Shimizu et al., 2007). 
 In large follicles TIE-2 protein expression was found mainly in the theca 
externa  layer.  As observed in small follicles, TIE-2 mRNA expression was found to 
be higher in the granulosa layer of large follicles. Although both theca layers 
expressed TIE-2 mRNA no significant difference was observed between them. 
 Neither progesterone priming nor LH seems to significantly interfere with TIE-
2 protein levels in large follicles. Eventhough TIE-2 mRNA levels prior to the LH 
surge were significantly higher in the theca externa and granulosa layers of 
progesterone primed animals no overall significant difference  between treatments 
could be observed. TIE-2 mRNA levels remained relatively similar after the LH 
surge, suggesting that LH has no significant influence on TIE-2 mRNA expression in 
the different follicular layers of large follicles. 
 Tissue growth and development depend upon the establishment of an adequate 
vascular supply. After the LH surge, the theca and granulosa cells of the pre-
ovulatory follicle undergo dramatic changes to form the CL. These rapid changes 
must be equally accompanied by the rapid development of new blood vessels 
(Berisha and Schams, 2005, Kaczmareck et al., 2005, Miyamoto et al., 2005, 




 After the LH surge theca capillaries invade and sprout into the avascular 
granulosa, forming the initial luteal vascular network (Shimizu et al., 2007). Most of 
the blood vessels of the early CL derive from the theca layer (Zheng et al., 1993) and 
further vascular development originates from sprouting from this existent vascular 
network (Kaczmareck et al., 2005, Ferrara et al., 1992, Berisha and Schams, 2005). 
Therefore, the formation of this initial vascular network is essential for the 
development of an adequate vascular network that will be able to support the 
demands of the developing CL. 
 High VEGF and high Ang-2 levels are essential for neovascularisation to occur 
(Hayashi et al., 2003). The significantly lower levels of VEGF observed in the large 
follicles of non-primed animals, associated with significantly lower levels of Ang-2 
protein after the LH surge, is potentially detrimental to angiogenesis and new blood 
vessel formation. This is further aggravated by the significantly lower levels of 
VEGFR-2 after the LH surge. This could possibly result in poor invasion and 
sprouting of theca capillaries into the granulosa and consequently result in a 
restricted and limited luteal vascular network. 
 Inadequate vascular supply has been suggested as a possible cause of defective 
luteal function (Southee et al., 1988a). A small vascular network would result in less 
angiogenesis taking place and therefore in a deficient vascular supply to the 
developing CL. Furthermore, after the LH surge, Ang-1 and Ang-2 are thought to 
stimulate early luteinisation and progesterone release from the peri-ovulatory follicle 
(Hayashi et al., 2003). Significantly lower levels of Ang-1 observed in non-primed 
animals after the LH surge could further interfere or delay the initial luteinisation 
process taking place in the follicular layers. 
 Therefore, the abnormal production of angiogenic factors in large follicles of 
non-primed animals could lead to inadequate development of the microvasculature of 
the pre-ovulatory follicle and delayed luteinisation of the follicular layers resulting in 
defective luteal function. 
 The effect of progesterone priming in overcoming luteal dysfunction cannot be 
attributed to altered angiogenic factor levels in small follicles. However, the lack of 
progesterone priming seems to lead to a defective production of these angiogenic 
factors in large follicles after the LH surge, potentially compromising luteal vascular 
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The CL is a secretory tissue which originates from the luteinisation of the theca 
and granulosa cell layers of the pre-ovulatory follicle (Berisha and Schams, 2005, 
Kaczmareck et al., 2005). Small and large luteal cells together with fibroblasts and 
vascular cells form the basic structure of the CL (Berisha and Schams, 2005, Sawyer, 
1995). 
Ovulation induced in seasonally anoestrous ewes with small-dose multiple 
injections of GnRH result in the formation of a defective CL (Southee et al., 1988a, 
Southee et al., 1988b, McLeod et al., 1982b). However, with progesterone priming 
prior to the induction of ovulation, the majority of these CL show normal luteal 
function (McLeod et al., 1982b, Bartlewski et al., 2001, Hunter et al., 1988, Husein 
and Kriddli, 2003, Haresign et al., 1996, Southee et al., 1988a). The defective CL 
formed following pulsatile GnRH treatment is morphologically similar to 
functionally normal  CL, with differences becoming apparent only 5 days after 
ovulation (Southee et al., 1988b, Hunter et al., 1988). It has been reported that 
defective CL have lower progesterone content (Hunter et al., 1989) and are paler than 
functional CLs (Hunter et al., 1988, Southee et al., 1988b), suggesting significantly 
reduced blood support. 
Adequate vascularisation is essential for satisfactory tissue growth and 
development. For the CL to have normal function, its rapid growth must be 
accompanied by rapid development of a vascular bed (Redmer et al., 2001, 
Kaczmareck et al., 2005, Berisha and Schams, 2005). 
The early CL is characterized by invasion of capillaries and rapid proliferation of 
endothelial cells (Zheng et al., 1993). The high proliferation of endothelial cells is 
responsible for the increased vascularity of the mature CL (Schams and Berisha, 
2004, Al-zi'abi et al., 2003). VEGF and VEGFR-2 protein levels are high during 
early luteal development (Kaczmareck et al., 2005, Tamanini and De Ambrogi, 
2004). Ang-2 levels are also high while Ang-1 levels are low, resulting in a high 
Ang-2:Ang-1 ratio during the initial phases of CL development (Schams and 
Berisha, 2004, Sugino et al., 2005). High VEGF levels and high Ang-2:Ang-1 ratio 




On the basis of available literature, a summary demonstrating the expected levels 
of ovarian angiogenic factors and their effect on luteal angiogenesis during the early 
and mid-luteal phases and early regression of functional CL can be found in Table 
21. 
 
Table 21. Expected levels of VEGF, VEGFR-2, Angiopoietin-1 and -2 and TIE-2 
protein and their effect on luteal angiogenesis during normal early and mid-luteal 
development and early luteal regression. 
Factors/Luteal phase Early Mid Early regression 
VEGF high moderate low 
VEGFR-2 high moderate low 
Ang-1 low high low 
Ang-2 moderate moderate high 
Ang-2:Ang-1 ratio high low high 
TIE-2 moderate moderate/high moderate 
Angiogenesis neovascularisation stabilization regression 
 
The development of a vascular bed incapable of supporting the growing CL has 
been attributed as one of the causes of defective luteal function (Reynolds and 
Redmer, 1998, Stellflug et al., 1997). It is thus possible that progesterone priming 
prior to the induction of ovulation with GnRH is directly or indirectly involved in 
establishing adequate luteal vascularity through regulation of angiogenic factors and 
their receptors.  
As angiogenesis is at its highest soon after ovulation (Al-zi'abi et al., 2003) and 
inadequate development of the luteal vasculature is believed to be one of the causes 
of defective luteal function (Reynolds and Redmer, 1998), the CL from the majority 
of non-primed animals are expected to show compromised angiogenesis during the 
early luteal phase. Therefore, VEGF and VEGFR-2 protein levels in these animals 
are expected to be reduced on day 1 and 2 after ovulation while Ang-2:Ang-1 ratio 
levels are expected to be moderate when compared to those in CL from progesterone 
primed animals. By day 4 after ovulation, the majority of these CL are expected to be 
showing signs of early vascular regression with low levels of VEGF and VEGFR-2 
accompanied by moderate to high levels of Ang-2:Ang-1 ratio. 
An abnormal production of ovarian angiogenic factors during early CL 
development could lead to an insufficient blood vessel network being established in 




development and most likely influence luteal functionality. Furthermore, insufficient 
blood supply would result in reduced delivery of nutrients and progesterone 
precursors to the developing CL limiting its development and, consequently, 
progesterone production. Lower progesterone levels would lead to impaired 
inhibition of oxytocin receptors resulting in premature release of endometrial PGF-
2α resulting in defective luteal function and premature regression.  
The lack of progesterone priming prior to GnRH-induced ovulation in seasonally 
anoestrous ewes may result in the abnormal production of angiogenic factors in the 
early CL leading to inadequate vascular support and consequent defective luteal 
functionality. The current study was designed to investigate this possibility. 
 
4.2 Materials and Methods 
 
In order to study if the lack of progesterone influences ovarian angiogenic factor 
production, seasonally anoestrous ewes were primed or non-primed with 
progesterone prior to pulsatile GnRH treatment using the experimental model 
described in Chapter 2. Luteal samples were collected at 50 (Groups 5 and 6), 74 
(Groups 7 and 8) and 122 hours (Groups 9 and 10) after GnRH bolus injection, 
which successfully induced an immediate LH peak (see Chapter 3). Ovulation 
following GnRH bolus injection is expected to occur 30 hours after the onset of the 
LH surge (Stellflug et al., 1997, Bazer et al., 1994), therefore, samples were collected 
1, 2 and 4 days after ovulation so that angiogenic factors levels could be analysed in 
early CLs, before morphological differences between defective and functional CL 
became apparent.  
Protein expression for VEGF, Ang-1 and -2 and their receptors (VEGFR-2 and 
TIE-2) were determined by Western Blotting while their gene expression (mRNA 
detection) was measured by in situ hybridization. Luteal vascular density was 
analysed by immunohistochemistry using antibody against Von Willebrand Factor 







4.2.1 Western Blotting 
 
Western Blotting assays were performed as described in Chapter 2; however, 
protein concentration, blotting time and antibody probing were optimized for each 
protein. For optimization gels were loaded with 25, 50, 75 and 100 μg of protein/well 
and probed with 1:200, 1:500 and 1:1,000 primary antibody and 1:5,000 and 
1:10,000 secondary antibody solutions. Based on the appearance and quality of the 
bands, optimal quantity of protein, primary and secondary antibody concentrations 
were selected. 
For VEGF assays, 100 μg of total protein/sample was loaded and separated using 
a 14% resolving gel. Blotting was performed for 90 minutes and membranes blocked 
in 10% w/v milk for 2 hours. Primary antibody probing took place overnight with 
1:350 Rabbit anti-human VEGF (VEGF A20, Santa Cruz Biotechnologies). 
Secondary antibody probing was done using 1:5,000 Goat anti-rabbit IgG 
(Perbiosciences) for 1 hour. Films were exposed for 5 minutes. 
For VEGFR-2 assays, 75 μg of total protein/sample was used and separated by an 
8% resolving gel. Blotting was performed for 105 minutes and blocking in 10% w/v 
milk took place overnight. Primary antibody probing with 1:500 Rabbit anti-mouse 
Flk-1 (Flk-1, Santa Cruz Biotechnologies) was performed for 12 hours followed by 1 
hour probing with 1:10,000 Goat anti-rabbit IgG (Perbiosciences). Films were 
exposed for 5 minutes. 
Ang-1 assays were performed using 30 μg of total protein/sample and a 10% 
resolving gel. Blotting took place for 105 minutes and blocking in 10% w/v milk for 
2 hours. Membranes were primed with 7 μg/ml Rabbit anti-mouse Ang-1 IgG 
(Ang11-A, Alpha Diagnostics International) overnight and incubated with 1:5,000 
Goat anti-rabbit IgG (Perbiosciences) for 1 hour. Films were exposed for 5 minutes. 
Ang-2 assays were performed using 50 μg of total protein/sample and a 10% 
resolving gel. Blotting was performed for 100 minutes and 10% w/v milk blocking 
for 2 hours. Primary antibody probing with 1:500 Rabbit anti-human Ang-2 (H-70, 
Santa Cruz Biotechnologies) was performed overnight and probing with 1:10,000 





For TIE-2 assays 50 μg of total protein/sample was run in a 10% resolving gel. 
Blotting took place for 90 minutes followed by 2 hours incubation with 10% w/v 
milk blocker. Membranes were placed in 1:500 Rabbit anti-mouse TIE-2 (C-20, 
Santa Cruz Biotechnologies) overnight and probed with 1:10,000 Goat anti-rabbit 
IgG (Perbiosciences) for 1 hour. Films were exposed for 15 minutes. 
To each gel, samples from different treatment groups were loaded in equal 
numbers. Gel to gel variation was eliminated by the same positive control being 
loaded into each gel. For each angiogenic factor, expression values (band intensities) 
were calculated in relation to controls.  
 
4.2.1.1 Blocking peptide 
 
To ascertain that the band observed after the assay was indeed VEGF, prior to 
membrane probing primary antibody against human VEGF (VEGF A20, Santa Cruz 
Biotechnologies) was incubated with an excess of blocking peptide VEGF (hBA-
165, Santa Cruz Biotechnologies) at 1:20 ratio for 2 hours and 30 minutes at 4 °C. 
The blocking peptide consisted of biologically active pure VEGF protein produced in 
E. coli.  
The blocking peptide attaches to the binding sites of the primary antibody, 
therefore, when the primary antibody is placed with the membrane there should not 
be enough free antibody to bind to the protein of interest and thus no signal should be 
detected. If the primary antibody used was not specific to VEGF, it would not bind to 
the blocking peptide and would still be able to bind to other proteins on the 
membrane. If a signal was detected then it would be most likely that the protein 
detected was other than VEGF. 
 
4.2.1.2 Heparinase treatment 
 
In order to determine if the high molecular weight observed for VEGF was due to 
its affinity to heparin-containing proteoglycans, some samples were submitted to 
heparinase treatment prior to loading on gel. Samples were incubated with 




4.2.2 Immunohistochemistry for Von Willebrand Factor 
 
Immunohistochemistry basic protocol was performed as described in Chapter 2. 
Primary antibody incubation was done using 1:100 Rabbit anti-human Von 
Willebrand Factor IgG (Sigma-Aldrich) overnight at 4 °C. Secondary antibody was 
used at a concentration of 1:25 followed by 1 minute colour development using 
DAB. For every animal one negative and three positive sections were used, making a 
total of 27 negative and 81 positive sections being analysed. 
 
4.2.3 In situ hybridization 
 
The in situ hybridization technique was performed as described in Chapter 2. For 
every assay, 81 positive (AS) and 27 negative (S) sections were used for each mRNA 
of interest. Enough riboprobe was made to ensure that each assay could at least be 
repeated once if needed. Hybridization and colour development times were 
optimized for each factor and are detailed below. 
For Ang-1 assays, slides were incubated with hybridization buffer (HB) for 20 
hours. Colour was allowed to develop for 20 hours prior to mounting. For Ang-2 
assays, slides were incubated with HB for 21 hours and left to develop colour for 19 
hours. TIE-2 hybridization was performed for 19 hours and colour development for a 
further 19 hours prior to mounting. 
VEGFR-2 probes were very limited but enough was made so that CL slides could 
be done. Slides were left in contact with HB for 22 hours prior to 19 hours of colour 
development. 
 
4.2.4 Statistical Analysis 
 
Data were analysed by two-way analysis of variance (ANOVA) using 
progesterone priming and days after ovulation as factors. The least significant 
difference (LSD) was used as a Post Hoc test for multiple comparisons between 
means. The overall effects of treatment (progesterone priming) and time (1, 2 and 4 




were analyzed. All analyses were done using GenStat 9
th
 edition (Version 9.1.0.147, 





 The proportion of seasonally anoestrous ewes that ovulated in response to 
pulsatile GnRH treatment associated with GnRH bolus injection ranged from 14/15 
in progesterone primed to 12/15 in non-primed animals.   
 The mean values observed for the different angiogenic factors in 1-, 2- and 4-
day old CL of progesterone primed and non-primed seasonally anoestrous ewes 
treated with small-dose multiple injections of GnRH can be seen in Table 22. 
 
4.3.1 VEGF protein 
 
Initial VEGF assays showed a band around 50 kDa (Figure 51) against the 
expected 22 kDa under reducing conditions. As variation of gel percentage (from 10 
to 16%) did not lead to a more accurate molecular weight estimative, blocking 
peptide assays were performed. 
The membrane exposed to primary antibody/blocking peptide showed no bands 
(Figure 52) confirming the specificity of the antibody used and that, therefore, the 
band observed was indeed VEGF, albeit at a different molecular weight than 
expected. 
Samples treated with heparinase still showed a main band around 50 kDa, 
however, a band around 22 kDa was much more evident in these samples than those 
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Figure 51. Representative autoradiograph of 10% acrylamide SDS/PAGE VEGF 
protein immunoblot showing luteal VEGF bands in early corpora lutea from 
progesterone primed seasonally anoestrous ewes induced to ovulate with small-dose 
multiple injections of GnRH. Bands show control sample (lane F) and luteal samples 
of 1- (lane D), 2- (lane B and C) and 4- (lane E) day old CL. Molecular weight 
markers (lane A) of 50 and 36 kDa are indicated by arrows. 
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Figure 52. Representative autoradiograph of VEGF protein immunoblot of 4-day old 
corpora lutea from progesterone primed seasonally anoestrous ewes induced to 
ovulate with small-dose multiple injections of GnRH, following incubation with 
(lanes B and C) and without (lanes D and E) blocking peptide. Molecular weight 
markers (lane A) of 50 and 36 kDa are indicated by arrows. 
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Figure 53. Representative autoradiograph of VEGF protein immunoblot of 4-day old 
corpus luteum from a progesterone primed seasonally anoestrous ewes before (lane 
C) and after (lane B) Heparinase treatment. Molecular weight marker (lane A) of 22 
kDa indicated by arrow.                           
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Although the reducing conditions used in this study did not have the expected 
effect on luteal VEGF samples, the specificity of the band observed was confirmed 
by the blocking peptide assay. 
No significant difference (P = 0.098) was observed in overall VEGF protein 
levels between progesterone primed and non-primed animals. A significant 
difference (P<0.05), however, was observed in VEGF protein levels between the 
different days after ovulation and the interaction between days and treatment was 
also significant (P<0.05).  
No significant difference was observed between treatment groups either at day 1 
or day 4 after ovulation. Both treatment groups showed significantly lower (P<0.05) 
levels of VEGF at day 1 when compared to days 2 and 4 after ovulation. Non-primed 
animals displayed similar VEGF levels on day 2 as on day 4 whilst progesterone 
primed animals showed significantly higher (P<0.05) levels of VEGF at day 2 when 




Figure 54. Mean expression of VEGF protein observed 1, 2 and 4 days after 
ovulation in corpora lutea of progesterone primed and non-primed seasonally 
anoestrous ewes induced to ovulate with small-dose multiple injections of GnRH. 
s.e.d. = 0.076, standard error of difference to compare mean values both within and 
between treatment groups. Different letters on bars indicate significant difference at 
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4.3.2 VEGFR-2 protein 
 
A significant difference (P<0.05) was observed in VEGFR-2 protein levels 
between progesterone primed and non-primed animals. No significant difference (P = 
0.288) was observed in VEGFR-2 protein levels between the different days after 
ovulation, however, a significant (P<0.05) interaction was observed between days 
and treatment.  
No significant difference could be observed in luteal VEGFR-2 protein 
expression between progesterone primed and non-primed animals at day 1 after 
ovulation. However, progesterone primed animals showed significantly higher 
(P<0.05) levels of VEGFR-2 both at days 2 and 4 when compared to non-primed 
animals.  
Progesterone primed animals maintained a high level of VEGFR-2 which did not 
vary over time. Non-primed animals, on the other hand, displayed a significant 
(P<0.05) decrease in luteal VEGF levels from day 1 to day 2 and this decline was 
maintained up to day 4 after ovulation (Figure 55). 
VEGFR-2 protein bands were observed just above the 148 kDa molecular weight 









Figure 55. Mean expression of VEGFR-2 protein observed 1, 2 and 4 days after 
ovulation in corpora lutea of progesterone primed and non-primed seasonally 
anoestrous ewes induced to ovulate with small-dose multiple injections of GnRH. 
s.e.d. = 0.225, standard error of difference to compare mean values both within and 
between treatment groups. Different letters on bars indicate significant difference at 








         A          B                     C                     D                   E 
 
Figure 56. Representative autoradiograph of 8% acrylamide SDS/PAGE VEGFR-2 
protein immunoblot showing luteal VEGFR-2 bands of early corpora lutea from 
progesterone primed and non-primed seasonally anoestrous ewes induced to ovulate 
with small-dose multiple injections of GnRH. Bands illustrate control sample (lane 
E) and progesterone primed (lane B and D) and non-primed (lanes A and C) luteal 
samples 2 days after ovulation. Molecular weight marker position is indicated by 
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4.3.3 VEGFR-2 mRNA levels 
 
No significant difference (P = 0.805) was observed in VEGFR-2 mRNA 
expression levels between progesterone primed and non-primed animals. A 
significant difference (P<0.05), however, was observed in VEGFR-2 mRNA 
expression levels between the different days after ovulation with no significant 
interaction (P = 0.528). 
VEGFR-2 mRNA expression levels were significantly higher (P<0.05) on day 1 
than on days 2 and 4 after ovulation. No significant difference in VEGFR-2 mRNA 
expression levels was observed between days 2 and 4 after ovulation (Figure 57). 




Figure 57. Mean Expression Index of VEGFR-2 mRNA observed 1, 2 and 4 days 
after ovulation in corpora lutea of seasonally anoestrous ewes induced to ovulate 
with small-dose multiple injections of GnRH. s.e.d. = 12.91, standard error of 
difference to compare mean values both within and between treatment groups. 
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Figure 58. In situ hybridization showing the expression of VEGFR-2 mRNA in a 2 
day corpus luteum from a progesterone primed seasonally anoestrous ewe induced to 
ovulate with small-dose multiple injections of GnRH. A sense image (left) is shown 




4.3.4 Angiopoietin-1 protein 
 
A significant difference (P<0.05) was observed in Ang-1 protein levels between 
progesterone primed and non-primed animals. No significant difference (P = 0.096) 
was observed in Ang-1 protein levels between the different days after ovulation, 
however, a significant interaction (P<0.05) was observed between days and 
treatment.  
Progesterone primed animals showed significantly higher (P<0.05) levels of 
Ang-1 at days 1 and 4 after ovulation than non-primed animals. However, no 
significant difference was observed between the two treatment groups at day 2 after 
ovulation. Progesterone primed animals maintained high levels of Ang-1 from day 1 
up to day 4 after ovulation. Non-primed animals, on the other hand, showed a 
significant increase (P<0.05) in Ang-1 levels between day 1 and day 2 followed by a 
significant decrease (P<0.05) on day 4 after ovulation (Figure 59). 






Figure 59. Mean expression of  Angiopoietin-1 protein observed 1, 2 and 4 days 
after ovulation in corpora lutea of progesterone primed and non-primed seasonally 
anoestrous ewes induced to ovulate with small-dose multiple injections of GnRH. 
s.e.d. = 0.142, standard error of difference to compare mean values both within and 
between treatment groups. Different letters on bars indicate significant difference at 
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Figure 60. Representative autoradiograph of 10% acrylamide SDS/PAGE 
Angiopoietin-1 protein immunoblot showing luteal Angiopoietin-1 bands of early 
corpora lutea from progesterone primed and non-primed seasonally anoestrous ewes 
induced to ovulate with small-dose multiple injections of GnRH. Bands shown are of 
control sample (lane H) and luteal samples from 1 (lane B and C), 2 (lane D and E) 
and 4 (lane F and G) days after ovulation from progesterone primed and non-primed 
animals, respectively. Molecular weight markers (lane A) of 64 and 50 kDa are 

















































4.3.5 Angiopoietin 1 mRNA  
 
Ang-1 sense and anti-sense images of CL sections can be seen in Figure 61. 
A significant difference (P<0.05) was observed in Ang-1 mRNA expression 
levels between progesterone primed and non-primed animals and between the 
different days after ovulation with no significant interaction (P = 0.109).  
Progesterone primed animals showed significantly higher (P<0.05) overall luteal 
Ang-1 mRNA expression levels than non-primed animals (Figure 62). Ang-1 mRNA 
expression levels were significantly higher (P>0.05) on day 1 than on day 2 after 
ovulation with no significant difference being observed in Ang-1 mRNA expression 




Figure 62. Mean Expression Index of Angiopoietin-1 mRNA observed in early 
corpora lutea of progesterone primed (+P4) and non-primed (-P4) seasonally 
anoestrous ewes induced to ovulate with small-dose multiple injections of GnRH. 
s.e.d. = 6.67, standard error of difference to compare mean values between treatment 
groups. Different letters on bars indicate significant difference at 5% level. n = 











n = 15 
 
+ P4 









































Figure 63. Mean Expression Index of Angiopoietin-1 mRNA observed 1, 2 and 4 
days after ovulation in corpora lutea of seasonally anoestrous ewes induced to 
ovulate with small-dose multiple injections of GnRH. s.e.d. = 8.17, standard error of 
difference to compare mean values between days after ovulation. Different letters on 






               
Figure 61. In situ hybridization showing the expression of Angiopoietin-1 mRNA in 
a 4-day corpus luteum from a progesterone primed seasonally anoestrous ewe 
induced to ovulate with small-dose multiple injections of GnRH. A sense image (left) 
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4.3.6 Angiopoietin-2 protein 
 
No significant difference (P = 0.922) was observed in Ang-2 protein levels 
between progesterone primed and non-primed animals. A significant difference 
(P<0.05), however, was observed in Ang-2 protein levels between the different days 
after ovulation with no significant interaction (P = 0.109).  
Ang-2 protein levels were significantly higher on day 1 after ovulation with no 
difference being observed in Ang-2 protein levels between days 2 and 4 after 
ovulation (Figure 62). 
Angiopoietin-2 protein has a molecular weight of approximately 83 kDa. Luteal 




Figure 62. Mean expression of Angiopoietin-2 protein observed 1, 2 and 4 days after 
ovulation in corpora lutea of seasonally anoestrous ewes induced to ovulate with 
small-dose multiple injections of GnRH. s.e.d. = 0.151, standard error of difference 
to compare mean values between days after ovulation. Different letters on bars 
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Figure 63. Representative autoradiograph of 10% acrylamide SDS/PAGE 
Angiopoietin-2 protein immunoblot showing luteal Angiopoietin-2 bands of early 
corpora lutea from progesterone primed and non-primed seasonally anoestrous ewes 
induced to ovulate with small-dose multiple injections of GnRH. Bands shown are of 
luteal samples from 1 (lanes B and C), 2 (lanes D and E) and 4 (lanes F and G) days 
after ovulation from progesterone primed and non-primed animals, respectively. 
Molecular weight markers (lane A) of 96 and 64 kDa are indicated by arrows. 
 
 
4.3.7 Angiopoietin-2 mRNA 
 
Ang-2 sense and anti-sense images of CL sections can be seen in Figure 64. 
No significant difference (P = 0.123) was observed in Ang-2 mRNA expression 
levels between progesterone primed and non-primed animals. A significant 
difference (P<0.05) was observed in Ang-2 mRNA expression levels between the 
different days after ovulation with no significant interaction (P = 0.352).  
Ang-2 mRNA expression levels were highest on day 1 but no significant 









Figure 65. Mean Expression Index of Angiopoietin-2 mRNA observed 1, 2 and 4 
days after ovulation in corpora lutea of seasonally anoestrous ewes induced to 
ovulate with small-dose multiple injections of GnRH. s.e.d. = 7.23, standard error of 
difference to compare mean values between days after ovulation. Different letters on 








      
Figure 64. In situ hybridization showing the expression of Angiopoietin-2 mRNA in 
a 1-day corpus luteum from a progesterone primed seasonally anoestrous ewe 
induced to ovulate with small-dose multiple injections of GnRH. A sense image (left) 
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4.3.8 Angiopoietin-2: Angiopoietin-1 protein ratio 
 
A significant difference (P<0.05) was observed in Ang-2:Ang-1 ratio between 
progesterone primed and non-primed animals as well as between the different days 
after ovulation but with no significant interaction (P = 0.250).  
Non-primed animals showed significantly (P = 0.055) higher overall Ang-2:Ang-
1 ratio during early CL development than progesterone primed animals (Figure 65). 
The Ang-2:Ang-1 ratio significantly decreased (P<0.05) from day 1 to day 2 after 
ovulation and then significantly increased (P<0.05) by day 4 after ovulation. No 
significant difference was observed between the Ang-2:Ang-1 ratio on days 1 and 4 




Figure 65. Mean Angiopoietin-2:Angiopoietin-1 ratio observed in early corpora 
lutea of progesterone primed (+P4) and non-primed (-P4)seasonally anoestrous ewes 
induced to ovulate with small-dose multiple injections of GnRH. s.e.d. = 0.136, 
standard error of difference to compare mean values between treatment groups. 
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Figure 66. Mean Angiopoietin-2:Angiopoietin-1 protein ratio observed 1, 2 and 4 
days after ovulation in corpora lutea of seasonally anoestrous ewes induced to 
ovulate with small-dose multiple injections of GnRH. s.e.d. = 0.160, standard error 
of difference to compare mean values between days after ovulation. Different letters 






4.3.9 TIE-2 protein 
 
No significant difference (P = 0.265) was observed in TIE-2 protein levels 
between the two treatment groups or between different days after ovulation (P = 
0.336).  The treatment x day interaction was also not significant (P = 0.082).  
TIE- 2 has a molecular weight of approximately 140 kDa. Luteal sample bands 
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Figure 67. Representative autoradiograph of 10% acrylamide SDS/PAGE TIE-2 
protein immunoblot showing luteal TIE-2 bands of early corpora lutea from 
progesterone primed and non-primed seasonally anoestrous ewes induced to ovulate 
with small-dose multiple injections of GnRH. Bands shown are of luteal samples 
from 1 (lanes B and E), 2 (lanes C and F) and 4 (lanes D and G) days after ovulation 
from progesterone primed and non-primed animals, respectively. Molecular weight 





4.3.10 TIE-2 mRNA  
 
TIE-2 sense and anti-sense images of CL sections can be seen in Figure 68. 
No significant difference (P = 0.786) was observed in TIE-2 mRNA expression 
levels between progesterone primed and non-primed animals. A significant 
difference (P<0.05) in TIE-2 mRNA expression levels was observed between the 
different days after ovulation with no significant interaction (P = 0.527).  
TIE-2 mRNA expression levels were found to be significantly higher on day 1 
than on day 2 and 4 after ovulation but with no significant difference being observed 








Figure 68. Mean Expression Index of TIE-2 mRNA observed 1, 2 and 4 days after 
ovulation in corpora lutea of seasonally anoestrous ewes induced to ovulate with 
small-dose multiple injections of GnRH. s.e.d. = 11.53, standard error of difference 
to compare mean values between days after ovulation. Different letters on bars 







           
Figure 69. In situ hybridization showing the expression of TIE-2 mRNA in a 2-day 
corpus luteum from a progesterone primed seasonally anoestrous ewe induced to 
ovulate with small-dose multiple injections of GnRH. A sense image (left) is shown 
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4.3.11 Von Willebrand Factor (VWF) protein 
 
Von Willebrand Factor protein levels between primed and non-primed animals 
was very nearly significant (P = 0.062) with progesterone primed animals showing 
higher overall levels of VWF protein than non-primed ones. Although not significant  
(P = 0.083) a trend in VWF protein levels could be observed in the different days 
after ovulation with highest levels being observed on day 2 and lowest on day 4. No 
significant difference (P = 0.483) was observed in the interaction between days and 
treatment.  
VWF distribution in luteal cells can be seen in Figure 70. 
 
 
       
Figure 70. Immunohistochemistry showing the expression of VWF protein in a 1 
day corpus luteum from a progesterone primed seasonally anoestrous ewe induced to 
ovulate with small-dose multiple injections of GnRH. A negative image (left) is 


















































The proportion of animals in this study that ovulated in response to small-dose 
multiple injections of GnRH are in agreement to those previously reported (Bramley 
et al., 2005, Haresign et al., 1996). 
VEGF is a glycoprotein of approximately 45 kDa (Ferrara et al., 2003b) which 
dissociates into 22 kDa homodimers under reducing conditions (Redmer et al., 
1996). The unexpected molecular weight observed for VEGF in the Western Blotting 
assays could be partially due to luteal VEGF being bound to heparin-containing 
proteins from the ECM. The different VEGF isoforms can be found either free or 
bound to the ECM (Ferrara, 2001, Poltorak et al., 1997, Wiesmann et al., 1997,  
Houck et al., 1991). The sheep CL has been shown to express at least three VEGF 
isoforms: VEGF121, VEGF165 and VEGF189 (Schams and Berisha, 2004) with 
VEGF121 corresponding to 1/3 of the total luteal VEGF content (Tamanini and De 
Ambrogi, 2004). As VEGF121 is the only isoform found completely free in its 
diffusible form (Poltorak et al., 1997), the majority of the luteal VEGF must, 
therefore, be bound to heparin-containing proteogycans. If the VEGF present in the 
luteal samples was bound to other proteins this could explain its lower migration 
through the gel. The fact that heparinase treatment resulted in a band being present at 
22 kDa supports this belief. 
It has also been reported that some proteins, including glycoproteins, show 
anomalous behaviour during SDS/PAGE electrophoresis. Under appropriate 
conditions most reduced polypeptides bind to SDS in a constant weight ratio. 
However, many factors may interfere with the ability of proteins to form complexes 
with the SDS detergent, resulting in a different molecular weight than expected 
(Matagne et al., 1991). This could be another explanation for the higher molecular 
weight observed in the samples in this study. Although VEGF bands were observed 
at a much higher molecular weight than expected under reducing conditions, the 
specificity of the primary antibody to VEGF was confirmed by the blocking peptide 
assay and the bands observed in the membranes were proven to be those of VEGF. 
Angiogenesis in the adult is mainly restricted to the female reproductive tract 




receptors (Ferrara, 2001, Maisonpierre et al., 1997, Reynolds et al., 2000). VEGF 
and Angiopoietins play an essential role throughout luteal development stimulating 
the proliferation, maturation and finally regression of blood vessels (Benjamin et al., 
1998, Ferrara et al., 1992, Davis et al., 1996, Maisonpierre et al., 1997). 
As the ovulatory follicle ruptures, theca vessels invade the granulosa layer and 
new blood vessels are formed to support the developing CL (Shimizu et al., 2007). 
Adequate blood supply is essential for normal tissue growth and development 
(Tamanini and De Ambrogi, 2004) and the developing CL requires an extensive 
vascular network to be established to support the morphological and functional 
changes taking place soon after ovulation (Schams and Berisha, 2004, Al-zi'abi et al., 
2003). 
GnRH-induced ovulation in seasonally anoestrous ewes, in the absence of 
progesterone, results in the development of a defective CL (McLeod et al., 1982b, 
Southee et al., 1988b). As inadequate vascularisation has been proposed as a possible 
cause of defective luteal function (Reynolds and Redmer, 1998), in this experiment 
we tested the hypothesis that progesterone priming stimulates angiogenesis by 
altering the expression and production of angiogenic factors and their receptors in the 
newly developing CL immediately after ovulation. 
By using seasonally anoestrous ewes primed and non-primed with progesterone 
prior to induced ovulation by small-dose multiple injections of GnRH, we were able 
to study the differences in angiogenic factor levels between functional and defective 
CL at their early stage of development. 
Results of this study have shown that the lack of progesterone priming prior to 
GnRH-induced ovulation has a negative impact on the VEGF-Angiopoietin system 
within the developing CL, probably compromising luteal angiogenesis and thus 
luteal function. 
VEGF levels, during early luteal development are expected to increase soon after 
ovulation to stimulate blood vessel formation. These levels gradually decrease by the 
mid-luteal phase when the CL has achieved its maximum size. During the mid-luteal 
phase cell proliferation is reduced and the vascular bed formed soon after ovulation 
matures and stabilizes (Ribeiro et al., 2006, Tamanini and De Ambrogi, 2004, 




 CL from progesterone primed and non-primed ewes induced to ovulate with 
GnRH showed low levels of VEGF straight after ovulation, followed a significant 
increase by day 2 after ovulation. Although VEGF levels are reported to be high 
during early luteal development (Redmer et al., 1996), it has been recently reported 
that luteal VEGF levels are low immediately after ovulation (Fraser and Duncan, 
2009), as observed in this study on day 1 CL.  The increase in VEGF levels 2 days 
after ovulation is in agreement with previous studies on VEGF expression during 
early luteal development (Kaczmareck et al., 2005, Al-zi'abi et al., 2003).  
Although no significant difference was observed in luteal VEGF levels between 
progesterone primed and non-primed animals on day 1 and 4 after ovulation, levels 
were significantly lower in non-primed compared with progesterone primed animals 
on day 2 with VEGF levels in CL from non-primed ewes being as low as those of 
progesterone primed animals on day 4 after ovulation. These findings indicate that 
CL from non-primed animals produce lower levels of VEGF at a critical time for 
angiogenesis in early luteal development. These lower levels of VEGF could lead to 
the formation of a limited vascular network which might prove to be inadequate to 
support normal luteal function. 
VEGFR-2 levels in CL on day 1 after ovulation were not different between 
progesterone primed and non-primed animals. While VEGFR-2 levels in CL from 
progesterone primed animals remained constant from day 1 up to day 4 after 
ovulation, confirming earlier findings of a similar pattern as that of VEGF protein 
(Tamanini and De Ambrogi, 2004), CL from non-primed animals, on the other hand, 
showed a marked and significant decrease in VEGFR-2 levels by days 2 and 4 after 
ovulation. These low VEGFR-2 levels found in the CL of non-primed ewes, at a time 
when angiogenesis should be high, further aggravate the low VEGF levels observed 
on day 2 after ovulation.  These findings suggest that at a time when both VEGF and 
VEGFR-2 are expected to be high, CL from non-primed animals show significantly 
lower levels of both VEGF protein and its receptor than those from progesterone 
primed animals. These findings strongly support the idea that a defective stimulus for 
the formation of new blood vessels could result in inadequate luteal vascularity and 




Overall VEGFR-2 mRNA expression, however, did not vary between primed and 
non-primed animals. VEGFR-2 mRNA levels were highest soon after ovulation 
followed by a significant decrease from day 1 to day 2 which persisted until day 4 
after ovulation. These reports are in agreement with previously reported data in 
humans in which VEGFR-2 mRNA levels were found to be high soon after ovulation 
(Ferrara et al., 2003a) followed by a significant decrease in expression as the luteal 
phase progressed (Ribeiro et al., 2006). Lack of a difference in the VEGFR-2 mRNA 
mRNA expression and a presence of difference in the protein levels in the CL 
between progesterone and non-primed ewes may suggest the effect of progesterone 
priming at the translational level for VEGFR-2. 
The Angiopoietin-TIE system is essential for functional luteal development and 
work in close association with the VEGF system to regulate ovarian angiogenesis 
(Shimizu et al., 2007). Ang-1 levels are mainly associated with vascular invasion and 
maturation while Ang-2 levels play an important role in vessel formation and 
regression (Maisonpierre et al., 1997). During early CL development Ang-2 levels 
are high and decrease by the mid-luteal phase. Ang-1 levels are low soon after 
ovulation and increase as the CL matures (Schams and Berisha, 2004, Sugino et al., 
2005). 
In this study, Ang-1 level was constant and high in CL from progesterone primed 
animals from day 1 to day 4 after ovulation. CL from non-primed animals, on the 
other hand, had significantly lower Ang-1 levels on day 1, showed a significant 
increase by day 2 (but not higher than primed CL) followed by a significant decrease 
by day 4 after ovulation. Ang-1 is known to stimulate vascular invasion 
(Maisonpierre et al., 1997) and these low levels of Ang-1, observed on day 1 CL 
from non-primed animals, may compromise the vascular invasion taking place soon 
after ovulation. This could result in a limited and insufficient vascular bed being 
developed in the CL from non-primed animals. 
Although Ang-1 levels were similar between primed and non-primed animals on 
day 2, on day 4 CL from non-primed animals showed significantly lower Ang-1 
levels than those of progesterone primed animals. At a time when blood vessels 
should be starting to stabilize, low levels of Ang-1 may indicate immature 




density due to low VEGF and VEGFR-2 levels on day 2, CL from non-primed 
animals seem unable to induce a desirable level of maturation on day 4 after 
ovulation on those blood vessels that have been formed. Non-stable vessels tend to 
regress as VEGF levels start to decline (Hayashi et al., 2003). Therefore, instead of 
developing a mature and stable vascularity by the mid-luteal phase, defective CL 
may well show early signs of vascular regression as a consequence of these 
differences in Ang-1 protein levels. 
Overall Ang-1 mRNA expression was significantly higher in CL from 
progesterone primed than non-primed animals which closely reflects the Ang-1 
protein production by the luteal cells.   
No significant difference was observed in Ang-2 levels between CL from primed 
and non-primed animals or during the different days after ovulation. These findings 
are in agreement with previously reported data in which Ang-2 levels remain stable 
throughout luteal development (Schams and Berisha, 2004). Interestingly, there was 
a significant decrease in Ang-2 mRNA expression by day 2 and 4 after ovulation, 
however, no significant difference was observed between progesterone primed and 
non-primed animals.  
Ang-2:Ang-1 ratio, also referred to as the stabilization ratio, in conjunction with 
VEGF levels will determine whether new blood vessels are to be formed, matured or 
regress (Hayashi et al., 2003). CL from non-primed animals showed significantly 
higher levels of Ang-2:Ang-1 ratio during early luteal development. Furthermore, the 
Ang-2:Ang-1 ratio was highest on days 1 and 4 after ovulation. These high levels of 
Ang-2:Ang-1 ratio observed soon after ovulation  are in agreement with previously 
reported data for functional CL (Schams and Berisha, 2004, Sugino et al., 2005). 
However, low levels of VEGF and VEGFR-2 associated with high Ang-2:Ang-1 
ratio observed on day 4 in CL from non-primed animals indicate a tendency of the 
newly formed blood vessels to regress instead of maturing as expected. 
TIE-2 protein and mRNA expression levels did not vary significantly between 
treatment groups. However, TIE-2 mRNA showed a significant decrease from day 1 
to 2 after ovulation with no significant variation on luteal TIE-2 protein levels.    
Higher Ang-2 compared to Ang-1 levels on day 4 are likely to result in de-




TIE-2 with the same affinity as Ang-1, high Ang-2 levels mean less receptor 
available for Ang-1-induced blood vessel maturation. Furthermore, the low levels of 
VEGF and VEGFR-2 result in the degeneration of the already limited newly formed 
vasculature in the early CL of non-primed animals, at a time when functional CL 
vessel network should be starting to stabilize to sustain the developing CL. 
Von Willebrand Factor (VWF) levels showed no significant difference between 
defective and functional CLs at any time of luteal development. However, 
differences between defective and functional CL were very nearly significant with 
progesterone primed animals showing higher overall levels of VWF protein than 
non-primed animals during early luteal development, supporting the hypothesis that 
progesterone priming ensures normal luteal function by enabling greater vascular 
development to take place during the early luteal phase. Furthermore, a trend could 
be observed in VWF protein levels in the different days after ovulation with the 
highest levels being observed on day 2 and the lowest on day 4. These findings are in 
agreement with the levels of the other angiogenic factors observed on those days, 
supporting the belief that on day 2 angiogenesis is at its highest whilst by day 4  
neovascularisation is declining and vascular maturation starting to take place. The 
levels of angiogenic factors observed on day 4 after ovulation suggest that CL from 
primed animals show greater stabilization of blood vessels than those from non-
primed animals. This seems to be true as CL from non-primed animals show 
significant lower vascular surface area by day 12 after ovulation than those from 
progesterone primed animals (Bramley et al., 2005). 
A lack of significant difference in the levels of some angiogenic factors between 
progesterone primed and non-primed animals when it was expected to be significant 
(according to our hypothesis) can also be supported by the fact that CL from non-
primed animals were of mixed type (some are defective and others are functional) 
where CL from primed groups were normal only (Southee et al., 1988b, Haresign et 
al., 1996, McLeod et al., 1982b). This may give more variation in the data from non-
primed animals and may therefore mask the differences between the two treatment 
groups. Furthermore, low number of animals (n = 4 or 5) per treatment group 
aggravates the lack of difference; had there been higher number of animals more 




In conclusion, the lack of progesterone priming seems to have a great impact on 
VEGF, VEGFR-2, Ang-1 and VWF protein production. A disruption in the delicate 
balance that governs angiogenesis may lead to inadequate vascular support by the 
mid-luteal phase and thus result in defective luteal function. Furthermore, low 
vascularity leads to lower levels of nutrients, hormones and steroidal precursors 
being delivered to the luteal cells. Low LH and GH being delivered to the CL 
consequently results in low progesterone output by the small and large luteal cells, a 
characteristic previously described for defective CL. Low progesterone levels may 
also compromise oxytocin receptor blocking in the endometrium and thus lead to 

















































5.1 Summary of Results 
 
 Infertility is a serious issue in both human and animal medicine and has a 
major economic impact on livestock production (Campbell et al., 2003). Many 
factors have been attributed as causes of infertility, among them defective luteal 
function (Yaniz et al., 2008). Defective luteal function is a relatively common 
occurrence in livestock reproduction. Seasonal species such as sheep, goats and 
mares show an initial short cycle during the transition from anoestrus to sexual 
activity, with a CL that prematurely regresses 5 to 6 days after ovulation (Rosa and 
Bryant, 2003). Non-seasonal animals such as cows are similarly affected. The first 
post-partum ovulation in both dairy and beef cows is generally silent, followed by a 
short cycle in more than 70% of the animals (Crowe, 2008). 
 It is now widely accepted that pulsatile GnRH treatment of seasonally 
anoestrous ewes is capable of inducing the final stages of preovulatory follicle 
development and ovulation in most animals (McLeod et al., 1982b, McLeod et al., 
1982a, McLeod et al., 1983); however, a defective CL is formed in the vast majority 
(60-80%) of animals. Progesterone priming prior to GnRH treatment results in 
normal luteal function (Southee et al., 1988b, Haresign et al., 1996, Hunter et al., 
1988, Husein and Kriddli, 2003).  Consequently, seasonally anoestrous ewes treated 
with pulsatile injections of GnRH, with and without progesterone priming, provides a 
useful and controlled in vivo model in which to study defective luteal function. 
 The defective CL that originates after GnRH-induced ovulation in the 
absence of progesterone priming is basically characterized by low progesterone 
production and early regression (Southee et al., 1988b). Although capable of 
producing normal levels of progesterone over the first 4 or 5 days after ovulation, 
progesterone returns to basal levels by day 6 after ovulation (Hunter et al., 1988). 
Morphological differences between functional and defective CL become evident 5 
days after ovulation when defective CL start showing signs of early regression 
(Hunter et al., 1989). 
 The exact mechanisms by which progesterone priming prior to GnRH 
treatment guarantees normal luteal function are still unclear. It has been suggested 




luteinisation of the granulosa cells which will compose the steroidogenic 
parenchyma of the developing CL (Murdoch and Van Kirk, 1998) resulting in low 
progesterone output. Another concept is that inadequate development of the follicular 
microvasculature leads to the formation of a luteal vascular network unable to 
support the demands of the developing CL (Southee et al., 1988a). 
 Normal follicle development and ovulation in cyclic animals directly depends 
upon adequate vascularisation (Shimizu et al., 2007). The thecal vascular network is 
the main source of nutrients, gonadotrophins and steroid precursors to the developing 
follicle (Mattioli et al., 2001, Kaczmareck et al., 2005). Around the time of the LH 
surge, the theca capillaries invade and sprout into the granulosa layer to form  a 
dense vascular network (Shimizu et al., 2007). After the LH surge the theca and 
granulosa layer undergo dramatic changes (luteinisation) to form the secretory 
parenchyma of the CL (Schams and Berisha, 2004, Berisha and Schams, 2005). 
 In order to meet the demands of the rapid changes taking place in the early 
CL a well established vascular supply is essential (Robinson et al., 2007). The high 
proliferation of endothelial cells in the early luteal phase is responsible for the 
increased vascularity of mature CL. Besides, the presence of a dense vascular 
network is essential for optimal delivery of nutrients and progesterone precursors to 
the developing CL (Schams and Berisha, 2004, Al-zi'abi et al., 2003). Therefore, an 
adequate vascular supply seems to be closely associated with progesterone 
production and normal luteal function. 
 Many factors have been considered as positive regulators of angiogenesis, 
including the VEGF, the Angiopoietins and their receptors (Bramley et al., 2005, 
Ferrara et al., 2003b, Kaczmareck et al., 2005). The main roles of VEGF in 
angiogenesis consist of stimulating endothelial cell proliferation and migration as 
well as maintaining immature blood vessel viability for either neovascularisation or 
regression (Benjamin et al., 1998). VEGFR-2 is the key signalling receptor for 
VEGF (Ferrara, 2001) and is indispensible for angiogenesis to take place (Gille et al., 
2001).  
Unlike VEGF, the Angiopoietins are mainly related to blood vessel 
stabilization. Ang-1 regulates vascular maturation after the initial stages of blood 




loosening their supporting cell matrix (Tamanini and De Ambrogi, 2004). Both 
Angiopoietins bind with the same affinity to TIE-2 receptor (Suri et al., 1996), 
however, Ang-2 is unable to cause TIE-2 phosphorylation thus antagonizing Ang-1 
activity mainly by competing for the same receptor (Maisonpierre et al., 1997). 
 Although individual angiogenic factors are important, angiogenesis depends 
on the interaction between these factors (Tamanini and De Ambrogi, 2004). When 
both the Ang-2:Ang-1 ratio and VEGF levels are high angiogenesis results in the 
formation of new blood vessels, however, when Ang-2:Ang-1 ratio is high and 
VEGF levels are low vascular regression can be seen. Furthermore, low Ang-2:Ang-
1 ratio usually results in the stabilization of blood vessels (Hayashi et al., 2003). 
 Follicular and luteal growth are directly dependent on blood vessel formation 
and proliferation (Ferrara et al., 2003a) and therefore dependent on VEGF (Ferrara, 
2001, Dickson et al., 2001, Hunter et al., 2004, Wulff et al., 2001b) and the 
Angiopoietin system (Tait and Jones, 2004, Maisonpierre et al., 1997). 
 As progesterone priming prior to GnRH treatment overcomes defective luteal 
functionality in seasonally anoestrous ewes, and as normal luteal function seems to 
be closely related to ovarian vascularity, it led us to the hypothesis that progesterone 
priming might be involved in regulating angiogenic factor levels in the pre-ovulatory 
follicle and early CL.  This hypothesis was tested using the GnRH treated seasonally 
anoestrous ewe, with and without progesterone priming as an experimental model.  
Animals were slaughtered at various times before and after the expected time of 
ovulation to permit comparison of both ovarian follicles prior to ovulation and early 
developing CL after ovulation. 
 In this study it was observed that neither progesterone priming nor the LH 
surge had any significant overall influence over VEGF, VEGFR-2, Ang-1, Ang-2 or 
TIE-2 protein or mRNA levels in small follicles. However, VEGF levels were found 
to be significantly lower in both treatment groups after the LH surge. These low 
levels of VEGF, associated with unaltered Angiopoietin levels, suggest that vascular 
development in these follicles had either stopped or started to regress. Degradation of 
the vascular network would result in decreased nutrients reaching the follicle leading 
to atresia (Tamanini and De Ambrogi, 2004). All small follicles analysed in this 




limited number of  receptors for LH in the granulosa layer (Hunter et al., 2004). 
Therefore, after the LH surge, these follicles were expected to either be dormant, if 
they were not part of the cohort of follicles selected for development, or undergoing 
atresia if they were (Driancourt, 2001). 
 The large potential pre-ovulatory follicles, on the other hand, showed a very 
different response to progesterone priming and LH surge. Non-primed animals 
showed significantly lower levels of VEGF than progesterone primed ones. 
Furthermore, non-primed animals showed significantly lower levels of VEGFR-2, 
Ang-1 and Ang-2 protein after the LH surge but no difference in TIE-2 levels. At a 
time when angiogenesis is expected to be high and theca blood vessels are invading 
and sprouting into the granulosa layer (Ferrara et al., 1992), low VEGF and VEGFR-
2 associated to low Ang-2 levels could lead to poor sprouting of the theca capillaries 
and deficient neovascularisation of the CL that forms from these pre-ovulatory 
follicles.  
As the formation of new blood vessels during luteal development originates 
from the existing vascular network of the follicle (Kaczmareck et al., 2005, Berisha 
and Schams, 2005, Zheng et al., 1993), low levels of angiogenic factors after the LH 
surge not only interfere with follicular irrigation but may also compromise luteal 
vascularity and consequently luteal function. Furthermore, Ang-1 and Ang-2 after 
the LH surge are known to influence luteinisation of the follicular layers (Hayashi et 
al., 2003). The lower levels of both Angiopoietins observed in non-primed animals 
after the LH surge would therefore likely interfere with the luteinisation process and 
progesterone production, further aggravating the defective luteal function (Murdoch 
and Van Kirk, 1998). 
The effects of progesterone priming prior to GnRH treatment were also 
analysed in CL at 1, 2 and 4 days after ovulation, before morphological differences 
between defective and functional CLs became apparent (Hunter et al., 1988, Southee 
et al., 1988b).  
Although no significant difference was observed in VEGF levels between 
treatment groups on day 1 and 4, non-primed animals showed significantly lower 
levels of VEGF than primed animals on day 2 after ovulation. Furthermore, non-




ovulation. Non-primed animals also expressed significantly lower levels of Ang-1 on 
day 4 after ovulation than primed animals. Progesterone priming, however, had no 
significant effect on Ang-2 levels during early luteal development.   
The lower VEGF and VEGFR-2 observed in non-primed animals on day 2 
after ovulation may result in limited angiogenesis and/or neovascularisation taking 
place in the developing CL. Considering that these new blood vessels are being 
formed from sprouting of the pre-existent luteal vasculature and that this initial luteal 
vascular network seems to be much more limited in non-primed animals due to the 
events that took place during follicular development after the LH surge, it is 
reasonable to believe that these lower levels of VEGF and VEGFR-2 during early 
luteal development may have a serious impact in restricting the luteal vascular 
network being formed. Although sufficient to support the CL during its early stages 
of development, this limited vascular supply may not be enough to support the 
demands of the growing CL and this may be the reason that at 5 days after ovulation 
morphological differences start to appear in the CL between non-primed (defective 
CL) and primed animals  (functional CL). 
Von Willebrand Factor data has shown that progesterone primed animals 
have greater vascular area than non-primed ones during early luteal development. 
Although this difference failed to reach the 5% statistical significance (P=0.062) its 
biological significance cannot be overlooked. This poorer vascular coverage 
observed in defective CL when compared to functional CL may not only interfere 
with early luteal development but may also prove to be a poorer template for any 
further vascularisation taking place during the luteal phase and may thus account for 
the reduced vascular surface observed in defective CL later in luteal development 
(Bramley et al., 2005). It is important to consider that approximately ¼ of the CL 
from non-primed animals may show normal luteal function (McLeod et al., 1982b, 
Haresign et al., 1996, Southee et al., 1988b) which is likely to have contributed to the 
lack of statistical difference in the luteal vascular area between primed and non-
primed animals observed in this study. 
The lower Ang-1 levels observed in non-primed animals on day 4 after 
ovulation suggest a lack of maturation and/or destabilisation of the blood vessels 




receptors being available for binding with the already limited amount of Ang-1 
present.  Moreover, a higher Ang2:Ang1 ratio at this time may cause the 
destabilisation of the existing newly formed blood vessels.  In addition, the relatively 
low levels of VEGF and VEGFR-2 observed on day 4 after ovulation in non-primed 
animals may also aggravate the process of degeneration of the newly formed 
vasculature whereas in progesterone-primed animals a lower Ang2:Ang1 ratio along 
with comparatively higher levels of VEGF and VEGFR-2 ensures further 





 It is concluded that the lack of progesterone priming had no influence on 
VEGF, VEGFR-2, Ang-1, Ang-2 and TIE-2 protein or mRNA expression levels in 
small follicles of seasonally anoestrous ewes treated with GnRH.  However, the lack 
of progesterone priming resulted in lower levels of VEGF, VEGFR-2, Ang-1 and 
Ang-2 protein after the LH surge in large pre-ovulatory follicles. No change was 
observed in Ang-1 nor Ang-2 mRNA or in TIE-2 protein or mRNA expression levels 
in large follicles. 
In the early CL lack of progesterone priming compromises the production of 
all angiogenic factors, with the exception of Ang-2 resulting in reduced vascular 
area. Furthermore, progesterone priming seems to influence the translation and post-
translation processes in VEGFR-2 and Ang-1 production by early CL. 
The limited sprouting and blood vessel formation and the compromised 
luteinisation taking place in large pre-ovulatory follicles after the LH surge, 
associated with low neovascularisation by day 2 and vascular instability and 
regression by day 4 after ovulation, could possibly explain the defective luteal 
function observed in non-primed seasonally anoestrous ewes treated with GnRH. 
Although angiogenesis plays a major role in luteal functionality, defective 
luteal function is most likely caused by an association of events taking place in late 
follicular and early luteal development, with defective production of angiogenic 
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